id	sid	tid	token	lemma	pos
dpc-2075	1	1	dermatology	dermatology	NOUN
dpc-2075	1	2	:	:	PUNCT
dpc-2075	1	3	practical	practical	ADJ
dpc-2075	1	4	and	and	CCONJ
dpc-2075	1	5	conceptual	conceptual	ADJ
dpc-2075	1	6	cutaneous	cutaneous	ADJ
dpc-2075	1	7	squamous	squamous	ADJ
dpc-2075	1	8	cell	cell	NOUN
dpc-2075	1	9	carcinoma	carcinoma	NOUN
dpc-2075	1	10	:	:	PUNCT
dpc-2075	1	11	an	an	DET
dpc-2075	1	12	update	update	NOUN
dpc-2075	1	13	on	on	ADP
dpc-2075	1	14	diagnosis	diagnosis	NOUN
dpc-2075	1	15	and	and	CCONJ
dpc-2075	1	16	treatment	treatment	NOUN
dpc-2075	1	17	table	table	NOUN
dpc-2075	1	18	of	of	ADP
dpc-2075	1	19	contents	content	NOUN
dpc-2075	1	20	risk	risk	NOUN
dpc-2075	1	21	factors	factor	NOUN
dpc-2075	1	22	and	and	CCONJ
dpc-2075	1	23	diagnosis	diagnosis	NOUN
dpc-2075	1	24	of	of	ADP
dpc-2075	1	25	advanced	advanced	ADJ
dpc-2075	1	26	cutaneous	cutaneous	ADJ
dpc-2075	1	27	squamous	squamous	ADJ
dpc-2075	1	28	cell	cell	NOUN
dpc-2075	1	29	carcinoma	carcinoma	NOUN
dpc-2075	1	30	gabriella	gabriella	PROPN
dpc-2075	1	31	brancaccio	brancaccio	PROPN
dpc-2075	1	32	,	,	PUNCT
dpc-2075	1	33	giulia	giulia	PROPN
dpc-2075	1	34	briatico	briatico	PROPN
dpc-2075	1	35	,	,	PUNCT
dpc-2075	1	36	cristina	cristina	PROPN
dpc-2075	1	37	pellegrini	pellegrini	PROPN
dpc-2075	1	38	,	,	PUNCT
dpc-2075	1	39	tea	tea	NOUN
dpc-2075	1	40	rocco	rocco	NOUN
dpc-2075	1	41	,	,	PUNCT
dpc-2075	1	42	elvira	elvira	PROPN
dpc-2075	1	43	moscarella	moscarella	PROPN
dpc-2075	1	44	,	,	PUNCT
dpc-2075	1	45	maria	maria	PROPN
dpc-2075	1	46	concetta	concetta	PROPN
dpc-2075	1	47	fargnoli	fargnoli	VERB
dpc-2075	1	48	surgery	surgery	NOUN
dpc-2075	1	49	for	for	ADP
dpc-2075	1	50	cutaneous	cutaneous	ADJ
dpc-2075	1	51	squamous	squamous	ADJ
dpc-2075	1	52	cell	cell	NOUN
dpc-2075	1	53	carcinoma	carcinoma	NOUN
dpc-2075	1	54	and	and	CCONJ
dpc-2075	1	55	its	its	PRON
dpc-2075	1	56	limits	limit	NOUN
dpc-2075	1	57	in	in	ADP
dpc-2075	1	58	advanced	advanced	ADJ
dpc-2075	1	59	disease	disease	NOUN
dpc-2075	1	60	david	david	PROPN
dpc-2075	1	61	moreno	moreno	PROPN
dpc-2075	1	62	-	-	PUNCT
dpc-2075	1	63	ramírez	ramírez	PROPN
dpc-2075	1	64	,	,	PUNCT
dpc-2075	1	65	francisca	francisca	PROPN
dpc-2075	1	66	silva	silva	PROPN
dpc-2075	1	67	-	-	PUNCT
dpc-2075	1	68	clavería	clavería	PROPN
dpc-2075	1	69	,	,	PUNCT
dpc-2075	1	70	almudena	almudena	PROPN
dpc-2075	1	71	fernández	fernández	PROPN
dpc-2075	1	72	-	-	PUNCT
dpc-2075	1	73	orland	orland	PROPN
dpc-2075	1	74	,	,	PUNCT
dpc-2075	1	75	noemí	noemí	PROPN
dpc-2075	1	76	eiris	eiris	PROPN
dpc-2075	1	77	,	,	PUNCT
dpc-2075	1	78	andrés	andrés	PROPN
dpc-2075	1	79	ruiz	ruiz	PROPN
dpc-2075	1	80	de	de	PROPN
dpc-2075	1	81	casas	casas	PROPN
dpc-2075	1	82	,	,	PUNCT
dpc-2075	1	83	lara	lara	PROPN
dpc-2075	1	84	ferrándiz	ferrándiz	PROPN
dpc-2075	1	85	radiotherapy	radiotherapy	PROPN
dpc-2075	1	86	in	in	ADP
dpc-2075	1	87	the	the	DET
dpc-2075	1	88	adjuvant	adjuvant	NOUN
dpc-2075	1	89	and	and	CCONJ
dpc-2075	1	90	advanced	advanced	ADJ
dpc-2075	1	91	setting	setting	NOUN
dpc-2075	1	92	of	of	ADP
dpc-2075	1	93	cscc	cscc	ADJ
dpc-2075	1	94	paolo	paolo	PROPN
dpc-2075	1	95	muto	muto	PROPN
dpc-2075	1	96	and	and	CCONJ
dpc-2075	1	97	francesco	francesco	PROPN
dpc-2075	1	98	pastore	pastore	PROPN
dpc-2075	1	99	immunotherapy	immunotherapy	NOUN
dpc-2075	1	100	and	and	CCONJ
dpc-2075	1	101	systemic	systemic	ADJ
dpc-2075	1	102	treatment	treatment	NOUN
dpc-2075	1	103	of	of	ADP
dpc-2075	1	104	cutaneous	cutaneous	ADJ
dpc-2075	1	105	squamous	squamous	ADJ
dpc-2075	1	106	cell	cell	NOUN
dpc-2075	1	107	carcinoma	carcinoma	NOUN
dpc-2075	1	108	nader	nader	VERB
dpc-2075	1	109	aboul	aboul	NOUN
dpc-2075	1	110	-	-	PUNCT
dpc-2075	1	111	fettouh	fettouh	PROPN
dpc-2075	1	112	,	,	PUNCT
dpc-2075	1	113	daniel	daniel	PROPN
dpc-2075	1	114	morse	morse	PROPN
dpc-2075	1	115	,	,	PUNCT
dpc-2075	1	116	jigar	jigar	PROPN
dpc-2075	1	117	patel	patel	PROPN
dpc-2075	1	118	,	,	PUNCT
dpc-2075	1	119	michael	michael	PROPN
dpc-2075	1	120	r.	r.	PROPN
dpc-2075	1	121	migden	migden	PROPN
dpc-2075	1	122	treatment	treatment	NOUN
dpc-2075	1	123	of	of	ADP
dpc-2075	1	124	cutaneous	cutaneous	ADJ
dpc-2075	1	125	squamous	squamous	ADJ
dpc-2075	1	126	cell	cell	NOUN
dpc-2075	1	127	carcinoma	carcinoma	NOUN
dpc-2075	1	128	with	with	ADP
dpc-2075	1	129	immune	immune	ADJ
dpc-2075	1	130	checkpoint	checkpoint	NOUN
dpc-2075	1	131	inhibitors	inhibitor	NOUN
dpc-2075	1	132	in	in	ADP
dpc-2075	1	133	special	special	ADJ
dpc-2075	1	134	populations	population	NOUN
dpc-2075	1	135	paolo	paolo	PROPN
dpc-2075	1	136	bossi	bossi	PROPN
dpc-2075	1	137	,	,	PUNCT
dpc-2075	1	138	luigi	luigi	PROPN
dpc-2075	1	139	lorini	lorini	PROPN
dpc-2075	1	140	mattioli	mattioli	PROPN
dpc-2075	1	141	1885	1885	NUM
dpc-2075	1	142	www.mattioli1885.com	www.mattioli1885.com	NOUN
dpc-2075	1	143	chief	chief	ADJ
dpc-2075	1	144	editor	editor	NOUN
dpc-2075	1	145	prof	prof	NOUN
dpc-2075	1	146	.	.	PUNCT
dpc-2075	2	1	giuseppe	giuseppe	PROPN
dpc-2075	2	2	argenziano	argenziano	PROPN
dpc-2075	2	3	,	,	PUNCT
dpc-2075	2	4	md	md	PROPN
dpc-2075	2	5	dermatology	dermatology	NOUN
dpc-2075	2	6	unit	unit	NOUN
dpc-2075	2	7	,	,	PUNCT
dpc-2075	2	8	university	university	PROPN
dpc-2075	2	9	of	of	ADP
dpc-2075	2	10	campania	campania	PROPN
dpc-2075	2	11	luigi	luigi	PROPN
dpc-2075	2	12	vanvitelli	vanvitelli	PROPN
dpc-2075	2	13	,	,	PUNCT
dpc-2075	2	14	naples	naples	PROPN
dpc-2075	2	15	,	,	PUNCT
dpc-2075	2	16	italy	italy	PROPN
dpc-2075	2	17	guest	guest	PROPN
dpc-2075	2	18	editors	editors	PROPN
dpc-2075	2	19	prof	prof	PROPN
dpc-2075	2	20	.	.	PUNCT
dpc-2075	3	1	luc	luc	PROPN
dpc-2075	3	2	thomas	thomas	PROPN
dpc-2075	3	3	,	,	PUNCT
dpc-2075	3	4	md	md	PROPN
dpc-2075	3	5	,	,	PUNCT
dpc-2075	3	6	phd	phd	NOUN
dpc-2075	3	7	full	full	ADJ
dpc-2075	3	8	professor	professor	NOUN
dpc-2075	3	9	and	and	CCONJ
dpc-2075	3	10	vice	vice	NOUN
dpc-2075	3	11	-	-	NOUN
dpc-2075	3	12	chair	chair	NOUN
dpc-2075	3	13	,	,	PUNCT
dpc-2075	3	14	department	department	NOUN
dpc-2075	3	15	of	of	ADP
dpc-2075	3	16	dermatology	dermatology	NOUN
dpc-2075	3	17	,	,	PUNCT
dpc-2075	3	18	lyon	lyon	PROPN
dpc-2075	3	19	cancer	cancer	PROPN
dpc-2075	3	20	research	research	PROPN
dpc-2075	3	21	center	center	PROPN
dpc-2075	3	22	,	,	PUNCT
dpc-2075	3	23	lyon	lyon	PROPN
dpc-2075	3	24	1	1	NUM
dpc-2075	3	25	university	university	NOUN
dpc-2075	3	26	,	,	PUNCT
dpc-2075	3	27	centre	centre	PROPN
dpc-2075	3	28	hospitalier	hospitalier	PROPN
dpc-2075	3	29	lyon	lyon	PROPN
dpc-2075	3	30	sud	sud	PROPN
dpc-2075	3	31	,	,	PUNCT
dpc-2075	3	32	france	france	PROPN
dpc-2075	3	33	.	.	PUNCT
dpc-2075	4	1	prof	prof	PROPN
dpc-2075	4	2	.	.	PUNCT
dpc-2075	5	1	ketty	ketty	PROPN
dpc-2075	5	2	peris	peris	PROPN
dpc-2075	5	3	,	,	PUNCT
dpc-2075	5	4	md	md	PROPN
dpc-2075	5	5	full	full	ADJ
dpc-2075	5	6	professor	professor	NOUN
dpc-2075	5	7	of	of	ADP
dpc-2075	5	8	dermatology	dermatology	NOUN
dpc-2075	5	9	,	,	PUNCT
dpc-2075	5	10	chief	chief	NOUN
dpc-2075	5	11	of	of	ADP
dpc-2075	5	12	the	the	DET
dpc-2075	5	13	complex	complex	ADJ
dpc-2075	5	14	operative	operative	ADJ
dpc-2075	5	15	unit	unit	NOUN
dpc-2075	5	16	of	of	ADP
dpc-2075	5	17	dermatology	dermatology	NOUN
dpc-2075	5	18	director	director	NOUN
dpc-2075	5	19	of	of	ADP
dpc-2075	5	20	the	the	DET
dpc-2075	5	21	dermatology	dermatology	NOUN
dpc-2075	5	22	and	and	CCONJ
dpc-2075	5	23	venereology	venereology	NOUN
dpc-2075	5	24	postgraduate	postgraduate	PROPN
dpc-2075	5	25	school	school	PROPN
dpc-2075	5	26	catholic	catholic	PROPN
dpc-2075	5	27	university	university	PROPN
dpc-2075	5	28	of	of	ADP
dpc-2075	5	29	rome	rome	PROPN
dpc-2075	5	30	fondazione	fondazione	PROPN
dpc-2075	5	31	policlinico	policlinico	PROPN
dpc-2075	5	32	universitario	universitario	PROPN
dpc-2075	5	33	agostino	agostino	PROPN
dpc-2075	5	34	gemelli	gemelli	PROPN
dpc-2075	5	35	irccs	irccs	PROPN
dpc-2075	5	36	rome	rome	PROPN
dpc-2075	5	37	,	,	PUNCT
dpc-2075	5	38	italy	italy	PROPN
dpc-2075	5	39	.	.	PUNCT
dpc-2075	6	1	dermatology	dermatology	PROPN
dpc-2075	6	2	practical	practical	ADJ
dpc-2075	6	3	&	&	CCONJ
dpc-2075	6	4	conceptual	conceptual	ADJ
dpc-2075	6	5	review	review	NOUN
dpc-2075	6	6	|	|	ADV
dpc-2075	6	7	dermatol	dermatol	ADJ
dpc-2075	6	8	pract	pract	NOUN
dpc-2075	6	9	concept	concept	NOUN
dpc-2075	6	10	.	.	PUNCT
dpc-2075	7	1	2021	2021	NUM
dpc-2075	7	2	;	;	PUNCT
dpc-2075	7	3	11(s2	11(s2	NUM
dpc-2075	7	4	):	):	PUNCT
dpc-2075	7	5	e2021168s	e2021168s	PROPN
dpc-2075	7	6	1	1	NUM
dpc-2075	7	7	radiotherapy	radiotherapy	NOUN
dpc-2075	7	8	in	in	ADP
dpc-2075	7	9	the	the	DET
dpc-2075	7	10	adjuvant	adjuvant	NOUN
dpc-2075	7	11	and	and	CCONJ
dpc-2075	7	12	advanced	advanced	ADJ
dpc-2075	7	13	setting	setting	NOUN
dpc-2075	7	14	of	of	ADP
dpc-2075	7	15	cscc	cscc	ADJ
dpc-2075	7	16	paolo	paolo	PROPN
dpc-2075	7	17	muto1	muto1	PROPN
dpc-2075	7	18	,	,	PUNCT
dpc-2075	7	19	francesco	francesco	PROPN
dpc-2075	7	20	pastore2	pastore2	PROPN
dpc-2075	7	21	1	1	NUM
dpc-2075	7	22	radiation	radiation	NOUN
dpc-2075	7	23	oncology	oncology	NOUN
dpc-2075	7	24	unit	unit	NOUN
dpc-2075	7	25	,	,	PUNCT
dpc-2075	7	26	istituto	istituto	PROPN
dpc-2075	7	27	nazionale	nazionale	PROPN
dpc-2075	7	28	tumori	tumori	PROPN
dpc-2075	7	29	irccs	ircc	VERB
dpc-2075	7	30	fondazione	fondazione	NOUN
dpc-2075	7	31	g.	g.	PROPN
dpc-2075	7	32	pascale	pascale	PROPN
dpc-2075	7	33	–	–	PUNCT
dpc-2075	7	34	naples	naples	PROPN
dpc-2075	7	35	,	,	PUNCT
dpc-2075	7	36	italy	italy	PROPN
dpc-2075	7	37	2	2	NUM
dpc-2075	7	38	radiation	radiation	NOUN
dpc-2075	7	39	oncology	oncology	NOUN
dpc-2075	7	40	,	,	PUNCT
dpc-2075	7	41	fondazione	fondazione	PROPN
dpc-2075	7	42	muto	muto	PROPN
dpc-2075	7	43	onlus	onlus	PROPN
dpc-2075	7	44	emicenter	emicenter	PROPN
dpc-2075	7	45	–	–	PUNCT
dpc-2075	7	46	naples	naples	PROPN
dpc-2075	7	47	,	,	PUNCT
dpc-2075	7	48	italy	italy	PROPN
dpc-2075	7	49	key	key	PROPN
dpc-2075	7	50	words	word	NOUN
dpc-2075	7	51	:	:	PUNCT
dpc-2075	7	52	radiotherapy	radiotherapy	NOUN
dpc-2075	7	53	,	,	PUNCT
dpc-2075	7	54	squamous	squamous	ADJ
dpc-2075	7	55	cell	cell	NOUN
dpc-2075	7	56	carcinoma	carcinoma	NOUN
dpc-2075	7	57	,	,	PUNCT
dpc-2075	7	58	brachytherapy	brachytherapy	NOUN
dpc-2075	7	59	.	.	PUNCT
dpc-2075	8	1	citation	citation	NOUN
dpc-2075	8	2	:	:	PUNCT
dpc-2075	9	1	muto	muto	PROPN
dpc-2075	9	2	p	p	PROPN
dpc-2075	9	3	,	,	PUNCT
dpc-2075	9	4	pastore	pastore	PROPN
dpc-2075	9	5	f.	f.	PROPN
dpc-2075	9	6	radiotherapy	radiotherapy	PROPN
dpc-2075	9	7	in	in	ADP
dpc-2075	9	8	the	the	DET
dpc-2075	9	9	adjuvant	adjuvant	NOUN
dpc-2075	9	10	and	and	CCONJ
dpc-2075	9	11	advanced	advanced	ADJ
dpc-2075	9	12	settings	setting	NOUN
dpc-2075	9	13	of	of	ADP
dpc-2075	9	14	cscc	cscc	ADJ
dpc-2075	9	15	.	.	PUNCT
dpc-2075	10	1	dermatol	dermatol	NOUN
dpc-2075	10	2	pract	pract	PROPN
dpc-2075	10	3	concept	concept	NOUN
dpc-2075	10	4	.	.	PUNCT
dpc-2075	11	1	2021	2021	NUM
dpc-2075	11	2	;	;	PUNCT
dpc-2075	11	3	11(s2	11(s2	NUM
dpc-2075	11	4	):	):	PUNCT
dpc-2075	11	5	e2021168s	e2021168s	PROPN
dpc-2075	11	6	.	.	PROPN
dpc-2075	11	7	doi	doi	PROPN
dpc-2075	11	8	:	:	PUNCT
dpc-2075	11	9	https://doi.org/10.5826/dpc.11s2a168s	https://doi.org/10.5826/dpc.11s2a168s	NOUN
dpc-2075	11	10	accepted	accept	VERB
dpc-2075	11	11	:	:	PUNCT
dpc-2075	11	12	september	september	PROPN
dpc-2075	11	13	22	22	NUM
dpc-2075	11	14	,	,	PUNCT
dpc-2075	11	15	2021	2021	NUM
dpc-2075	11	16	;	;	PUNCT
dpc-2075	11	17	published	publish	VERB
dpc-2075	11	18	:	:	PUNCT
dpc-2075	11	19	october	october	PROPN
dpc-2075	11	20	,	,	PUNCT
dpc-2075	11	21	2021	2021	NUM
dpc-2075	11	22	copyright	copyright	NOUN
dpc-2075	11	23	:	:	PUNCT
dpc-2075	11	24	©	©	PROPN
dpc-2075	11	25	2021	2021	NUM
dpc-2075	11	26	muto	muto	PROPN
dpc-2075	11	27	and	and	CCONJ
dpc-2075	11	28	pastore	pastore	NOUN
dpc-2075	11	29	.	.	PUNCT
dpc-2075	12	1	this	this	PRON
dpc-2075	12	2	is	be	AUX
dpc-2075	12	3	an	an	DET
dpc-2075	12	4	open	open	ADJ
dpc-2075	12	5	-	-	PUNCT
dpc-2075	12	6	access	access	NOUN
dpc-2075	12	7	article	article	NOUN
dpc-2075	12	8	distributed	distribute	VERB
dpc-2075	12	9	under	under	ADP
dpc-2075	12	10	the	the	DET
dpc-2075	12	11	terms	term	NOUN
dpc-2075	12	12	of	of	ADP
dpc-2075	12	13	the	the	DET
dpc-2075	12	14	creative	creative	ADJ
dpc-2075	12	15	commons	common	NOUN
dpc-2075	12	16	attribution	attribution	NOUN
dpc-2075	12	17	license	license	NOUN
dpc-2075	12	18	by	by	ADP
dpc-2075	12	19	-	-	PUNCT
dpc-2075	12	20	nc-4.0	nc-4.0	NOUN
dpc-2075	12	21	,	,	PUNCT
dpc-2075	12	22	which	which	PRON
dpc-2075	12	23	permits	permit	VERB
dpc-2075	12	24	unrestricted	unrestricted	ADJ
dpc-2075	12	25	noncommercial	noncommercial	ADJ
dpc-2075	12	26	use	use	NOUN
dpc-2075	12	27	,	,	PUNCT
dpc-2075	12	28	distribution	distribution	NOUN
dpc-2075	12	29	,	,	PUNCT
dpc-2075	12	30	and	and	CCONJ
dpc-2075	12	31	reproduction	reproduction	NOUN
dpc-2075	12	32	in	in	ADP
dpc-2075	12	33	any	any	DET
dpc-2075	12	34	medium	medium	NOUN
dpc-2075	12	35	,	,	PUNCT
dpc-2075	12	36	provided	provide	VERB
dpc-2075	12	37	the	the	DET
dpc-2075	12	38	original	original	ADJ
dpc-2075	12	39	authors	author	NOUN
dpc-2075	12	40	and	and	CCONJ
dpc-2075	12	41	source	source	NOUN
dpc-2075	12	42	are	be	AUX
dpc-2075	12	43	credited	credit	VERB
dpc-2075	12	44	.	.	PUNCT
dpc-2075	13	1	funding	funding	NOUN
dpc-2075	13	2	:	:	PUNCT
dpc-2075	13	3	none	none	NOUN
dpc-2075	13	4	.	.	PUNCT
dpc-2075	14	1	competing	compete	VERB
dpc-2075	14	2	interests	interest	NOUN
dpc-2075	14	3	:	:	PUNCT
dpc-2075	14	4	the	the	DET
dpc-2075	14	5	authors	author	NOUN
dpc-2075	14	6	have	have	VERB
dpc-2075	14	7	no	no	DET
dpc-2075	14	8	conflicts	conflict	NOUN
dpc-2075	14	9	of	of	ADP
dpc-2075	14	10	interest	interest	NOUN
dpc-2075	14	11	to	to	PART
dpc-2075	14	12	disclose	disclose	VERB
dpc-2075	14	13	.	.	PUNCT
dpc-2075	15	1	authorship	authorship	NOUN
dpc-2075	15	2	:	:	PUNCT
dpc-2075	15	3	all	all	DET
dpc-2075	15	4	authors	author	NOUN
dpc-2075	15	5	have	have	AUX
dpc-2075	15	6	contributed	contribute	VERB
dpc-2075	15	7	significantly	significantly	ADV
dpc-2075	15	8	to	to	ADP
dpc-2075	15	9	this	this	DET
dpc-2075	15	10	publication	publication	NOUN
dpc-2075	15	11	.	.	PUNCT
dpc-2075	16	1	corresponding	correspond	VERB
dpc-2075	16	2	author	author	NOUN
dpc-2075	16	3	:	:	PUNCT
dpc-2075	16	4	francesco	francesco	PROPN
dpc-2075	16	5	pastore	pastore	PROPN
dpc-2075	16	6	,	,	PUNCT
dpc-2075	16	7	radiation	radiation	NOUN
dpc-2075	16	8	oncology	oncology	NOUN
dpc-2075	16	9	,	,	PUNCT
dpc-2075	16	10	fondazione	fondazione	PROPN
dpc-2075	16	11	muto	muto	PROPN
dpc-2075	16	12	onlus	onlus	PROPN
dpc-2075	16	13	emicenter	emicenter	PROPN
dpc-2075	16	14	–	–	PUNCT
dpc-2075	16	15	naples	naples	PROPN
dpc-2075	16	16	,	,	PUNCT
dpc-2075	16	17	italy	italy	PROPN
dpc-2075	16	18	.	.	PUNCT
dpc-2075	17	1	email	email	NOUN
dpc-2075	17	2	:	:	PUNCT
dpc-2075	18	1	fr.pastore@libero.it	fr.pastore@libero.it	NOUN
dpc-2075	18	2	this	this	DET
dpc-2075	18	3	article	article	NOUN
dpc-2075	18	4	is	be	AUX
dpc-2075	18	5	part	part	NOUN
dpc-2075	18	6	of	of	ADP
dpc-2075	18	7	the	the	DET
dpc-2075	18	8	dpc	dpc	PROPN
dpc-2075	18	9	journal	journal	PROPN
dpc-2075	18	10	special	special	ADJ
dpc-2075	18	11	issue	issue	NOUN
dpc-2075	18	12	cutaneous	cutaneous	ADJ
dpc-2075	18	13	squamous	squamous	ADJ
dpc-2075	18	14	cell	cell	NOUN
dpc-2075	18	15	carcinoma	carcinoma	NOUN
dpc-2075	18	16	:	:	PUNCT
dpc-2075	18	17	an	an	DET
dpc-2075	18	18	update	update	NOUN
dpc-2075	18	19	on	on	ADP
dpc-2075	18	20	diagnosis	diagnosis	NOUN
dpc-2075	18	21	and	and	CCONJ
dpc-2075	18	22	treatment	treatment	NOUN
dpc-2075	18	23	guest	guest	NOUN
dpc-2075	18	24	editors	editor	NOUN
dpc-2075	18	25	prof	prof	PROPN
dpc-2075	18	26	.	.	PUNCT
dpc-2075	19	1	luc	luc	PROPN
dpc-2075	19	2	thomas	thomas	PROPN
dpc-2075	19	3	,	,	PUNCT
dpc-2075	19	4	md	md	PROPN
dpc-2075	19	5	,	,	PUNCT
dpc-2075	19	6	phd	phd	NOUN
dpc-2075	19	7	full	full	ADJ
dpc-2075	19	8	professor	professor	NOUN
dpc-2075	19	9	and	and	CCONJ
dpc-2075	19	10	vice	vice	NOUN
dpc-2075	19	11	-	-	NOUN
dpc-2075	19	12	chair	chair	NOUN
dpc-2075	19	13	,	,	PUNCT
dpc-2075	19	14	department	department	NOUN
dpc-2075	19	15	of	of	ADP
dpc-2075	19	16	dermatology	dermatology	NOUN
dpc-2075	19	17	,	,	PUNCT
dpc-2075	19	18	lyon	lyon	PROPN
dpc-2075	19	19	cancer	cancer	PROPN
dpc-2075	19	20	research	research	PROPN
dpc-2075	19	21	center	center	PROPN
dpc-2075	19	22	,	,	PUNCT
dpc-2075	19	23	lyon	lyon	PROPN
dpc-2075	19	24	1	1	NUM
dpc-2075	19	25	university	university	NOUN
dpc-2075	19	26	,	,	PUNCT
dpc-2075	19	27	centre	centre	PROPN
dpc-2075	19	28	hospitalier	hospitalier	PROPN
dpc-2075	19	29	lyon	lyon	PROPN
dpc-2075	19	30	sud	sud	PROPN
dpc-2075	19	31	,	,	PUNCT
dpc-2075	19	32	france	france	PROPN
dpc-2075	19	33	.	.	PUNCT
dpc-2075	20	1	prof	prof	PROPN
dpc-2075	20	2	.	.	PUNCT
dpc-2075	21	1	ketty	ketty	PROPN
dpc-2075	21	2	peris	peris	PROPN
dpc-2075	21	3	,	,	PUNCT
dpc-2075	21	4	md	md	PROPN
dpc-2075	21	5	full	full	ADJ
dpc-2075	21	6	professor	professor	NOUN
dpc-2075	21	7	of	of	ADP
dpc-2075	21	8	dermatology	dermatology	NOUN
dpc-2075	21	9	,	,	PUNCT
dpc-2075	21	10	chief	chief	NOUN
dpc-2075	21	11	of	of	ADP
dpc-2075	21	12	the	the	DET
dpc-2075	21	13	complex	complex	ADJ
dpc-2075	21	14	operative	operative	ADJ
dpc-2075	21	15	unit	unit	NOUN
dpc-2075	21	16	of	of	ADP
dpc-2075	21	17	dermatology	dermatology	NOUN
dpc-2075	21	18	director	director	NOUN
dpc-2075	21	19	of	of	ADP
dpc-2075	21	20	the	the	DET
dpc-2075	21	21	dermatology	dermatology	NOUN
dpc-2075	21	22	and	and	CCONJ
dpc-2075	21	23	venereology	venereology	NOUN
dpc-2075	21	24	postgraduate	postgraduate	PROPN
dpc-2075	21	25	school	school	PROPN
dpc-2075	21	26	catholic	catholic	PROPN
dpc-2075	21	27	university	university	PROPN
dpc-2075	21	28	of	of	ADP
dpc-2075	21	29	rome	rome	PROPN
dpc-2075	21	30	fondazione	fondazione	PROPN
dpc-2075	21	31	policlinico	policlinico	PROPN
dpc-2075	21	32	universitario	universitario	PROPN
dpc-2075	21	33	agostino	agostino	PROPN
dpc-2075	21	34	gemelli	gemelli	PROPN
dpc-2075	21	35	irccs	irccs	PROPN
dpc-2075	21	36	rome	rome	PROPN
dpc-2075	21	37	,	,	PUNCT
dpc-2075	21	38	italy	italy	PROPN
dpc-2075	21	39	.	.	PUNCT
dpc-2075	22	1	introduction	introduction	NOUN
dpc-2075	22	2	:	:	PUNCT
dpc-2075	22	3	the	the	DET
dpc-2075	22	4	use	use	NOUN
dpc-2075	22	5	of	of	ADP
dpc-2075	22	6	radiotherapy	radiotherapy	NOUN
dpc-2075	22	7	for	for	ADP
dpc-2075	22	8	cutaneous	cutaneous	ADJ
dpc-2075	22	9	squamous	squamous	ADJ
dpc-2075	22	10	cell	cell	NOUN
dpc-2075	22	11	carcinoma	carcinoma	NOUN
dpc-2075	22	12	(	(	PUNCT
dpc-2075	22	13	cscc	cscc	ADJ
dpc-2075	22	14	)	)	PUNCT
dpc-2075	22	15	has	have	VERB
dpc-2075	22	16	solid	solid	ADJ
dpc-2075	22	17	historical	historical	ADJ
dpc-2075	22	18	roots	root	NOUN
dpc-2075	22	19	.	.	PUNCT
dpc-2075	23	1	it	it	PRON
dpc-2075	23	2	is	be	AUX
dpc-2075	23	3	used	use	VERB
dpc-2075	23	4	with	with	ADP
dpc-2075	23	5	patients	patient	NOUN
dpc-2075	23	6	who	who	PRON
dpc-2075	23	7	are	be	AUX
dpc-2075	23	8	not	not	PART
dpc-2075	23	9	suitable	suitable	ADJ
dpc-2075	23	10	for	for	ADP
dpc-2075	23	11	surgery	surgery	NOUN
dpc-2075	23	12	,	,	PUNCT
dpc-2075	23	13	with	with	ADP
dpc-2075	23	14	patients	patient	NOUN
dpc-2075	23	15	with	with	ADP
dpc-2075	23	16	high	high	ADJ
dpc-2075	23	17	-	-	PUNCT
dpc-2075	23	18	risk	risk	NOUN
dpc-2075	23	19	histological	histological	ADJ
dpc-2075	23	20	features	feature	NOUN
dpc-2075	23	21	in	in	ADP
dpc-2075	23	22	the	the	DET
dpc-2075	23	23	adjuvant	adjuvant	ADJ
dpc-2075	23	24	setting	setting	NOUN
dpc-2075	23	25	,	,	PUNCT
dpc-2075	23	26	and	and	CCONJ
dpc-2075	23	27	in	in	ADP
dpc-2075	23	28	palliative	palliative	ADJ
dpc-2075	23	29	care	care	NOUN
dpc-2075	23	30	.	.	PUNCT
dpc-2075	24	1	objectives	objective	NOUN
dpc-2075	24	2	:	:	PUNCT
dpc-2075	24	3	the	the	DET
dpc-2075	24	4	aim	aim	NOUN
dpc-2075	24	5	of	of	ADP
dpc-2075	24	6	this	this	DET
dpc-2075	24	7	article	article	NOUN
dpc-2075	24	8	is	be	AUX
dpc-2075	24	9	to	to	PART
dpc-2075	24	10	summarize	summarize	VERB
dpc-2075	24	11	and	and	CCONJ
dpc-2075	24	12	provide	provide	VERB
dpc-2075	24	13	a	a	DET
dpc-2075	24	14	radiation	radiation	NOUN
dpc-2075	24	15	therapy	therapy	NOUN
dpc-2075	24	16	overview	overview	NOUN
dpc-2075	24	17	on	on	ADP
dpc-2075	24	18	the	the	DET
dpc-2075	24	19	indications	indication	NOUN
dpc-2075	24	20	,	,	PUNCT
dpc-2075	24	21	effectiveness	effectiveness	NOUN
dpc-2075	24	22	,	,	PUNCT
dpc-2075	24	23	and	and	CCONJ
dpc-2075	24	24	potential	potential	ADJ
dpc-2075	24	25	adverse	adverse	ADJ
dpc-2075	24	26	events	event	NOUN
dpc-2075	24	27	of	of	ADP
dpc-2075	24	28	radiotherapy	radiotherapy	NOUN
dpc-2075	24	29	in	in	ADP
dpc-2075	24	30	the	the	DET
dpc-2075	24	31	adjuvant	adjuvant	NOUN
dpc-2075	24	32	and	and	CCONJ
dpc-2075	24	33	advanced	advanced	ADJ
dpc-2075	24	34	setting	setting	NOUN
dpc-2075	24	35	of	of	ADP
dpc-2075	24	36	cscc	cscc	NOUN
dpc-2075	24	37	.	.	PUNCT
dpc-2075	25	1	methods	method	NOUN
dpc-2075	25	2	:	:	PUNCT
dpc-2075	25	3	we	we	PRON
dpc-2075	25	4	performed	perform	VERB
dpc-2075	25	5	a	a	DET
dpc-2075	25	6	comprehensive	comprehensive	ADJ
dpc-2075	25	7	literature	literature	NOUN
dpc-2075	25	8	review	review	NOUN
dpc-2075	25	9	on	on	ADP
dpc-2075	25	10	pubmed	pubmed	PROPN
dpc-2075	25	11	,	,	PUNCT
dpc-2075	25	12	adopted	adopt	VERB
dpc-2075	25	13	as	as	ADP
dpc-2075	25	14	our	our	PRON
dpc-2075	25	15	biomedical	biomedical	ADJ
dpc-2075	25	16	literature	literature	NOUN
dpc-2075	25	17	database	database	NOUN
dpc-2075	25	18	.	.	PUNCT
dpc-2075	26	1	articles	article	NOUN
dpc-2075	26	2	were	be	AUX
dpc-2075	26	3	selected	select	VERB
dpc-2075	26	4	based	base	VERB
dpc-2075	26	5	on	on	ADP
dpc-2075	26	6	their	their	PRON
dpc-2075	26	7	date	date	NOUN
dpc-2075	26	8	of	of	ADP
dpc-2075	26	9	publication	publication	NOUN
dpc-2075	26	10	(	(	PUNCT
dpc-2075	26	11	in	in	ADP
dpc-2075	26	12	the	the	DET
dpc-2075	26	13	last	last	ADJ
dpc-2075	26	14	30	30	NUM
dpc-2075	26	15	years	year	NOUN
dpc-2075	26	16	)	)	PUNCT
dpc-2075	26	17	and	and	CCONJ
dpc-2075	26	18	relevance	relevance	NOUN
dpc-2075	26	19	.	.	PUNCT
dpc-2075	27	1	abstract	abstract	ADJ
dpc-2075	27	2	2	2	NUM
dpc-2075	27	3	review	review	NOUN
dpc-2075	27	4	|	|	ADV
dpc-2075	27	5	dermatol	dermatol	ADJ
dpc-2075	27	6	pract	pract	NOUN
dpc-2075	27	7	concept	concept	NOUN
dpc-2075	27	8	.	.	PUNCT
dpc-2075	28	1	2021	2021	NUM
dpc-2075	28	2	;	;	PUNCT
dpc-2075	28	3	11(s2	11(s2	NUM
dpc-2075	28	4	):	):	PUNCT
dpc-2075	28	5	e2021168s	e2021168s	NOUN
dpc-2075	28	6	introduction	introduction	NOUN
dpc-2075	28	7	cutaneous	cutaneous	ADJ
dpc-2075	28	8	squamous	squamous	ADJ
dpc-2075	28	9	cell	cell	NOUN
dpc-2075	28	10	carcinoma	carcinoma	NOUN
dpc-2075	28	11	(	(	PUNCT
dpc-2075	28	12	cscc	cscc	ADJ
dpc-2075	28	13	)	)	PUNCT
dpc-2075	28	14	is	be	AUX
dpc-2075	28	15	the	the	DET
dpc-2075	28	16	second	second	ADJ
dpc-2075	28	17	most	most	ADV
dpc-2075	28	18	common	common	ADJ
dpc-2075	28	19	type	type	NOUN
dpc-2075	28	20	of	of	ADP
dpc-2075	28	21	non	non	ADJ
dpc-2075	28	22	-	-	ADJ
dpc-2075	28	23	melanoma	melanoma	ADJ
dpc-2075	28	24	skin	skin	NOUN
dpc-2075	28	25	cancer	cancer	NOUN
dpc-2075	28	26	(	(	PUNCT
dpc-2075	28	27	nmsc	nmsc	NOUN
dpc-2075	28	28	)	)	PUNCT
dpc-2075	28	29	after	after	ADP
dpc-2075	28	30	basal	basal	ADJ
dpc-2075	28	31	cell	cell	NOUN
dpc-2075	28	32	carcinoma	carcinoma	NOUN
dpc-2075	28	33	(	(	PUNCT
dpc-2075	28	34	cbcc	cbcc	ADJ
dpc-2075	28	35	)	)	PUNCT
dpc-2075	28	36	.	.	PUNCT
dpc-2075	29	1	it	it	PRON
dpc-2075	29	2	arises	arise	VERB
dpc-2075	29	3	most	most	ADV
dpc-2075	29	4	commonly	commonly	ADV
dpc-2075	29	5	in	in	ADP
dpc-2075	29	6	sun	sun	NOUN
dpc-2075	29	7	-	-	PUNCT
dpc-2075	29	8	exposed	expose	VERB
dpc-2075	29	9	areas	area	NOUN
dpc-2075	29	10	of	of	ADP
dpc-2075	29	11	the	the	DET
dpc-2075	29	12	body	body	NOUN
dpc-2075	29	13	and	and	CCONJ
dpc-2075	29	14	originates	originate	NOUN
dpc-2075	29	15	from	from	ADP
dpc-2075	29	16	keratinocytes	keratinocyte	NOUN
dpc-2075	29	17	in	in	ADP
dpc-2075	29	18	the	the	DET
dpc-2075	29	19	epidermis	epidermis	NOUN
dpc-2075	29	20	through	through	ADP
dpc-2075	29	21	a	a	DET
dpc-2075	29	22	carcinogenesis	carcinogenesis	NOUN
dpc-2075	29	23	process	process	NOUN
dpc-2075	29	24	[	[	X
dpc-2075	29	25	1	1	NUM
dpc-2075	29	26	]	]	PUNCT
dpc-2075	29	27	.	.	PUNCT
dpc-2075	30	1	as	as	SCONJ
dpc-2075	30	2	the	the	DET
dpc-2075	30	3	world	world	NOUN
dpc-2075	30	4	’s	’s	PART
dpc-2075	30	5	population	population	NOUN
dpc-2075	30	6	ages	age	NOUN
dpc-2075	30	7	,	,	PUNCT
dpc-2075	30	8	the	the	DET
dpc-2075	30	9	incidence	incidence	NOUN
dpc-2075	30	10	of	of	ADP
dpc-2075	30	11	both	both	DET
dpc-2075	30	12	types	type	NOUN
dpc-2075	30	13	of	of	ADP
dpc-2075	30	14	nmsc	nmsc	NOUN
dpc-2075	30	15	(	(	PUNCT
dpc-2075	30	16	scc	scc	NOUN
dpc-2075	30	17	and	and	CCONJ
dpc-2075	30	18	bcc	bcc	PROPN
dpc-2075	30	19	)	)	PUNCT
dpc-2075	30	20	is	be	AUX
dpc-2075	30	21	dramatically	dramatically	ADV
dpc-2075	30	22	increasing	increase	VERB
dpc-2075	30	23	and	and	CCONJ
dpc-2075	30	24	disease	disease	NOUN
dpc-2075	30	25	implications	implication	NOUN
dpc-2075	30	26	on	on	ADP
dpc-2075	30	27	public	public	ADJ
dpc-2075	30	28	health	health	NOUN
dpc-2075	30	29	are	be	AUX
dpc-2075	30	30	vastly	vastly	ADV
dpc-2075	30	31	underestimated	underestimate	VERB
dpc-2075	30	32	in	in	ADP
dpc-2075	30	33	terms	term	NOUN
dpc-2075	30	34	of	of	ADP
dpc-2075	30	35	morbidity	morbidity	NOUN
dpc-2075	30	36	and	and	CCONJ
dpc-2075	30	37	treatment	treatment	NOUN
dpc-2075	30	38	costs	cost	NOUN
dpc-2075	30	39	.	.	PUNCT
dpc-2075	31	1	these	these	DET
dpc-2075	31	2	costs	cost	NOUN
dpc-2075	31	3	are	be	AUX
dpc-2075	31	4	unavoidably	unavoidably	ADV
dpc-2075	31	5	going	go	VERB
dpc-2075	31	6	to	to	PART
dpc-2075	31	7	rise	rise	VERB
dpc-2075	31	8	[	[	X
dpc-2075	31	9	2	2	NUM
dpc-2075	31	10	]	]	PUNCT
dpc-2075	31	11	.	.	PUNCT
dpc-2075	32	1	cscc	cscc	PROPN
dpc-2075	32	2	can	can	AUX
dpc-2075	32	3	arise	arise	VERB
dpc-2075	32	4	from	from	ADP
dpc-2075	32	5	precancerous	precancerous	ADJ
dpc-2075	32	6	precursor	precursor	NOUN
dpc-2075	32	7	lesions	lesion	NOUN
dpc-2075	32	8	such	such	ADJ
dpc-2075	32	9	as	as	ADP
dpc-2075	32	10	actinic	actinic	ADJ
dpc-2075	32	11	keratosis	keratosis	NOUN
dpc-2075	32	12	or	or	CCONJ
dpc-2075	32	13	can	can	AUX
dpc-2075	32	14	grow	grow	VERB
dpc-2075	32	15	de	de	ADP
dpc-2075	32	16	novo	novo	NOUN
dpc-2075	32	17	,	,	PUNCT
dpc-2075	32	18	in	in	ADP
dpc-2075	32	19	particular	particular	ADJ
dpc-2075	32	20	on	on	ADP
dpc-2075	32	21	chronically	chronically	ADV
dpc-2075	32	22	inflamed	inflame	VERB
dpc-2075	32	23	skin	skin	NOUN
dpc-2075	32	24	and	and	CCONJ
dpc-2075	32	25	consequently	consequently	ADV
dpc-2075	32	26	more	more	ADV
dpc-2075	32	27	exposed	expose	VERB
dpc-2075	32	28	to	to	ADP
dpc-2075	32	29	pro	pro	ADJ
dpc-2075	32	30	-	-	ADJ
dpc-2075	32	31	carcinogenetic	carcinogenetic	ADJ
dpc-2075	32	32	stimuli	stimulus	NOUN
dpc-2075	32	33	[	[	X
dpc-2075	32	34	3	3	NUM
dpc-2075	32	35	]	]	PUNCT
dpc-2075	32	36	.	.	PUNCT
dpc-2075	33	1	invasive	invasive	ADJ
dpc-2075	33	2	cscc	cscc	PROPN
dpc-2075	33	3	(	(	PUNCT
dpc-2075	33	4	histologically	histologically	ADV
dpc-2075	33	5	characterized	characterize	VERB
dpc-2075	33	6	by	by	ADP
dpc-2075	33	7	the	the	DET
dpc-2075	33	8	presence	presence	NOUN
dpc-2075	33	9	of	of	ADP
dpc-2075	33	10	infiltrating	infiltrate	VERB
dpc-2075	33	11	cells	cell	NOUN
dpc-2075	33	12	crossing	cross	VERB
dpc-2075	33	13	the	the	DET
dpc-2075	33	14	basement	basement	NOUN
dpc-2075	33	15	membrane	membrane	NOUN
dpc-2075	33	16	)	)	PUNCT
dpc-2075	33	17	has	have	VERB
dpc-2075	33	18	the	the	DET
dpc-2075	33	19	ability	ability	NOUN
dpc-2075	33	20	to	to	PART
dpc-2075	33	21	relapse	relapse	VERB
dpc-2075	33	22	and	and	CCONJ
dpc-2075	33	23	metastasize	metastasize	VERB
dpc-2075	33	24	to	to	ADP
dpc-2075	33	25	regional	regional	ADJ
dpc-2075	33	26	lymph	lymph	NOUN
dpc-2075	33	27	nodes	node	NOUN
dpc-2075	33	28	or	or	CCONJ
dpc-2075	33	29	distant	distant	ADJ
dpc-2075	33	30	organs	organ	NOUN
dpc-2075	33	31	and	and	CCONJ
dpc-2075	33	32	,	,	PUNCT
dpc-2075	33	33	if	if	SCONJ
dpc-2075	33	34	left	leave	VERB
dpc-2075	33	35	untreated	untreated	ADJ
dpc-2075	33	36	or	or	CCONJ
dpc-2075	33	37	if	if	SCONJ
dpc-2075	33	38	inadequately	inadequately	ADV
dpc-2075	33	39	treated	treat	VERB
dpc-2075	33	40	,	,	PUNCT
dpc-2075	33	41	can	can	AUX
dpc-2075	33	42	lead	lead	VERB
dpc-2075	33	43	to	to	ADP
dpc-2075	33	44	extensive	extensive	ADJ
dpc-2075	33	45	tissue	tissue	NOUN
dpc-2075	33	46	destruction	destruction	NOUN
dpc-2075	33	47	up	up	ADP
dpc-2075	33	48	to	to	ADP
dpc-2075	33	49	massive	massive	ADJ
dpc-2075	33	50	patterns	pattern	NOUN
dpc-2075	33	51	of	of	ADP
dpc-2075	33	52	tumour	tumour	NOUN
dpc-2075	33	53	infiltration	infiltration	NOUN
dpc-2075	33	54	.	.	PUNCT
dpc-2075	34	1	even	even	ADV
dpc-2075	34	2	though	though	SCONJ
dpc-2075	34	3	the	the	DET
dpc-2075	34	4	ability	ability	NOUN
dpc-2075	34	5	of	of	ADP
dpc-2075	34	6	cscc	cscc	NOUN
dpc-2075	34	7	to	to	PART
dpc-2075	34	8	metastasize	metastasize	VERB
dpc-2075	34	9	is	be	AUX
dpc-2075	34	10	limited	limit	VERB
dpc-2075	34	11	,	,	PUNCT
dpc-2075	34	12	the	the	DET
dpc-2075	34	13	presence	presence	NOUN
dpc-2075	34	14	of	of	ADP
dpc-2075	34	15	distant	distant	ADJ
dpc-2075	34	16	metastases	metastasis	NOUN
dpc-2075	34	17	in	in	ADP
dpc-2075	34	18	cscc	cscc	ADJ
dpc-2075	34	19	patients	patient	NOUN
dpc-2075	34	20	is	be	AUX
dpc-2075	34	21	associated	associate	VERB
dpc-2075	34	22	with	with	ADP
dpc-2075	34	23	poor	poor	ADJ
dpc-2075	34	24	prognosis	prognosis	NOUN
dpc-2075	34	25	and	and	CCONJ
dpc-2075	34	26	a	a	DET
dpc-2075	34	27	median	median	ADJ
dpc-2075	34	28	survival	survival	NOUN
dpc-2075	34	29	of	of	ADP
dpc-2075	34	30	less	less	ADJ
dpc-2075	34	31	than	than	ADP
dpc-2075	34	32	2	2	NUM
dpc-2075	34	33	years	year	NOUN
dpc-2075	34	34	.	.	PUNCT
dpc-2075	35	1	for	for	ADP
dpc-2075	35	2	this	this	DET
dpc-2075	35	3	reason	reason	NOUN
dpc-2075	35	4	,	,	PUNCT
dpc-2075	35	5	it	it	PRON
dpc-2075	35	6	is	be	AUX
dpc-2075	35	7	fundamental	fundamental	ADJ
dpc-2075	35	8	to	to	PART
dpc-2075	35	9	perform	perform	VERB
dpc-2075	35	10	a	a	DET
dpc-2075	35	11	careful	careful	ADJ
dpc-2075	35	12	clinical	clinical	ADJ
dpc-2075	35	13	and	and	CCONJ
dpc-2075	35	14	surgical	surgical	ADJ
dpc-2075	35	15	evaluation	evaluation	NOUN
dpc-2075	35	16	,	,	PUNCT
dpc-2075	35	17	that	that	PRON
dpc-2075	35	18	goes	go	VERB
dpc-2075	35	19	hand	hand	NOUN
dpc-2075	35	20	in	in	ADP
dpc-2075	35	21	hand	hand	NOUN
dpc-2075	35	22	with	with	ADP
dpc-2075	35	23	a	a	DET
dpc-2075	35	24	correct	correct	ADJ
dpc-2075	35	25	early	early	ADJ
dpc-2075	35	26	management	management	NOUN
dpc-2075	35	27	of	of	ADP
dpc-2075	35	28	all	all	DET
dpc-2075	35	29	cases	case	NOUN
dpc-2075	35	30	.	.	PUNCT
dpc-2075	36	1	multidisciplinary	multidisciplinary	ADJ
dpc-2075	36	2	management	management	NOUN
dpc-2075	36	3	is	be	AUX
dpc-2075	36	4	essential	essential	ADJ
dpc-2075	36	5	in	in	ADP
dpc-2075	36	6	order	order	NOUN
dpc-2075	36	7	to	to	PART
dpc-2075	36	8	guide	guide	VERB
dpc-2075	36	9	the	the	DET
dpc-2075	36	10	patient	patient	NOUN
dpc-2075	36	11	towards	towards	ADP
dpc-2075	36	12	the	the	DET
dpc-2075	36	13	best	good	ADJ
dpc-2075	36	14	possible	possible	ADJ
dpc-2075	36	15	treatment	treatment	NOUN
dpc-2075	36	16	options	option	NOUN
dpc-2075	36	17	[	[	X
dpc-2075	36	18	4	4	NUM
dpc-2075	36	19	]	]	PUNCT
dpc-2075	36	20	.	.	PUNCT
dpc-2075	37	1	the	the	DET
dpc-2075	37	2	ultimate	ultimate	ADJ
dpc-2075	37	3	scc	scc	PROPN
dpc-2075	37	4	treatment	treatment	NOUN
dpc-2075	37	5	goals	goal	NOUN
dpc-2075	37	6	are	be	AUX
dpc-2075	37	7	complete	complete	ADJ
dpc-2075	37	8	removal	removal	NOUN
dpc-2075	37	9	of	of	ADP
dpc-2075	37	10	the	the	DET
dpc-2075	37	11	tumor	tumor	NOUN
dpc-2075	37	12	or	or	CCONJ
dpc-2075	37	13	,	,	PUNCT
dpc-2075	37	14	when	when	SCONJ
dpc-2075	37	15	this	this	PRON
dpc-2075	37	16	is	be	AUX
dpc-2075	37	17	not	not	PART
dpc-2075	37	18	possible	possible	ADJ
dpc-2075	37	19	,	,	PUNCT
dpc-2075	37	20	tumor	tumor	NOUN
dpc-2075	37	21	debulking	debulking	NOUN
dpc-2075	37	22	,	,	PUNCT
dpc-2075	37	23	and	and	CCONJ
dpc-2075	37	24	the	the	DET
dpc-2075	37	25	minimization	minimization	NOUN
dpc-2075	37	26	of	of	ADP
dpc-2075	37	27	functional	functional	ADJ
dpc-2075	37	28	and	and	CCONJ
dpc-2075	37	29	aesthetic	aesthetic	ADJ
dpc-2075	37	30	impairment	impairment	NOUN
dpc-2075	37	31	that	that	PRON
dpc-2075	37	32	often	often	ADV
dpc-2075	37	33	,	,	PUNCT
dpc-2075	37	34	for	for	ADP
dpc-2075	37	35	particular	particular	ADJ
dpc-2075	37	36	anatomical	anatomical	ADJ
dpc-2075	37	37	areas	area	NOUN
dpc-2075	37	38	,	,	PUNCT
dpc-2075	37	39	can	can	AUX
dpc-2075	37	40	be	be	AUX
dpc-2075	37	41	a	a	DET
dpc-2075	37	42	very	very	ADV
dpc-2075	37	43	central	central	ADJ
dpc-2075	37	44	issue	issue	NOUN
dpc-2075	37	45	.	.	PUNCT
dpc-2075	38	1	[	[	X
dpc-2075	38	2	1	1	NUM
dpc-2075	38	3	]	]	PUNCT
dpc-2075	38	4	.	.	PUNCT
dpc-2075	39	1	surgery	surgery	NOUN
dpc-2075	39	2	with	with	ADP
dpc-2075	39	3	adequate	adequate	ADJ
dpc-2075	39	4	margins	margin	NOUN
dpc-2075	39	5	is	be	AUX
dpc-2075	39	6	the	the	DET
dpc-2075	39	7	most	most	ADV
dpc-2075	39	8	common	common	ADJ
dpc-2075	39	9	treatment	treatment	NOUN
dpc-2075	39	10	option	option	NOUN
dpc-2075	39	11	for	for	ADP
dpc-2075	39	12	most	most	ADJ
dpc-2075	39	13	csccs	csccs	NOUN
dpc-2075	39	14	,	,	PUNCT
dpc-2075	39	15	but	but	CCONJ
dpc-2075	39	16	radiation	radiation	NOUN
dpc-2075	39	17	therapy	therapy	NOUN
dpc-2075	39	18	(	(	PUNCT
dpc-2075	39	19	rt	rt	PROPN
dpc-2075	39	20	)	)	PUNCT
dpc-2075	39	21	can	can	AUX
dpc-2075	39	22	be	be	AUX
dpc-2075	39	23	an	an	DET
dpc-2075	39	24	effective	effective	ADJ
dpc-2075	39	25	non	non	ADJ
dpc-2075	39	26	-	-	ADJ
dpc-2075	39	27	surgical	surgical	ADJ
dpc-2075	39	28	option	option	NOUN
dpc-2075	39	29	in	in	ADP
dpc-2075	39	30	the	the	DET
dpc-2075	39	31	definitive	definitive	ADJ
dpc-2075	39	32	(	(	PUNCT
dpc-2075	39	33	inoperable	inoperable	ADJ
dpc-2075	39	34	patients	patient	NOUN
dpc-2075	39	35	)	)	PUNCT
dpc-2075	39	36	,	,	PUNCT
dpc-2075	39	37	adjuvant	adjuvant	ADJ
dpc-2075	39	38	(	(	PUNCT
dpc-2075	39	39	high	high	ADJ
dpc-2075	39	40	postoperative	postoperative	ADJ
dpc-2075	39	41	risk	risk	NOUN
dpc-2075	39	42	)	)	PUNCT
dpc-2075	39	43	,	,	PUNCT
dpc-2075	39	44	and	and	CCONJ
dpc-2075	39	45	palliative	palliative	ADJ
dpc-2075	39	46	(	(	PUNCT
dpc-2075	39	47	cytoreductive	cytoreductive	ADJ
dpc-2075	39	48	,	,	PUNCT
dpc-2075	39	49	pain	pain	NOUN
dpc-2075	39	50	-	-	PUNCT
dpc-2075	39	51	relieving	relieve	VERB
dpc-2075	39	52	)	)	PUNCT
dpc-2075	39	53	setting	setting	NOUN
dpc-2075	39	54	.	.	PUNCT
dpc-2075	40	1	rt	rt	PROPN
dpc-2075	40	2	is	be	AUX
dpc-2075	40	3	also	also	ADV
dpc-2075	40	4	a	a	DET
dpc-2075	40	5	tissue	tissue	NOUN
dpc-2075	40	6	-	-	PUNCT
dpc-2075	40	7	preserving	preserve	VERB
dpc-2075	40	8	modality	modality	NOUN
dpc-2075	40	9	that	that	PRON
dpc-2075	40	10	might	might	AUX
dpc-2075	40	11	offer	offer	VERB
dpc-2075	40	12	a	a	DET
dpc-2075	40	13	better	well	ADV
dpc-2075	40	14	cosmetic	cosmetic	ADJ
dpc-2075	40	15	and	and	CCONJ
dpc-2075	40	16	functional	functional	ADJ
dpc-2075	40	17	outcome	outcome	NOUN
dpc-2075	40	18	than	than	ADP
dpc-2075	40	19	surgery	surgery	NOUN
dpc-2075	40	20	[	[	X
dpc-2075	40	21	4	4	NUM
dpc-2075	40	22	]	]	PUNCT
dpc-2075	40	23	.	.	PUNCT
dpc-2075	41	1	a	a	DET
dpc-2075	41	2	variety	variety	NOUN
dpc-2075	41	3	of	of	ADP
dpc-2075	41	4	radiation	radiation	NOUN
dpc-2075	41	5	therapy	therapy	NOUN
dpc-2075	41	6	techniques	technique	NOUN
dpc-2075	41	7	have	have	AUX
dpc-2075	41	8	been	be	AUX
dpc-2075	41	9	used	use	VERB
dpc-2075	41	10	to	to	PART
dpc-2075	41	11	treat	treat	VERB
dpc-2075	41	12	epithelial	epithelial	ADJ
dpc-2075	41	13	skin	skin	NOUN
dpc-2075	41	14	tumors	tumor	NOUN
dpc-2075	41	15	.	.	PUNCT
dpc-2075	42	1	nmsc	nmsc	NOUN
dpc-2075	42	2	have	have	AUX
dpc-2075	42	3	historically	historically	ADV
dpc-2075	42	4	been	be	AUX
dpc-2075	42	5	among	among	ADP
dpc-2075	42	6	the	the	DET
dpc-2075	42	7	first	first	ADJ
dpc-2075	42	8	to	to	PART
dpc-2075	42	9	be	be	AUX
dpc-2075	42	10	irradiated	irradiate	VERB
dpc-2075	42	11	since	since	SCONJ
dpc-2075	42	12	discovery	discovery	NOUN
dpc-2075	42	13	of	of	ADP
dpc-2075	42	14	radioactivity	radioactivity	NOUN
dpc-2075	42	15	.	.	PUNCT
dpc-2075	43	1	the	the	DET
dpc-2075	43	2	appropriate	appropriate	ADJ
dpc-2075	43	3	radiation	radiation	NOUN
dpc-2075	43	4	therapy	therapy	NOUN
dpc-2075	43	5	technique	technique	NOUN
dpc-2075	43	6	depends	depend	VERB
dpc-2075	43	7	on	on	ADP
dpc-2075	43	8	multiple	multiple	ADJ
dpc-2075	43	9	factors	factor	NOUN
dpc-2075	43	10	,	,	PUNCT
dpc-2075	43	11	including	include	VERB
dpc-2075	43	12	the	the	DET
dpc-2075	43	13	primary	primary	ADJ
dpc-2075	43	14	tumor	tumor	NOUN
dpc-2075	43	15	’s	’s	PART
dpc-2075	43	16	location	location	NOUN
dpc-2075	43	17	,	,	PUNCT
dpc-2075	43	18	the	the	DET
dpc-2075	43	19	neoplasm	neoplasm	ADJ
dpc-2075	43	20	size	size	NOUN
dpc-2075	43	21	,	,	PUNCT
dpc-2075	43	22	the	the	DET
dpc-2075	43	23	scar	scar	NOUN
dpc-2075	43	24	length	length	NOUN
dpc-2075	43	25	(	(	PUNCT
dpc-2075	43	26	in	in	ADP
dpc-2075	43	27	the	the	DET
dpc-2075	43	28	adjuvant	adjuvant	ADJ
dpc-2075	43	29	setting	setting	NOUN
dpc-2075	43	30	)	)	PUNCT
dpc-2075	43	31	which	which	PRON
dpc-2075	43	32	may	may	AUX
dpc-2075	43	33	be	be	AUX
dpc-2075	43	34	difficult	difficult	ADJ
dpc-2075	43	35	to	to	PART
dpc-2075	43	36	cover	cover	VERB
dpc-2075	43	37	with	with	ADP
dpc-2075	43	38	radiation	radiation	NOUN
dpc-2075	43	39	planning	planning	NOUN
dpc-2075	43	40	,	,	PUNCT
dpc-2075	43	41	the	the	DET
dpc-2075	43	42	surrounding	surround	VERB
dpc-2075	43	43	anatomy	anatomy	NOUN
dpc-2075	43	44	(	(	PUNCT
dpc-2075	43	45	presence	presence	NOUN
dpc-2075	43	46	of	of	ADP
dpc-2075	43	47	organs	organ	NOUN
dpc-2075	43	48	at	at	ADP
dpc-2075	43	49	risk	risk	NOUN
dpc-2075	43	50	that	that	PRON
dpc-2075	43	51	must	must	AUX
dpc-2075	43	52	be	be	AUX
dpc-2075	43	53	preserved	preserve	VERB
dpc-2075	43	54	)	)	PUNCT
dpc-2075	43	55	,	,	PUNCT
dpc-2075	43	56	and	and	CCONJ
dpc-2075	43	57	the	the	DET
dpc-2075	43	58	presence	presence	NOUN
dpc-2075	43	59	of	of	ADP
dpc-2075	43	60	disease	disease	NOUN
dpc-2075	43	61	-	-	PUNCT
dpc-2075	43	62	affected	affect	VERB
dpc-2075	43	63	lymph	lymph	NOUN
dpc-2075	43	64	nodes	node	NOUN
dpc-2075	43	65	that	that	PRON
dpc-2075	43	66	deserve	deserve	VERB
dpc-2075	43	67	to	to	PART
dpc-2075	43	68	be	be	AUX
dpc-2075	43	69	included	include	VERB
dpc-2075	43	70	in	in	ADP
dpc-2075	43	71	the	the	DET
dpc-2075	43	72	radiation	radiation	NOUN
dpc-2075	43	73	field	field	NOUN
dpc-2075	44	1	[	[	X
dpc-2075	44	2	5	5	NUM
dpc-2075	44	3	]	]	PUNCT
dpc-2075	44	4	.	.	PUNCT
dpc-2075	45	1	surface	surface	NOUN
dpc-2075	45	2	electrons	electron	NOUN
dpc-2075	45	3	are	be	AUX
dpc-2075	45	4	typically	typically	ADV
dpc-2075	45	5	used	use	VERB
dpc-2075	45	6	for	for	ADP
dpc-2075	45	7	primary	primary	ADJ
dpc-2075	45	8	lesions	lesion	NOUN
dpc-2075	45	9	or	or	CCONJ
dpc-2075	45	10	tumor	tumor	NOUN
dpc-2075	45	11	beds	bed	NOUN
dpc-2075	45	12	>	>	X
dpc-2075	45	13	5	5	NUM
dpc-2075	45	14	mm	mm	NOUN
dpc-2075	45	15	or	or	CCONJ
dpc-2075	45	16	deeper	deep	ADJ
dpc-2075	45	17	,	,	PUNCT
dpc-2075	45	18	because	because	SCONJ
dpc-2075	45	19	of	of	ADP
dpc-2075	45	20	their	their	PRON
dpc-2075	45	21	unique	unique	ADJ
dpc-2075	45	22	physical	physical	ADJ
dpc-2075	45	23	penetration	penetration	NOUN
dpc-2075	45	24	features	feature	NOUN
dpc-2075	45	25	.	.	PUNCT
dpc-2075	46	1	electrons	electron	NOUN
dpc-2075	46	2	are	be	AUX
dpc-2075	46	3	produced	produce	VERB
dpc-2075	46	4	by	by	ADP
dpc-2075	46	5	modern	modern	ADJ
dpc-2075	46	6	linear	linear	NOUN
dpc-2075	46	7	accelerators	accelerator	NOUN
dpc-2075	46	8	and	and	CCONJ
dpc-2075	46	9	have	have	VERB
dpc-2075	46	10	a	a	DET
dpc-2075	46	11	dose	dose	ADJ
dpc-2075	46	12	distribution	distribution	NOUN
dpc-2075	46	13	with	with	ADP
dpc-2075	46	14	a	a	DET
dpc-2075	46	15	peak	peak	NOUN
dpc-2075	46	16	dose	dose	NOUN
dpc-2075	46	17	near	near	ADP
dpc-2075	46	18	the	the	DET
dpc-2075	46	19	skin	skin	NOUN
dpc-2075	46	20	surface	surface	NOUN
dpc-2075	46	21	and	and	CCONJ
dpc-2075	46	22	a	a	DET
dpc-2075	46	23	rapid	rapid	ADJ
dpc-2075	46	24	dose	dose	NOUN
dpc-2075	46	25	drop	drop	NOUN
dpc-2075	46	26	beyond	beyond	ADP
dpc-2075	46	27	the	the	DET
dpc-2075	46	28	target	target	NOUN
dpc-2075	46	29	.	.	PUNCT
dpc-2075	47	1	this	this	PRON
dpc-2075	47	2	allows	allow	VERB
dpc-2075	47	3	adequate	adequate	ADJ
dpc-2075	47	4	coverage	coverage	NOUN
dpc-2075	47	5	of	of	ADP
dpc-2075	47	6	the	the	DET
dpc-2075	47	7	disease	disease	NOUN
dpc-2075	47	8	or	or	CCONJ
dpc-2075	47	9	surgical	surgical	ADJ
dpc-2075	47	10	bed	bed	NOUN
dpc-2075	47	11	and	and	CCONJ
dpc-2075	47	12	the	the	DET
dpc-2075	47	13	ability	ability	NOUN
dpc-2075	47	14	to	to	PART
dpc-2075	47	15	minimize	minimize	VERB
dpc-2075	47	16	side	side	ADJ
dpc-2075	47	17	effects	effect	NOUN
dpc-2075	47	18	.	.	PUNCT
dpc-2075	48	1	superficial	superficial	ADJ
dpc-2075	48	2	x	x	NOUN
dpc-2075	48	3	-	-	NOUN
dpc-2075	48	4	rays	ray	NOUN
dpc-2075	48	5	,	,	PUNCT
dpc-2075	48	6	or	or	CCONJ
dpc-2075	48	7	photons	photon	NOUN
dpc-2075	48	8	,	,	PUNCT
dpc-2075	48	9	have	have	VERB
dpc-2075	48	10	greater	great	ADJ
dpc-2075	48	11	physical	physical	ADJ
dpc-2075	48	12	penetration	penetration	NOUN
dpc-2075	48	13	compared	compare	VERB
dpc-2075	48	14	with	with	ADP
dpc-2075	48	15	surface	surface	NOUN
dpc-2075	48	16	electrons	electron	NOUN
dpc-2075	48	17	and	and	CCONJ
dpc-2075	48	18	have	have	AUX
dpc-2075	48	19	been	be	AUX
dpc-2075	48	20	used	use	VERB
dpc-2075	48	21	to	to	PART
dpc-2075	48	22	treat	treat	VERB
dpc-2075	48	23	deep	deep	ADV
dpc-2075	48	24	cscc	cscc	ADJ
dpc-2075	48	25	or	or	CCONJ
dpc-2075	48	26	more	more	ADV
dpc-2075	48	27	advanced	advanced	ADJ
dpc-2075	48	28	diseases	disease	NOUN
dpc-2075	48	29	(	(	PUNCT
dpc-2075	48	30	with	with	ADP
dpc-2075	48	31	or	or	CCONJ
dpc-2075	48	32	without	without	ADP
dpc-2075	48	33	positive	positive	ADJ
dpc-2075	48	34	nodes	node	NOUN
dpc-2075	48	35	)	)	PUNCT
dpc-2075	49	1	[	[	X
dpc-2075	49	2	6	6	NUM
dpc-2075	49	3	]	]	PUNCT
dpc-2075	49	4	.	.	PUNCT
dpc-2075	50	1	this	this	DET
dpc-2075	50	2	article	article	NOUN
dpc-2075	50	3	aims	aim	VERB
dpc-2075	50	4	to	to	PART
dpc-2075	50	5	summarize	summarize	VERB
dpc-2075	50	6	the	the	DET
dpc-2075	50	7	effectiveness	effectiveness	NOUN
dpc-2075	50	8	,	,	PUNCT
dpc-2075	50	9	potential	potential	ADJ
dpc-2075	50	10	adverse	adverse	ADJ
dpc-2075	50	11	events	event	NOUN
dpc-2075	50	12	,	,	PUNCT
dpc-2075	50	13	and	and	CCONJ
dpc-2075	50	14	indications	indication	NOUN
dpc-2075	50	15	of	of	ADP
dpc-2075	50	16	rt	rt	PROPN
dpc-2075	50	17	in	in	ADP
dpc-2075	50	18	the	the	DET
dpc-2075	50	19	adjuvant	adjuvant	NOUN
dpc-2075	50	20	,	,	PUNCT
dpc-2075	50	21	advanced	advanced	ADJ
dpc-2075	50	22	,	,	PUNCT
dpc-2075	50	23	and	and	CCONJ
dpc-2075	50	24	palliative	palliative	ADJ
dpc-2075	50	25	setting	setting	NOUN
dpc-2075	50	26	of	of	ADP
dpc-2075	50	27	cscc	cscc	NOUN
dpc-2075	50	28	,	,	PUNCT
dpc-2075	50	29	performed	perform	VERB
dpc-2075	50	30	through	through	ADP
dpc-2075	50	31	a	a	DET
dpc-2075	50	32	thorough	thorough	ADJ
dpc-2075	50	33	and	and	CCONJ
dpc-2075	50	34	broad	broad	ADJ
dpc-2075	50	35	literature	literature	PROPN
dpc-2075	50	36	review	review	NOUN
dpc-2075	50	37	.	.	PUNCT
dpc-2075	51	1	when	when	SCONJ
dpc-2075	51	2	is	be	AUX
dpc-2075	51	3	radiotherapy	radiotherapy	NOUN
dpc-2075	51	4	recommended	recommend	VERB
dpc-2075	51	5	?	?	PUNCT
dpc-2075	52	1	rt	rt	PROPN
dpc-2075	52	2	is	be	AUX
dpc-2075	52	3	recommended	recommend	VERB
dpc-2075	52	4	as	as	ADP
dpc-2075	52	5	adjuvant	adjuvant	ADJ
dpc-2075	52	6	therapy	therapy	NOUN
dpc-2075	52	7	in	in	ADP
dpc-2075	52	8	high	high	ADJ
dpc-2075	52	9	-	-	PUNCT
dpc-2075	52	10	risk	risk	NOUN
dpc-2075	52	11	cscc	cscc	NOUN
dpc-2075	52	12	or	or	CCONJ
dpc-2075	52	13	when	when	SCONJ
dpc-2075	52	14	surgery	surgery	NOUN
dpc-2075	52	15	is	be	AUX
dpc-2075	52	16	excluded	exclude	VERB
dpc-2075	52	17	due	due	ADP
dpc-2075	52	18	to	to	ADP
dpc-2075	52	19	cosmetic	cosmetic	ADJ
dpc-2075	52	20	or	or	CCONJ
dpc-2075	52	21	functional	functional	ADJ
dpc-2075	52	22	reasons	reason	NOUN
dpc-2075	53	1	[	[	X
dpc-2075	53	2	6	6	NUM
dpc-2075	53	3	]	]	PUNCT
dpc-2075	53	4	.	.	PUNCT
dpc-2075	54	1	rt	rt	PROPN
dpc-2075	54	2	allows	allow	VERB
dpc-2075	54	3	treatment	treatment	NOUN
dpc-2075	54	4	of	of	ADP
dpc-2075	54	5	anatomic	anatomic	ADJ
dpc-2075	54	6	sites	site	NOUN
dpc-2075	54	7	that	that	PRON
dpc-2075	54	8	are	be	AUX
dpc-2075	54	9	difficult	difficult	ADJ
dpc-2075	54	10	to	to	PART
dpc-2075	54	11	manage	manage	VERB
dpc-2075	54	12	surgically	surgically	ADV
dpc-2075	54	13	,	,	PUNCT
dpc-2075	54	14	and	and	CCONJ
dpc-2075	54	15	to	to	PART
dpc-2075	54	16	achieve	achieve	VERB
dpc-2075	54	17	a	a	DET
dpc-2075	54	18	good	good	ADJ
dpc-2075	54	19	cosmetic	cosmetic	ADJ
dpc-2075	54	20	result	result	NOUN
dpc-2075	54	21	.	.	PUNCT
dpc-2075	55	1	this	this	PRON
dpc-2075	55	2	applies	apply	VERB
dpc-2075	55	3	in	in	ADP
dpc-2075	55	4	particular	particular	ADJ
dpc-2075	55	5	to	to	ADP
dpc-2075	55	6	the	the	DET
dpc-2075	55	7	head	head	NOUN
dpc-2075	55	8	and	and	CCONJ
dpc-2075	55	9	neck	neck	NOUN
dpc-2075	55	10	(	(	PUNCT
dpc-2075	55	11	h	h	NOUN
dpc-2075	55	12	/	/	SYM
dpc-2075	55	13	n	n	CCONJ
dpc-2075	55	14	)	)	PUNCT
dpc-2075	55	15	region	region	NOUN
dpc-2075	55	16	.	.	PUNCT
dpc-2075	56	1	rt	rt	PROPN
dpc-2075	56	2	is	be	AUX
dpc-2075	56	3	also	also	ADV
dpc-2075	56	4	preferred	prefer	VERB
dpc-2075	56	5	for	for	ADP
dpc-2075	56	6	elderly	elderly	ADJ
dpc-2075	56	7	patients	patient	NOUN
dpc-2075	56	8	(	(	PUNCT
dpc-2075	56	9	>	>	NOUN
dpc-2075	56	10	60	60	NUM
dpc-2075	56	11	years	year	NOUN
dpc-2075	56	12	)	)	PUNCT
dpc-2075	57	1	[	[	X
dpc-2075	57	2	7	7	NUM
dpc-2075	57	3	]	]	PUNCT
dpc-2075	57	4	.	.	PUNCT
dpc-2075	58	1	the	the	DET
dpc-2075	58	2	dose	dose	PROPN
dpc-2075	58	3	of	of	ADP
dpc-2075	58	4	rt	rt	PROPN
dpc-2075	58	5	can	can	AUX
dpc-2075	58	6	be	be	AUX
dpc-2075	58	7	delivered	deliver	VERB
dpc-2075	58	8	with	with	ADP
dpc-2075	58	9	external	external	ADJ
dpc-2075	58	10	beams	beam	NOUN
dpc-2075	58	11	(	(	PUNCT
dpc-2075	58	12	external	external	ADJ
dpc-2075	58	13	beam	beam	NOUN
dpc-2075	58	14	radiation	radiation	NOUN
dpc-2075	58	15	therapy	therapy	NOUN
dpc-2075	58	16	(	(	PUNCT
dpc-2075	58	17	ebrt	ebrt	ADJ
dpc-2075	58	18	)	)	PUNCT
dpc-2075	58	19	)	)	PUNCT
dpc-2075	58	20	and	and	CCONJ
dpc-2075	58	21	by	by	ADP
dpc-2075	58	22	direct	direct	ADJ
dpc-2075	58	23	results	result	NOUN
dpc-2075	58	24	:	:	PUNCT
dpc-2075	58	25	radiotherapy	radiotherapy	NOUN
dpc-2075	58	26	(	(	PUNCT
dpc-2075	58	27	rt	rt	PROPN
dpc-2075	58	28	)	)	PUNCT
dpc-2075	58	29	can	can	AUX
dpc-2075	58	30	safely	safely	ADV
dpc-2075	58	31	be	be	AUX
dpc-2075	58	32	used	use	VERB
dpc-2075	58	33	to	to	PART
dpc-2075	58	34	manage	manage	VERB
dpc-2075	58	35	non	non	ADJ
dpc-2075	58	36	-	-	ADJ
dpc-2075	58	37	surgical	surgical	ADJ
dpc-2075	58	38	patients	patient	NOUN
dpc-2075	58	39	and	and	CCONJ
dpc-2075	58	40	high	high	ADJ
dpc-2075	58	41	-	-	PUNCT
dpc-2075	58	42	risk	risk	NOUN
dpc-2075	58	43	patients	patient	NOUN
dpc-2075	58	44	in	in	ADP
dpc-2075	58	45	the	the	DET
dpc-2075	58	46	advanced	advanced	ADJ
dpc-2075	58	47	cscc	cscc	ADJ
dpc-2075	58	48	setting	setting	NOUN
dpc-2075	58	49	.	.	PUNCT
dpc-2075	59	1	the	the	DET
dpc-2075	59	2	remarkable	remarkable	ADJ
dpc-2075	59	3	progress	progress	NOUN
dpc-2075	59	4	of	of	ADP
dpc-2075	59	5	delivery	delivery	NOUN
dpc-2075	59	6	techniques	technique	NOUN
dpc-2075	59	7	has	have	AUX
dpc-2075	59	8	greatly	greatly	ADV
dpc-2075	59	9	improved	improve	VERB
dpc-2075	59	10	the	the	DET
dpc-2075	59	11	effectiveness	effectiveness	NOUN
dpc-2075	59	12	and	and	CCONJ
dpc-2075	59	13	toxicity	toxicity	NOUN
dpc-2075	59	14	profile	profile	NOUN
dpc-2075	59	15	of	of	ADP
dpc-2075	59	16	rt	rt	PROPN
dpc-2075	59	17	treatments	treatment	NOUN
dpc-2075	59	18	.	.	PUNCT
dpc-2075	60	1	from	from	ADP
dpc-2075	60	2	2d	2d	NUM
dpc-2075	60	3	techniques	technique	NOUN
dpc-2075	60	4	to	to	ADP
dpc-2075	60	5	intensity	intensity	NOUN
dpc-2075	60	6	modulated	modulate	VERB
dpc-2075	60	7	radiation	radiation	NOUN
dpc-2075	60	8	therapy	therapy	NOUN
dpc-2075	60	9	(	(	PUNCT
dpc-2075	60	10	imrt	imrt	NOUN
dpc-2075	60	11	)	)	PUNCT
dpc-2075	60	12	,	,	PUNCT
dpc-2075	60	13	and	and	CCONJ
dpc-2075	60	14	brachytherapy	brachytherapy	NOUN
dpc-2075	60	15	,	,	PUNCT
dpc-2075	60	16	all	all	DET
dpc-2075	60	17	rt	rt	NOUN
dpc-2075	60	18	techniques	technique	NOUN
dpc-2075	60	19	have	have	AUX
dpc-2075	60	20	greatly	greatly	ADV
dpc-2075	60	21	advanced	advance	VERB
dpc-2075	60	22	.	.	PUNCT
dpc-2075	61	1	to	to	PART
dpc-2075	61	2	improve	improve	VERB
dpc-2075	61	3	acute	acute	ADJ
dpc-2075	61	4	and	and	CCONJ
dpc-2075	61	5	chronic	chronic	ADJ
dpc-2075	61	6	side	side	NOUN
dpc-2075	61	7	effects	effect	NOUN
dpc-2075	61	8	,	,	PUNCT
dpc-2075	61	9	a	a	DET
dpc-2075	61	10	deeper	deep	ADJ
dpc-2075	61	11	care	care	NOUN
dpc-2075	61	12	has	have	AUX
dpc-2075	61	13	been	be	AUX
dpc-2075	61	14	used	use	VERB
dpc-2075	61	15	.	.	PUNCT
dpc-2075	62	1	as	as	SCONJ
dpc-2075	62	2	regards	regard	NOUN
dpc-2075	62	3	cscc	cscc	VERB
dpc-2075	62	4	,	,	PUNCT
dpc-2075	62	5	several	several	ADJ
dpc-2075	62	6	dose	dose	NOUN
dpc-2075	62	7	fractionations	fractionation	NOUN
dpc-2075	62	8	and	and	CCONJ
dpc-2075	62	9	schedules	schedule	NOUN
dpc-2075	62	10	have	have	AUX
dpc-2075	62	11	been	be	AUX
dpc-2075	62	12	suggested	suggest	VERB
dpc-2075	62	13	,	,	PUNCT
dpc-2075	62	14	in	in	ADP
dpc-2075	62	15	line	line	NOUN
dpc-2075	62	16	with	with	ADP
dpc-2075	62	17	the	the	DET
dpc-2075	62	18	patient	patient	NOUN
dpc-2075	62	19	’s	’s	PART
dpc-2075	62	20	age	age	NOUN
dpc-2075	62	21	and	and	CCONJ
dpc-2075	62	22	medical	medical	ADJ
dpc-2075	62	23	conditions	condition	NOUN
dpc-2075	62	24	.	.	PUNCT
dpc-2075	63	1	conclusions	conclusion	NOUN
dpc-2075	63	2	:	:	PUNCT
dpc-2075	63	3	rt	rt	PROPN
dpc-2075	63	4	is	be	AUX
dpc-2075	63	5	a	a	DET
dpc-2075	63	6	fundamental	fundamental	ADJ
dpc-2075	63	7	and	and	CCONJ
dpc-2075	63	8	constantly	constantly	ADV
dpc-2075	63	9	evolving	evolve	VERB
dpc-2075	63	10	therapeutic	therapeutic	ADJ
dpc-2075	63	11	option	option	NOUN
dpc-2075	63	12	in	in	ADP
dpc-2075	63	13	the	the	DET
dpc-2075	63	14	treatment	treatment	NOUN
dpc-2075	63	15	of	of	ADP
dpc-2075	63	16	cscc	cscc	NOUN
dpc-2075	63	17	,	,	PUNCT
dpc-2075	63	18	to	to	PART
dpc-2075	63	19	minimize	minimize	VERB
dpc-2075	63	20	the	the	DET
dpc-2075	63	21	risk	risk	NOUN
dpc-2075	63	22	of	of	ADP
dpc-2075	63	23	recurrence	recurrence	NOUN
dpc-2075	63	24	and	and	CCONJ
dpc-2075	63	25	metastases	metastasis	NOUN
dpc-2075	63	26	in	in	ADP
dpc-2075	63	27	the	the	DET
dpc-2075	63	28	adjuvant	adjuvant	ADJ
dpc-2075	63	29	setting	setting	NOUN
dpc-2075	63	30	and	and	CCONJ
dpc-2075	63	31	in	in	ADP
dpc-2075	63	32	the	the	DET
dpc-2075	63	33	exclusive	exclusive	ADJ
dpc-2075	63	34	treatment	treatment	NOUN
dpc-2075	63	35	for	for	ADP
dpc-2075	63	36	non	non	ADJ
dpc-2075	63	37	-	-	ADJ
dpc-2075	63	38	surgical	surgical	ADJ
dpc-2075	63	39	patients	patient	NOUN
dpc-2075	63	40	.	.	PUNCT
dpc-2075	64	1	patients	patient	NOUN
dpc-2075	64	2	’	'	PUNCT
dpc-2075	64	3	selection	selection	NOUN
dpc-2075	64	4	is	be	AUX
dpc-2075	64	5	crucial	crucial	ADJ
dpc-2075	64	6	,	,	PUNCT
dpc-2075	64	7	together	together	ADV
dpc-2075	64	8	with	with	ADP
dpc-2075	64	9	and	and	CCONJ
dpc-2075	64	10	a	a	DET
dpc-2075	64	11	collaborative	collaborative	ADJ
dpc-2075	64	12	team	team	NOUN
dpc-2075	64	13	working	work	VERB
dpc-2075	64	14	approach	approach	NOUN
dpc-2075	64	15	among	among	ADP
dpc-2075	64	16	the	the	DET
dpc-2075	64	17	specialists	specialist	NOUN
dpc-2075	64	18	involved	involve	VERB
dpc-2075	64	19	in	in	ADP
dpc-2075	64	20	disease	disease	NOUN
dpc-2075	64	21	management	management	NOUN
dpc-2075	64	22	in	in	ADP
dpc-2075	64	23	the	the	DET
dpc-2075	64	24	perspective	perspective	NOUN
dpc-2075	64	25	of	of	ADP
dpc-2075	64	26	the	the	DET
dpc-2075	64	27	best	good	ADJ
dpc-2075	64	28	multidisciplinary	multidisciplinary	ADJ
dpc-2075	64	29	assessment	assessment	NOUN
dpc-2075	64	30	.	.	PUNCT
dpc-2075	65	1	review	review	VERB
dpc-2075	65	2	|	|	ADV
dpc-2075	65	3	dermatol	dermatol	ADJ
dpc-2075	65	4	pract	pract	NOUN
dpc-2075	65	5	concept	concept	NOUN
dpc-2075	65	6	.	.	PUNCT
dpc-2075	66	1	2021	2021	NUM
dpc-2075	66	2	;	;	PUNCT
dpc-2075	66	3	11(s2	11(s2	NUM
dpc-2075	66	4	):	):	PUNCT
dpc-2075	66	5	e2021168s	e2021168s	X
dpc-2075	66	6	3	3	NUM
dpc-2075	66	7	application	application	NOUN
dpc-2075	66	8	using	use	VERB
dpc-2075	66	9	brachytherapy	brachytherapy	NOUN
dpc-2075	66	10	(	(	PUNCT
dpc-2075	66	11	brt	brt	PROPN
dpc-2075	66	12	)	)	PUNCT
dpc-2075	66	13	.	.	PUNCT
dpc-2075	67	1	ebrt	ebrt	PROPN
dpc-2075	67	2	is	be	AUX
dpc-2075	67	3	delivered	deliver	VERB
dpc-2075	67	4	via	via	ADP
dpc-2075	67	5	photon	photon	NOUN
dpc-2075	67	6	or	or	CCONJ
dpc-2075	67	7	electron	electron	NOUN
dpc-2075	67	8	beams	beam	NOUN
dpc-2075	67	9	and	and	CCONJ
dpc-2075	67	10	can	can	AUX
dpc-2075	67	11	be	be	AUX
dpc-2075	67	12	superficial	superficial	ADJ
dpc-2075	67	13	or	or	CCONJ
dpc-2075	67	14	deeply	deeply	ADV
dpc-2075	67	15	penetrating	penetrate	VERB
dpc-2075	67	16	,	,	PUNCT
dpc-2075	67	17	depending	depend	VERB
dpc-2075	67	18	on	on	ADP
dpc-2075	67	19	the	the	DET
dpc-2075	67	20	megavoltage	megavoltage	NOUN
dpc-2075	67	21	of	of	ADP
dpc-2075	67	22	the	the	DET
dpc-2075	67	23	different	different	ADJ
dpc-2075	67	24	energy	energy	NOUN
dpc-2075	67	25	sources	source	NOUN
dpc-2075	67	26	[	[	X
dpc-2075	67	27	8	8	NUM
dpc-2075	67	28	]	]	PUNCT
dpc-2075	67	29	.	.	PUNCT
dpc-2075	68	1	rt	rt	PROPN
dpc-2075	68	2	can	can	AUX
dpc-2075	68	3	be	be	AUX
dpc-2075	68	4	delivered	deliver	VERB
dpc-2075	68	5	to	to	ADP
dpc-2075	68	6	fields	field	NOUN
dpc-2075	68	7	of	of	ADP
dpc-2075	68	8	different	different	ADJ
dpc-2075	68	9	sizes	size	NOUN
dpc-2075	68	10	and	and	CCONJ
dpc-2075	68	11	with	with	ADP
dpc-2075	68	12	different	different	ADJ
dpc-2075	68	13	complex	complex	ADJ
dpc-2075	68	14	shapes	shape	NOUN
dpc-2075	68	15	.	.	PUNCT
dpc-2075	69	1	highly	highly	ADV
dpc-2075	69	2	conformal	conformal	ADJ
dpc-2075	69	3	rt	rt	PROPN
dpc-2075	69	4	,	,	PUNCT
dpc-2075	69	5	such	such	ADJ
dpc-2075	69	6	as	as	ADP
dpc-2075	69	7	tomotherapy	tomotherapy	NOUN
dpc-2075	69	8	or	or	CCONJ
dpc-2075	69	9	volumetric	volumetric	NOUN
dpc-2075	69	10	modulated	modulate	VERB
dpc-2075	69	11	arc	arc	NOUN
dpc-2075	69	12	therapy	therapy	NOUN
dpc-2075	69	13	(	(	PUNCT
dpc-2075	69	14	vmat	vmat	NOUN
dpc-2075	69	15	)	)	PUNCT
dpc-2075	69	16	,	,	PUNCT
dpc-2075	69	17	allows	allow	VERB
dpc-2075	69	18	delivery	delivery	NOUN
dpc-2075	69	19	of	of	ADP
dpc-2075	69	20	relatively	relatively	ADV
dpc-2075	69	21	superficial	superficial	ADJ
dpc-2075	69	22	rt	rt	NOUN
dpc-2075	69	23	to	to	AUX
dpc-2075	69	24	complex	complex	ADJ
dpc-2075	69	25	and	and	CCONJ
dpc-2075	69	26	often	often	ADV
dpc-2075	69	27	irregular	irregular	ADJ
dpc-2075	69	28	targets	target	NOUN
dpc-2075	69	29	,	,	PUNCT
dpc-2075	69	30	while	while	SCONJ
dpc-2075	69	31	limiting	limit	VERB
dpc-2075	69	32	the	the	DET
dpc-2075	69	33	dose	dose	NOUN
dpc-2075	69	34	to	to	ADP
dpc-2075	69	35	adjacent	adjacent	ADJ
dpc-2075	69	36	organs	organ	NOUN
dpc-2075	69	37	at	at	ADP
dpc-2075	69	38	risk	risk	NOUN
dpc-2075	69	39	(	(	PUNCT
dpc-2075	69	40	oars	oar	NOUN
dpc-2075	69	41	)	)	PUNCT
dpc-2075	70	1	[	[	X
dpc-2075	70	2	9	9	NUM
dpc-2075	70	3	,	,	PUNCT
dpc-2075	70	4	10	10	NUM
dpc-2075	70	5	]	]	PUNCT
dpc-2075	70	6	.	.	PUNCT
dpc-2075	71	1	radiation	radiation	NOUN
dpc-2075	71	2	therapy	therapy	NOUN
dpc-2075	71	3	can	can	AUX
dpc-2075	71	4	be	be	AUX
dpc-2075	71	5	administered	administer	VERB
dpc-2075	71	6	via	via	ADP
dpc-2075	71	7	different	different	ADJ
dpc-2075	71	8	techniques	technique	NOUN
dpc-2075	71	9	,	,	PUNCT
dpc-2075	71	10	several	several	ADJ
dpc-2075	71	11	fractionations	fractionation	NOUN
dpc-2075	71	12	,	,	PUNCT
dpc-2075	71	13	and	and	CCONJ
dpc-2075	71	14	total	total	ADJ
dpc-2075	71	15	doses	dose	NOUN
dpc-2075	71	16	.	.	PUNCT
dpc-2075	72	1	the	the	DET
dpc-2075	72	2	aim	aim	NOUN
dpc-2075	72	3	is	be	AUX
dpc-2075	72	4	to	to	PART
dpc-2075	72	5	match	match	VERB
dpc-2075	72	6	the	the	DET
dpc-2075	72	7	tumor	tumor	NOUN
dpc-2075	72	8	and	and	CCONJ
dpc-2075	72	9	spare	spare	ADJ
dpc-2075	72	10	healthy	healthy	ADJ
dpc-2075	72	11	tissues	tissue	NOUN
dpc-2075	72	12	from	from	ADP
dpc-2075	72	13	radiation	radiation	NOUN
dpc-2075	72	14	.	.	PUNCT
dpc-2075	73	1	rt	rt	PROPN
dpc-2075	73	2	delivery	delivery	NOUN
dpc-2075	73	3	has	have	AUX
dpc-2075	73	4	greatly	greatly	ADV
dpc-2075	73	5	improved	improve	VERB
dpc-2075	73	6	,	,	PUNCT
dpc-2075	73	7	starting	start	VERB
dpc-2075	73	8	from	from	ADP
dpc-2075	73	9	a	a	DET
dpc-2075	73	10	better	well	ADJ
dpc-2075	73	11	visualization	visualization	NOUN
dpc-2075	73	12	of	of	ADP
dpc-2075	73	13	the	the	DET
dpc-2075	73	14	target	target	NOUN
dpc-2075	73	15	with	with	ADP
dpc-2075	73	16	ever	ever	ADV
dpc-2075	73	17	-	-	PUNCT
dpc-2075	73	18	improving	improve	VERB
dpc-2075	73	19	imaging	imaging	NOUN
dpc-2075	73	20	techniques	technique	NOUN
dpc-2075	73	21	,	,	PUNCT
dpc-2075	73	22	through	through	ADP
dpc-2075	73	23	precise	precise	ADJ
dpc-2075	73	24	contouring	contouring	NOUN
dpc-2075	73	25	and	and	CCONJ
dpc-2075	73	26	treatment	treatment	NOUN
dpc-2075	73	27	planning	planning	NOUN
dpc-2075	73	28	systems	system	NOUN
dpc-2075	73	29	.	.	PUNCT
dpc-2075	74	1	many	many	ADJ
dpc-2075	74	2	quality	quality	NOUN
dpc-2075	74	3	-	-	PUNCT
dpc-2075	74	4	control	control	NOUN
dpc-2075	74	5	checks	check	NOUN
dpc-2075	74	6	have	have	AUX
dpc-2075	74	7	been	be	AUX
dpc-2075	74	8	added	add	VERB
dpc-2075	74	9	in	in	ADP
dpc-2075	74	10	the	the	DET
dpc-2075	74	11	intraand	intraand	NOUN
dpc-2075	74	12	inter	inter	ADJ
dpc-2075	74	13	-	-	ADJ
dpc-2075	74	14	fraction	fraction	ADJ
dpc-2075	74	15	assurance	assurance	NOUN
dpc-2075	74	16	.	.	PUNCT
dpc-2075	75	1	the	the	DET
dpc-2075	75	2	choice	choice	NOUN
dpc-2075	75	3	of	of	ADP
dpc-2075	75	4	the	the	DET
dpc-2075	75	5	technique	technique	NOUN
dpc-2075	75	6	is	be	AUX
dpc-2075	75	7	certainly	certainly	ADV
dpc-2075	75	8	influenced	influence	VERB
dpc-2075	75	9	by	by	ADP
dpc-2075	75	10	the	the	DET
dpc-2075	75	11	type	type	NOUN
dpc-2075	75	12	of	of	ADP
dpc-2075	75	13	tumor	tumor	NOUN
dpc-2075	75	14	,	,	PUNCT
dpc-2075	75	15	treatment	treatment	NOUN
dpc-2075	75	16	setting	setting	NOUN
dpc-2075	75	17	(	(	PUNCT
dpc-2075	75	18	radical	radical	ADJ
dpc-2075	75	19	,	,	PUNCT
dpc-2075	75	20	adjuvant	adjuvant	ADJ
dpc-2075	75	21	,	,	PUNCT
dpc-2075	75	22	or	or	CCONJ
dpc-2075	75	23	palliative	palliative	NOUN
dpc-2075	75	24	)	)	PUNCT
dpc-2075	75	25	,	,	PUNCT
dpc-2075	75	26	tumor	tumor	NOUN
dpc-2075	75	27	depth	depth	NOUN
dpc-2075	75	28	,	,	PUNCT
dpc-2075	75	29	and	and	CCONJ
dpc-2075	75	30	location	location	NOUN
dpc-2075	75	31	of	of	ADP
dpc-2075	75	32	the	the	DET
dpc-2075	75	33	tumour	tumour	NOUN
dpc-2075	75	34	that	that	PRON
dpc-2075	75	35	can	can	AUX
dpc-2075	75	36	be	be	AUX
dpc-2075	75	37	particularly	particularly	ADV
dpc-2075	75	38	unfavorable	unfavorable	ADJ
dpc-2075	75	39	and	and	CCONJ
dpc-2075	75	40	close	close	ADJ
dpc-2075	75	41	to	to	ADP
dpc-2075	75	42	sensitive	sensitive	ADJ
dpc-2075	75	43	organs	organ	NOUN
dpc-2075	75	44	at	at	ADP
dpc-2075	75	45	risk	risk	NOUN
dpc-2075	75	46	.	.	PUNCT
dpc-2075	76	1	high	high	ADJ
dpc-2075	76	2	-	-	PUNCT
dpc-2075	76	3	energy	energy	NOUN
dpc-2075	76	4	radiation	radiation	NOUN
dpc-2075	76	5	therapy	therapy	NOUN
dpc-2075	76	6	,	,	PUNCT
dpc-2075	76	7	delivered	deliver	VERB
dpc-2075	76	8	by	by	ADP
dpc-2075	76	9	a	a	DET
dpc-2075	76	10	linear	linear	ADJ
dpc-2075	76	11	accelerator	accelerator	NOUN
dpc-2075	76	12	,	,	PUNCT
dpc-2075	76	13	has	have	VERB
dpc-2075	76	14	greater	great	ADJ
dpc-2075	76	15	penetration	penetration	NOUN
dpc-2075	76	16	capacity	capacity	NOUN
dpc-2075	76	17	and	and	CCONJ
dpc-2075	76	18	is	be	AUX
dpc-2075	76	19	therefore	therefore	ADV
dpc-2075	76	20	useful	useful	ADJ
dpc-2075	76	21	to	to	PART
dpc-2075	76	22	treat	treat	VERB
dpc-2075	76	23	deeper	deep	ADJ
dpc-2075	76	24	malignant	malignant	ADJ
dpc-2075	76	25	tumors	tumor	NOUN
dpc-2075	76	26	while	while	SCONJ
dpc-2075	76	27	largely	largely	ADV
dpc-2075	76	28	sparing	spare	VERB
dpc-2075	76	29	the	the	DET
dpc-2075	76	30	skin	skin	NOUN
dpc-2075	76	31	.	.	PUNCT
dpc-2075	77	1	low	low	ADJ
dpc-2075	77	2	-	-	PUNCT
dpc-2075	77	3	energy	energy	NOUN
dpc-2075	77	4	radiation	radiation	NOUN
dpc-2075	77	5	(	(	PUNCT
dpc-2075	77	6	kilovoltage	kilovoltage	NOUN
dpc-2075	77	7	and	and	CCONJ
dpc-2075	77	8	orthovoltage	orthovoltage	NOUN
dpc-2075	77	9	)	)	PUNCT
dpc-2075	77	10	is	be	AUX
dpc-2075	77	11	preferred	prefer	VERB
dpc-2075	77	12	to	to	PART
dpc-2075	77	13	treat	treat	VERB
dpc-2075	77	14	skin	skin	NOUN
dpc-2075	77	15	lesions	lesion	NOUN
dpc-2075	77	16	where	where	SCONJ
dpc-2075	77	17	deep	deep	ADJ
dpc-2075	77	18	penetration	penetration	NOUN
dpc-2075	77	19	is	be	AUX
dpc-2075	77	20	not	not	PART
dpc-2075	77	21	necessary	necessary	ADJ
dpc-2075	77	22	and	and	CCONJ
dpc-2075	77	23	skin	skin	NOUN
dpc-2075	77	24	preservation	preservation	NOUN
dpc-2075	77	25	is	be	AUX
dpc-2075	77	26	the	the	DET
dpc-2075	77	27	main	main	ADJ
dpc-2075	77	28	concern	concern	NOUN
dpc-2075	77	29	[	[	X
dpc-2075	77	30	11	11	NUM
dpc-2075	77	31	,	,	PUNCT
dpc-2075	77	32	12	12	NUM
dpc-2075	77	33	]	]	PUNCT
dpc-2075	77	34	.	.	PUNCT
dpc-2075	78	1	rt	rt	PROPN
dpc-2075	78	2	is	be	AUX
dpc-2075	78	3	usually	usually	ADV
dpc-2075	78	4	a	a	DET
dpc-2075	78	5	well	well	ADV
dpc-2075	78	6	-	-	PUNCT
dpc-2075	78	7	tolerated	tolerate	VERB
dpc-2075	78	8	treatment	treatment	NOUN
dpc-2075	78	9	with	with	ADP
dpc-2075	78	10	specific	specific	ADJ
dpc-2075	78	11	acute	acute	ADJ
dpc-2075	78	12	and	and	CCONJ
dpc-2075	78	13	late	late	ADJ
dpc-2075	78	14	toxicities	toxicity	NOUN
dpc-2075	78	15	and	and	CCONJ
dpc-2075	78	16	documented	document	VERB
dpc-2075	78	17	advantages	advantage	NOUN
dpc-2075	78	18	and	and	CCONJ
dpc-2075	78	19	disadvantages	disadvantage	NOUN
dpc-2075	78	20	compared	compare	VERB
dpc-2075	78	21	with	with	ADP
dpc-2075	78	22	surgery	surgery	NOUN
dpc-2075	78	23	.	.	PUNCT
dpc-2075	79	1	the	the	DET
dpc-2075	79	2	most	most	ADV
dpc-2075	79	3	striking	striking	ADJ
dpc-2075	79	4	limits	limit	NOUN
dpc-2075	79	5	of	of	ADP
dpc-2075	79	6	radiation	radiation	NOUN
dpc-2075	79	7	therapy	therapy	NOUN
dpc-2075	79	8	are	be	AUX
dpc-2075	79	9	adverse	adverse	ADJ
dpc-2075	79	10	effects	effect	NOUN
dpc-2075	79	11	and	and	CCONJ
dpc-2075	79	12	contraindications	contraindication	NOUN
dpc-2075	79	13	.	.	PUNCT
dpc-2075	80	1	skin	skin	NOUN
dpc-2075	80	2	reactions	reaction	NOUN
dpc-2075	80	3	triggered	trigger	VERB
dpc-2075	80	4	by	by	ADP
dpc-2075	80	5	radiation	radiation	NOUN
dpc-2075	80	6	therapy	therapy	NOUN
dpc-2075	80	7	are	be	AUX
dpc-2075	80	8	called	call	VERB
dpc-2075	80	9	radiation	radiation	NOUN
dpc-2075	80	10	therapy	therapy	NOUN
dpc-2075	80	11	-	-	PUNCT
dpc-2075	80	12	induced	induce	VERB
dpc-2075	80	13	dermatitis	dermatitis	NOUN
dpc-2075	80	14	or	or	CCONJ
dpc-2075	80	15	radiodermatitis	radiodermatitis	PROPN
dpc-2075	80	16	.	.	PUNCT
dpc-2075	81	1	they	they	PRON
dpc-2075	81	2	can	can	AUX
dpc-2075	81	3	be	be	AUX
dpc-2075	81	4	acute	acute	ADJ
dpc-2075	81	5	(	(	PUNCT
dpc-2075	81	6	up	up	ADP
dpc-2075	81	7	to	to	PART
dpc-2075	81	8	6	6	NUM
dpc-2075	81	9	months	month	NOUN
dpc-2075	81	10	after	after	ADP
dpc-2075	81	11	the	the	DET
dpc-2075	81	12	end	end	NOUN
dpc-2075	81	13	of	of	ADP
dpc-2075	81	14	treatment	treatment	NOUN
dpc-2075	81	15	)	)	PUNCT
dpc-2075	81	16	or	or	CCONJ
dpc-2075	81	17	delayed	delay	VERB
dpc-2075	81	18	.	.	PUNCT
dpc-2075	82	1	they	they	PRON
dpc-2075	82	2	are	be	AUX
dpc-2075	82	3	related	relate	VERB
dpc-2075	82	4	to	to	ADP
dpc-2075	82	5	the	the	DET
dpc-2075	82	6	dose	dose	NOUN
dpc-2075	82	7	delivered	deliver	VERB
dpc-2075	82	8	and	and	CCONJ
dpc-2075	82	9	the	the	DET
dpc-2075	82	10	anatomical	anatomical	ADJ
dpc-2075	82	11	location	location	NOUN
dpc-2075	82	12	.	.	PUNCT
dpc-2075	83	1	acute	acute	ADJ
dpc-2075	83	2	reactions	reaction	NOUN
dpc-2075	83	3	lasts	last	VERB
dpc-2075	83	4	several	several	ADJ
dpc-2075	83	5	weeks	week	NOUN
dpc-2075	83	6	,	,	PUNCT
dpc-2075	83	7	patients	patient	NOUN
dpc-2075	83	8	may	may	AUX
dpc-2075	83	9	experience	experience	VERB
dpc-2075	83	10	skin	skin	NOUN
dpc-2075	83	11	changes	change	NOUN
dpc-2075	83	12	(	(	PUNCT
dpc-2075	83	13	ranging	range	VERB
dpc-2075	83	14	from	from	ADP
dpc-2075	83	15	faint	faint	ADJ
dpc-2075	83	16	erythema	erythema	NOUN
dpc-2075	83	17	and	and	CCONJ
dpc-2075	83	18	desquamation	desquamation	VERB
dpc-2075	83	19	to	to	ADP
dpc-2075	83	20	skin	skin	NOUN
dpc-2075	83	21	necrosis	necrosis	NOUN
dpc-2075	83	22	)	)	PUNCT
dpc-2075	83	23	and	and	CCONJ
dpc-2075	83	24	ulceration	ulceration	NOUN
dpc-2075	83	25	,	,	PUNCT
dpc-2075	83	26	depending	depend	VERB
dpc-2075	83	27	on	on	ADP
dpc-2075	83	28	the	the	DET
dpc-2075	83	29	severity	severity	NOUN
dpc-2075	83	30	of	of	ADP
dpc-2075	83	31	the	the	DET
dpc-2075	83	32	reaction	reaction	NOUN
dpc-2075	83	33	.	.	PUNCT
dpc-2075	84	1	delayed	delay	VERB
dpc-2075	84	2	reactions	reaction	NOUN
dpc-2075	84	3	usually	usually	ADV
dpc-2075	84	4	appear	appear	VERB
dpc-2075	84	5	months	month	NOUN
dpc-2075	84	6	or	or	CCONJ
dpc-2075	84	7	years	year	NOUN
dpc-2075	84	8	after	after	ADP
dpc-2075	84	9	treatment	treatment	NOUN
dpc-2075	84	10	and	and	CCONJ
dpc-2075	84	11	are	be	AUX
dpc-2075	84	12	more	more	ADV
dpc-2075	84	13	common	common	ADJ
dpc-2075	84	14	with	with	ADP
dpc-2075	84	15	higher	high	ADJ
dpc-2075	84	16	treatment	treatment	NOUN
dpc-2075	84	17	doses	dose	NOUN
dpc-2075	84	18	.	.	PUNCT
dpc-2075	85	1	the	the	DET
dpc-2075	85	2	most	most	ADV
dpc-2075	85	3	common	common	ADJ
dpc-2075	85	4	late	late	ADJ
dpc-2075	85	5	reactions	reaction	NOUN
dpc-2075	85	6	are	be	AUX
dpc-2075	85	7	hypopigmentation	hypopigmentation	NOUN
dpc-2075	85	8	and	and	CCONJ
dpc-2075	85	9	hyperpigmentation	hyperpigmentation	NOUN
dpc-2075	85	10	,	,	PUNCT
dpc-2075	85	11	telangiectasia	telangiectasia	NOUN
dpc-2075	85	12	,	,	PUNCT
dpc-2075	85	13	epidermal	epidermal	ADJ
dpc-2075	85	14	atrophy	atrophy	NOUN
dpc-2075	85	15	,	,	PUNCT
dpc-2075	85	16	skin	skin	NOUN
dpc-2075	85	17	fragility	fragility	NOUN
dpc-2075	85	18	,	,	PUNCT
dpc-2075	85	19	sebaceous	sebaceous	ADJ
dpc-2075	85	20	gland	gland	NOUN
dpc-2075	85	21	atrophy	atrophy	NOUN
dpc-2075	85	22	,	,	PUNCT
dpc-2075	85	23	alopecia	alopecia	NOUN
dpc-2075	85	24	,	,	PUNCT
dpc-2075	85	25	fibrosis	fibrosis	NOUN
dpc-2075	85	26	,	,	PUNCT
dpc-2075	85	27	necrosis	necrosis	NOUN
dpc-2075	85	28	,	,	PUNCT
dpc-2075	85	29	and	and	CCONJ
dpc-2075	85	30	an	an	DET
dpc-2075	85	31	increased	increase	VERB
dpc-2075	85	32	risk	risk	NOUN
dpc-2075	85	33	of	of	ADP
dpc-2075	85	34	certain	certain	ADJ
dpc-2075	85	35	cancers	cancer	NOUN
dpc-2075	85	36	,	,	PUNCT
dpc-2075	85	37	such	such	ADJ
dpc-2075	85	38	as	as	ADP
dpc-2075	85	39	angiosarcoma	angiosarcoma	NOUN
dpc-2075	85	40	.	.	PUNCT
dpc-2075	86	1	rt	rt	NOUN
dpc-2075	86	2	contraindications	contraindication	NOUN
dpc-2075	86	3	include	include	VERB
dpc-2075	86	4	young	young	ADJ
dpc-2075	86	5	age	age	NOUN
dpc-2075	86	6	(	(	PUNCT
dpc-2075	86	7	for	for	ADP
dpc-2075	86	8	cscc	cscc	NOUN
dpc-2075	86	9	is	be	AUX
dpc-2075	86	10	a	a	DET
dpc-2075	86	11	minor	minor	ADJ
dpc-2075	86	12	concern	concern	NOUN
dpc-2075	86	13	)	)	PUNCT
dpc-2075	86	14	,	,	PUNCT
dpc-2075	86	15	verrucous	verrucous	ADJ
dpc-2075	86	16	scc	scc	NOUN
dpc-2075	86	17	,	,	PUNCT
dpc-2075	86	18	cancer	cancer	NOUN
dpc-2075	86	19	-	-	PUNCT
dpc-2075	86	20	predisposing	predispose	VERB
dpc-2075	86	21	genodermatoses	genodermatose	NOUN
dpc-2075	86	22	,	,	PUNCT
dpc-2075	86	23	and	and	CCONJ
dpc-2075	86	24	immunodepression	immunodepression	NOUN
dpc-2075	86	25	(	(	PUNCT
dpc-2075	86	26	essential	essential	ADJ
dpc-2075	86	27	cost	cost	NOUN
dpc-2075	86	28	-	-	PUNCT
dpc-2075	86	29	benefits	benefit	NOUN
dpc-2075	86	30	analysis	analysis	NOUN
dpc-2075	86	31	)	)	PUNCT
dpc-2075	87	1	[	[	X
dpc-2075	87	2	13	13	NUM
dpc-2075	87	3	]	]	PUNCT
dpc-2075	87	4	.	.	PUNCT
dpc-2075	88	1	radiotherapy	radiotherapy	NOUN
dpc-2075	88	2	in	in	ADP
dpc-2075	88	3	the	the	DET
dpc-2075	88	4	adjuvant	adjuvant	NOUN
dpc-2075	88	5	setting	set	VERB
dpc-2075	88	6	the	the	DET
dpc-2075	88	7	goal	goal	NOUN
dpc-2075	88	8	of	of	ADP
dpc-2075	88	9	adjuvant	adjuvant	ADJ
dpc-2075	88	10	radiation	radiation	NOUN
dpc-2075	88	11	therapy	therapy	NOUN
dpc-2075	88	12	is	be	AUX
dpc-2075	88	13	to	to	PART
dpc-2075	88	14	reduce	reduce	VERB
dpc-2075	88	15	the	the	DET
dpc-2075	88	16	risk	risk	NOUN
dpc-2075	88	17	of	of	ADP
dpc-2075	88	18	local	local	ADJ
dpc-2075	88	19	or	or	CCONJ
dpc-2075	88	20	regional	regional	ADJ
dpc-2075	88	21	recurrence	recurrence	NOUN
dpc-2075	88	22	after	after	ADP
dpc-2075	88	23	surgical	surgical	ADJ
dpc-2075	88	24	excision	excision	NOUN
dpc-2075	88	25	.	.	PUNCT
dpc-2075	89	1	in	in	ADP
dpc-2075	89	2	general	general	ADJ
dpc-2075	89	3	,	,	PUNCT
dpc-2075	89	4	adjuvant	adjuvant	ADJ
dpc-2075	89	5	radiation	radiation	NOUN
dpc-2075	89	6	therapy	therapy	NOUN
dpc-2075	89	7	is	be	AUX
dpc-2075	89	8	offered	offer	VERB
dpc-2075	89	9	when	when	SCONJ
dpc-2075	89	10	the	the	DET
dpc-2075	89	11	risk	risk	NOUN
dpc-2075	89	12	of	of	ADP
dpc-2075	89	13	recurrence	recurrence	NOUN
dpc-2075	89	14	is	be	AUX
dpc-2075	89	15	high	high	ADJ
dpc-2075	89	16	or	or	CCONJ
dpc-2075	89	17	the	the	DET
dpc-2075	89	18	likelihood	likelihood	NOUN
dpc-2075	89	19	of	of	ADP
dpc-2075	89	20	successful	successful	ADJ
dpc-2075	89	21	salvage	salvage	NOUN
dpc-2075	89	22	surgery	surgery	NOUN
dpc-2075	89	23	is	be	AUX
dpc-2075	89	24	relatively	relatively	ADV
dpc-2075	89	25	low	low	ADJ
dpc-2075	90	1	[	[	X
dpc-2075	90	2	11	11	NUM
dpc-2075	90	3	]	]	PUNCT
dpc-2075	90	4	.	.	PUNCT
dpc-2075	91	1	risk	risk	NOUN
dpc-2075	91	2	factors	factor	NOUN
dpc-2075	91	3	to	to	PART
dpc-2075	91	4	look	look	VERB
dpc-2075	91	5	out	out	ADP
dpc-2075	91	6	for	for	ADP
dpc-2075	91	7	in	in	ADP
dpc-2075	91	8	cscc	cscc	ADJ
dpc-2075	91	9	include	include	VERB
dpc-2075	91	10	male	male	ADJ
dpc-2075	91	11	sex	sex	NOUN
dpc-2075	91	12	,	,	PUNCT
dpc-2075	91	13	recurrent	recurrent	ADJ
dpc-2075	91	14	disease	disease	NOUN
dpc-2075	91	15	,	,	PUNCT
dpc-2075	91	16	neoplasms	neoplasm	NOUN
dpc-2075	91	17	located	locate	VERB
dpc-2075	91	18	at	at	ADP
dpc-2075	91	19	the	the	DET
dpc-2075	91	20	center	center	NOUN
dpc-2075	91	21	of	of	ADP
dpc-2075	91	22	the	the	DET
dpc-2075	91	23	face	face	NOUN
dpc-2075	91	24	,	,	PUNCT
dpc-2075	91	25	poor	poor	ADJ
dpc-2075	91	26	histologic	histologic	ADJ
dpc-2075	91	27	differentiation	differentiation	NOUN
dpc-2075	91	28	,	,	PUNCT
dpc-2075	91	29	and	and	CCONJ
dpc-2075	91	30	deep	deep	ADJ
dpc-2075	91	31	subclinical	subclinical	ADJ
dpc-2075	91	32	extension	extension	NOUN
dpc-2075	91	33	.	.	PUNCT
dpc-2075	92	1	other	other	ADJ
dpc-2075	92	2	high	high	ADJ
dpc-2075	92	3	-	-	PUNCT
dpc-2075	92	4	risk	risk	NOUN
dpc-2075	92	5	factors	factor	NOUN
dpc-2075	92	6	for	for	ADP
dpc-2075	92	7	cscc	cscc	ADJ
dpc-2075	92	8	include	include	VERB
dpc-2075	92	9	tumor	tumor	NOUN
dpc-2075	92	10	location	location	NOUN
dpc-2075	92	11	(	(	PUNCT
dpc-2075	92	12	lip	lip	NOUN
dpc-2075	92	13	or	or	CCONJ
dpc-2075	92	14	ear	ear	NOUN
dpc-2075	92	15	)	)	PUNCT
dpc-2075	92	16	,	,	PUNCT
dpc-2075	92	17	tumors	tumor	NOUN
dpc-2075	92	18	arising	arise	VERB
dpc-2075	92	19	from	from	ADP
dpc-2075	92	20	scarring	scar	VERB
dpc-2075	92	21	tissues	tissue	NOUN
dpc-2075	92	22	,	,	PUNCT
dpc-2075	92	23	size	size	NOUN
dpc-2075	92	24	>	>	X
dpc-2075	92	25	2	2	NUM
dpc-2075	92	26	cm	cm	NOUN
dpc-2075	92	27	,	,	PUNCT
dpc-2075	92	28	depth	depth	NOUN
dpc-2075	92	29	>	>	X
dpc-2075	92	30	4	4	NUM
dpc-2075	92	31	mm	mm	NOUN
dpc-2075	92	32	or	or	CCONJ
dpc-2075	92	33	clark	clark	NOUN
dpc-2075	92	34	level	level	NOUN
dpc-2075	92	35	≥	≥	NUM
dpc-2075	92	36	iv	iv	NUM
dpc-2075	92	37	,	,	PUNCT
dpc-2075	92	38	invasion	invasion	NOUN
dpc-2075	92	39	beyond	beyond	ADP
dpc-2075	92	40	subcutaneous	subcutaneous	ADJ
dpc-2075	92	41	tissues	tissue	NOUN
dpc-2075	92	42	,	,	PUNCT
dpc-2075	92	43	rapidly	rapidly	ADV
dpc-2075	92	44	growing	grow	VERB
dpc-2075	92	45	lesions	lesion	NOUN
dpc-2075	92	46	,	,	PUNCT
dpc-2075	92	47	perineural	perineural	ADJ
dpc-2075	92	48	invasion	invasion	NOUN
dpc-2075	92	49	,	,	PUNCT
dpc-2075	92	50	desmoplasia	desmoplasia	NOUN
dpc-2075	92	51	,	,	PUNCT
dpc-2075	92	52	poor	poor	ADJ
dpc-2075	92	53	differentiation	differentiation	NOUN
dpc-2075	92	54	,	,	PUNCT
dpc-2075	92	55	and	and	CCONJ
dpc-2075	92	56	infiltrative	infiltrative	ADJ
dpc-2075	92	57	margins	margin	NOUN
dpc-2075	92	58	[	[	X
dpc-2075	92	59	14	14	NUM
dpc-2075	92	60	]	]	PUNCT
dpc-2075	92	61	.	.	PUNCT
dpc-2075	93	1	adjuvant	adjuvant	ADJ
dpc-2075	93	2	radiation	radiation	NOUN
dpc-2075	93	3	therapy	therapy	NOUN
dpc-2075	93	4	is	be	AUX
dpc-2075	93	5	recommended	recommend	VERB
dpc-2075	93	6	after	after	ADP
dpc-2075	93	7	extensive	extensive	ADJ
dpc-2075	93	8	surgical	surgical	ADJ
dpc-2075	93	9	excision	excision	NOUN
dpc-2075	93	10	with	with	ADP
dpc-2075	93	11	close	close	ADJ
dpc-2075	93	12	or	or	CCONJ
dpc-2075	93	13	positive	positive	ADJ
dpc-2075	93	14	margins	margin	NOUN
dpc-2075	93	15	(	(	PUNCT
dpc-2075	93	16	only	only	ADV
dpc-2075	93	17	if	if	SCONJ
dpc-2075	93	18	the	the	DET
dpc-2075	93	19	tumor	tumor	NOUN
dpc-2075	93	20	can	can	AUX
dpc-2075	93	21	not	not	PART
dpc-2075	93	22	be	be	AUX
dpc-2075	93	23	re	re	VERB
dpc-2075	93	24	-	-	VERB
dpc-2075	93	25	excised	excise	VERB
dpc-2075	93	26	)	)	PUNCT
dpc-2075	93	27	or	or	CCONJ
dpc-2075	93	28	in	in	ADP
dpc-2075	93	29	the	the	DET
dpc-2075	93	30	presence	presence	NOUN
dpc-2075	93	31	of	of	ADP
dpc-2075	93	32	high	high	ADJ
dpc-2075	93	33	-	-	PUNCT
dpc-2075	93	34	risk	risk	NOUN
dpc-2075	93	35	factors	factor	NOUN
dpc-2075	93	36	,	,	PUNCT
dpc-2075	93	37	including	include	VERB
dpc-2075	93	38	perineural	perineural	ADJ
dpc-2075	93	39	invasion	invasion	NOUN
dpc-2075	93	40	(	(	PUNCT
dpc-2075	93	41	pni	pni	NOUN
dpc-2075	93	42	)	)	PUNCT
dpc-2075	93	43	,	,	PUNCT
dpc-2075	93	44	invasion	invasion	NOUN
dpc-2075	93	45	of	of	ADP
dpc-2075	93	46	bone	bone	NOUN
dpc-2075	93	47	or	or	CCONJ
dpc-2075	93	48	nerves	nerve	NOUN
dpc-2075	93	49	,	,	PUNCT
dpc-2075	93	50	or	or	CCONJ
dpc-2075	93	51	in	in	ADP
dpc-2075	93	52	case	case	NOUN
dpc-2075	93	53	of	of	ADP
dpc-2075	93	54	recurrent	recurrent	ADJ
dpc-2075	93	55	disease	disease	NOUN
dpc-2075	93	56	after	after	ADP
dpc-2075	93	57	previous	previous	ADJ
dpc-2075	93	58	surgical	surgical	ADJ
dpc-2075	93	59	excision	excision	NOUN
dpc-2075	93	60	or	or	CCONJ
dpc-2075	93	61	other	other	ADJ
dpc-2075	93	62	medical	medical	ADJ
dpc-2075	93	63	therapy	therapy	NOUN
dpc-2075	93	64	[	[	X
dpc-2075	93	65	15	15	NUM
dpc-2075	93	66	]	]	PUNCT
dpc-2075	93	67	.	.	PUNCT
dpc-2075	94	1	the	the	DET
dpc-2075	94	2	rate	rate	NOUN
dpc-2075	94	3	of	of	ADP
dpc-2075	94	4	positive	positive	ADJ
dpc-2075	94	5	margins	margin	NOUN
dpc-2075	94	6	after	after	ADP
dpc-2075	94	7	excision	excision	NOUN
dpc-2075	94	8	in	in	ADP
dpc-2075	94	9	cscc	cscc	ADJ
dpc-2075	94	10	ranges	range	NOUN
dpc-2075	94	11	from	from	ADP
dpc-2075	94	12	5.8	5.8	NUM
dpc-2075	94	13	%	%	NOUN
dpc-2075	94	14	to	to	ADP
dpc-2075	94	15	17.6	17.6	NUM
dpc-2075	94	16	%	%	NOUN
dpc-2075	94	17	and	and	CCONJ
dpc-2075	94	18	is	be	AUX
dpc-2075	94	19	influenced	influence	VERB
dpc-2075	94	20	by	by	ADP
dpc-2075	94	21	the	the	DET
dpc-2075	94	22	adopted	adopt	VERB
dpc-2075	94	23	technique	technique	NOUN
dpc-2075	94	24	[	[	X
dpc-2075	94	25	16,17	16,17	NUM
dpc-2075	94	26	]	]	PUNCT
dpc-2075	94	27	.	.	PUNCT
dpc-2075	95	1	positive	positive	ADJ
dpc-2075	95	2	margins	margin	NOUN
dpc-2075	95	3	after	after	ADP
dpc-2075	95	4	surgery	surgery	NOUN
dpc-2075	95	5	have	have	AUX
dpc-2075	95	6	been	be	AUX
dpc-2075	95	7	reported	report	VERB
dpc-2075	95	8	as	as	ADP
dpc-2075	95	9	prognostic	prognostic	ADJ
dpc-2075	95	10	in	in	ADP
dpc-2075	95	11	a	a	DET
dpc-2075	95	12	study	study	NOUN
dpc-2075	95	13	[	[	X
dpc-2075	95	14	18	18	NUM
dpc-2075	95	15	]	]	PUNCT
dpc-2075	95	16	.	.	PUNCT
dpc-2075	96	1	indeed	indeed	ADV
dpc-2075	96	2	,	,	PUNCT
dpc-2075	96	3	csccs	csccs	VERB
dpc-2075	96	4	with	with	ADP
dpc-2075	96	5	a	a	DET
dpc-2075	96	6	close	close	ADJ
dpc-2075	96	7	or	or	CCONJ
dpc-2075	96	8	positive	positive	ADJ
dpc-2075	96	9	surgical	surgical	ADJ
dpc-2075	96	10	margin	margin	NOUN
dpc-2075	96	11	have	have	VERB
dpc-2075	96	12	an	an	DET
dpc-2075	96	13	increased	increase	VERB
dpc-2075	96	14	risk	risk	NOUN
dpc-2075	96	15	of	of	ADP
dpc-2075	96	16	local	local	ADJ
dpc-2075	96	17	recurrence	recurrence	NOUN
dpc-2075	96	18	and	and	CCONJ
dpc-2075	96	19	locoregional	locoregional	ADJ
dpc-2075	96	20	metastasis	metastasis	NOUN
dpc-2075	96	21	[	[	X
dpc-2075	96	22	19	19	NUM
dpc-2075	96	23	]	]	PUNCT
dpc-2075	96	24	.	.	PUNCT
dpc-2075	97	1	postoperative	postoperative	ADJ
dpc-2075	97	2	rt	rt	PROPN
dpc-2075	97	3	is	be	AUX
dpc-2075	97	4	a	a	DET
dpc-2075	97	5	treatment	treatment	NOUN
dpc-2075	97	6	option	option	NOUN
dpc-2075	97	7	for	for	ADP
dpc-2075	97	8	tumors	tumor	NOUN
dpc-2075	97	9	with	with	ADP
dpc-2075	97	10	margins	margin	NOUN
dpc-2075	97	11	that	that	PRON
dpc-2075	97	12	are	be	AUX
dpc-2075	97	13	not	not	PART
dpc-2075	97	14	completely	completely	ADV
dpc-2075	97	15	excised	excise	VERB
dpc-2075	97	16	or	or	CCONJ
dpc-2075	97	17	can	can	AUX
dpc-2075	97	18	not	not	PART
dpc-2075	97	19	be	be	AUX
dpc-2075	97	20	completely	completely	ADV
dpc-2075	97	21	resected	resect	VERB
dpc-2075	97	22	.	.	PUNCT
dpc-2075	98	1	in	in	ADP
dpc-2075	98	2	a	a	DET
dpc-2075	98	3	study	study	NOUN
dpc-2075	98	4	of	of	ADP
dpc-2075	98	5	cscc	cscc	NOUN
dpc-2075	98	6	of	of	ADP
dpc-2075	98	7	the	the	DET
dpc-2075	98	8	lower	low	ADJ
dpc-2075	98	9	lip	lip	NOUN
dpc-2075	98	10	that	that	PRON
dpc-2075	98	11	included	include	VERB
dpc-2075	98	12	tumors	tumor	NOUN
dpc-2075	98	13	with	with	ADP
dpc-2075	98	14	a	a	DET
dpc-2075	98	15	close	close	ADJ
dpc-2075	98	16	or	or	CCONJ
dpc-2075	98	17	positive	positive	ADJ
dpc-2075	98	18	margin	margin	NOUN
dpc-2075	98	19	,	,	PUNCT
dpc-2075	98	20	the	the	DET
dpc-2075	98	21	local	local	ADJ
dpc-2075	98	22	recurrence	recurrence	NOUN
dpc-2075	98	23	rate	rate	NOUN
dpc-2075	98	24	was	be	AUX
dpc-2075	98	25	64	64	NUM
dpc-2075	98	26	%	%	NOUN
dpc-2075	98	27	for	for	ADP
dpc-2075	98	28	tumors	tumor	NOUN
dpc-2075	98	29	with	with	ADP
dpc-2075	98	30	positive	positive	ADJ
dpc-2075	98	31	margins	margin	NOUN
dpc-2075	98	32	that	that	PRON
dpc-2075	98	33	were	be	AUX
dpc-2075	98	34	not	not	PART
dpc-2075	98	35	subsequently	subsequently	ADV
dpc-2075	98	36	excised	excise	VERB
dpc-2075	98	37	versus	versus	ADP
dpc-2075	98	38	a	a	DET
dpc-2075	98	39	6	6	NUM
dpc-2075	98	40	%	%	NOUN
dpc-2075	98	41	rate	rate	NOUN
dpc-2075	98	42	for	for	ADP
dpc-2075	98	43	those	those	PRON
dpc-2075	98	44	treated	treat	VERB
dpc-2075	98	45	with	with	ADP
dpc-2075	98	46	postoperative	postoperative	ADJ
dpc-2075	98	47	rt	rt	PROPN
dpc-2075	99	1	[	[	X
dpc-2075	99	2	20	20	NUM
dpc-2075	99	3	]	]	PUNCT
dpc-2075	99	4	.	.	PUNCT
dpc-2075	100	1	pni	pni	PROPN
dpc-2075	100	2	is	be	AUX
dpc-2075	100	3	an	an	DET
dpc-2075	100	4	important	important	ADJ
dpc-2075	100	5	risk	risk	NOUN
dpc-2075	100	6	factor	factor	NOUN
dpc-2075	100	7	because	because	SCONJ
dpc-2075	100	8	it	it	PRON
dpc-2075	100	9	has	have	AUX
dpc-2075	100	10	been	be	AUX
dpc-2075	100	11	shown	show	VERB
dpc-2075	100	12	to	to	PART
dpc-2075	100	13	be	be	AUX
dpc-2075	100	14	associated	associate	VERB
dpc-2075	100	15	with	with	ADP
dpc-2075	100	16	a	a	DET
dpc-2075	100	17	higher	high	ADJ
dpc-2075	100	18	risk	risk	NOUN
dpc-2075	100	19	of	of	ADP
dpc-2075	100	20	recurrence	recurrence	NOUN
dpc-2075	100	21	and	and	CCONJ
dpc-2075	100	22	a	a	DET
dpc-2075	100	23	higher	high	ADJ
dpc-2075	100	24	incidence	incidence	NOUN
dpc-2075	100	25	of	of	ADP
dpc-2075	100	26	lymph	lymph	NOUN
dpc-2075	100	27	node	node	VERB
dpc-2075	100	28	metastasis	metastasis	NOUN
dpc-2075	100	29	[	[	X
dpc-2075	100	30	18	18	NUM
dpc-2075	100	31	]	]	PUNCT
dpc-2075	100	32	.	.	PUNCT
dpc-2075	101	1	pni	pni	PROPN
dpc-2075	101	2	occurs	occur	VERB
dpc-2075	101	3	in	in	ADP
dpc-2075	101	4	between	between	ADP
dpc-2075	101	5	2.5	2.5	NUM
dpc-2075	101	6	%	%	NOUN
dpc-2075	101	7	and	and	CCONJ
dpc-2075	101	8	14	14	NUM
dpc-2075	101	9	%	%	NOUN
dpc-2075	101	10	of	of	ADP
dpc-2075	101	11	csccs	csccs	PROPN
dpc-2075	101	12	,	,	PUNCT
dpc-2075	101	13	usually	usually	ADV
dpc-2075	101	14	found	find	VERB
dpc-2075	101	15	as	as	ADP
dpc-2075	101	16	an	an	DET
dpc-2075	101	17	incidental	incidental	ADJ
dpc-2075	101	18	histologic	histologic	NOUN
dpc-2075	101	19	finding	finding	NOUN
dpc-2075	101	20	.	.	PUNCT
dpc-2075	102	1	it	it	PRON
dpc-2075	102	2	has	have	AUX
dpc-2075	102	3	been	be	AUX
dpc-2075	102	4	linked	link	VERB
dpc-2075	102	5	to	to	ADP
dpc-2075	102	6	poor	poor	ADJ
dpc-2075	102	7	prognosis	prognosis	NOUN
dpc-2075	102	8	and	and	CCONJ
dpc-2075	102	9	a	a	DET
dpc-2075	102	10	higher	high	ADJ
dpc-2075	102	11	rate	rate	NOUN
dpc-2075	102	12	of	of	ADP
dpc-2075	102	13	metastasis	metastasis	NOUN
dpc-2075	102	14	and	and	CCONJ
dpc-2075	102	15	disease	disease	NOUN
dpc-2075	102	16	-	-	PUNCT
dpc-2075	102	17	specific	specific	ADJ
dpc-2075	102	18	death	death	NOUN
dpc-2075	102	19	[	[	X
dpc-2075	102	20	14,21,22	14,21,22	NUM
dpc-2075	102	21	]	]	X
dpc-2075	102	22	.	.	PUNCT
dpc-2075	103	1	extensive	extensive	ADJ
dpc-2075	103	2	pni	pni	NOUN
dpc-2075	103	3	is	be	AUX
dpc-2075	103	4	an	an	DET
dpc-2075	103	5	indication	indication	NOUN
dpc-2075	103	6	for	for	ADP
dpc-2075	103	7	postoperative	postoperative	ADJ
dpc-2075	103	8	rt	rt	PROPN
dpc-2075	103	9	according	accord	VERB
dpc-2075	103	10	to	to	ADP
dpc-2075	103	11	nccn	nccn	ADJ
dpc-2075	103	12	guidelines	guideline	NOUN
dpc-2075	103	13	[	[	X
dpc-2075	103	14	23	23	NUM
dpc-2075	103	15	]	]	PUNCT
dpc-2075	103	16	.	.	PUNCT
dpc-2075	104	1	postoperative	postoperative	PROPN
dpc-2075	104	2	rt	rt	PROPN
dpc-2075	104	3	has	have	AUX
dpc-2075	104	4	also	also	ADV
dpc-2075	104	5	been	be	AUX
dpc-2075	104	6	recommended	recommend	VERB
dpc-2075	104	7	for	for	ADP
dpc-2075	104	8	high	high	ADJ
dpc-2075	104	9	-	-	PUNCT
dpc-2075	104	10	risk	risk	NOUN
dpc-2075	104	11	tumors	tumor	NOUN
dpc-2075	104	12	.	.	PUNCT
dpc-2075	105	1	historically	historically	ADV
dpc-2075	105	2	,	,	PUNCT
dpc-2075	105	3	the	the	DET
dpc-2075	105	4	definition	definition	NOUN
dpc-2075	105	5	of	of	ADP
dpc-2075	105	6	high	high	ADJ
dpc-2075	105	7	risk	risk	NOUN
dpc-2075	105	8	has	have	AUX
dpc-2075	105	9	been	be	AUX
dpc-2075	105	10	a	a	DET
dpc-2075	105	11	matter	matter	NOUN
dpc-2075	105	12	of	of	ADP
dpc-2075	105	13	debate	debate	NOUN
dpc-2075	105	14	.	.	PUNCT
dpc-2075	106	1	guidelines	guideline	NOUN
dpc-2075	106	2	agree	agree	VERB
dpc-2075	106	3	on	on	ADP
dpc-2075	106	4	the	the	DET
dpc-2075	106	5	definition	definition	NOUN
dpc-2075	106	6	of	of	ADP
dpc-2075	106	7	high	high	ADJ
dpc-2075	106	8	risk	risk	NOUN
dpc-2075	106	9	as	as	ADP
dpc-2075	106	10	a	a	DET
dpc-2075	106	11	disease	disease	NOUN
dpc-2075	106	12	characterized	characterize	VERB
dpc-2075	106	13	by	by	ADP
dpc-2075	106	14	diameter	diameter	NOUN
dpc-2075	106	15	>	>	X
dpc-2075	106	16	2	2	NUM
dpc-2075	106	17	cm	cm	NOUN
dpc-2075	106	18	,	,	PUNCT
dpc-2075	106	19	a	a	DET
dpc-2075	106	20	thickness	thickness	NOUN
dpc-2075	106	21	>	>	X
dpc-2075	106	22	2	2	NUM
dpc-2075	106	23	mm	mm	NOUN
dpc-2075	106	24	(	(	PUNCT
dpc-2075	106	25	and	and	CCONJ
dpc-2075	106	26	especially	especially	ADV
dpc-2075	106	27	6	6	NUM
dpc-2075	106	28	mm	mm	NOUN
dpc-2075	106	29	)	)	PUNCT
dpc-2075	106	30	,	,	PUNCT
dpc-2075	106	31	poor	poor	ADJ
dpc-2075	106	32	differentiation	differentiation	NOUN
dpc-2075	106	33	,	,	PUNCT
dpc-2075	106	34	ear	ear	NOUN
dpc-2075	106	35	or	or	CCONJ
dpc-2075	106	36	lip	lip	NOUN
dpc-2075	106	37	location	location	NOUN
dpc-2075	106	38	,	,	PUNCT
dpc-2075	106	39	pni	pni	NOUN
dpc-2075	106	40	,	,	PUNCT
dpc-2075	106	41	recurrence	recurrence	NOUN
dpc-2075	106	42	,	,	PUNCT
dpc-2075	106	43	and	and	CCONJ
dpc-2075	106	44	immunosuppression	immunosuppression	NOUN
dpc-2075	106	45	[	[	X
dpc-2075	106	46	24	24	NUM
dpc-2075	106	47	]	]	PUNCT
dpc-2075	106	48	.	.	PUNCT
dpc-2075	107	1	most	most	ADJ
dpc-2075	107	2	of	of	ADP
dpc-2075	107	3	the	the	DET
dpc-2075	107	4	evidence	evidence	NOUN
dpc-2075	107	5	regarding	regard	VERB
dpc-2075	107	6	the	the	DET
dpc-2075	107	7	role	role	NOUN
dpc-2075	107	8	of	of	ADP
dpc-2075	107	9	postoperative	postoperative	ADJ
dpc-2075	107	10	rt	rt	PROPN
dpc-2075	107	11	in	in	ADP
dpc-2075	107	12	the	the	DET
dpc-2075	107	13	other	other	ADJ
dpc-2075	107	14	risk	risk	NOUN
dpc-2075	107	15	is	be	AUX
dpc-2075	107	16	derived	derive	VERB
dpc-2075	107	17	from	from	ADP
dpc-2075	107	18	a	a	DET
dpc-2075	107	19	2009	2009	NUM
dpc-2075	107	20	systematic	systematic	ADJ
dpc-2075	107	21	review	review	NOUN
dpc-2075	107	22	indicating	indicate	VERB
dpc-2075	107	23	that	that	SCONJ
dpc-2075	107	24	prognosis	prognosis	NOUN
dpc-2075	107	25	is	be	AUX
dpc-2075	107	26	generally	generally	ADV
dpc-2075	107	27	excellent	excellent	ADJ
dpc-2075	107	28	as	as	ADV
dpc-2075	107	29	long	long	ADV
dpc-2075	107	30	as	as	SCONJ
dpc-2075	107	31	margins	margin	NOUN
dpc-2075	107	32	are	be	AUX
dpc-2075	107	33	negative	negative	ADJ
dpc-2075	107	34	and	and	CCONJ
dpc-2075	107	35	pni	pni	NOUN
dpc-2075	107	36	is	be	AUX
dpc-2075	107	37	not	not	PART
dpc-2075	107	38	observed	observe	VERB
dpc-2075	107	39	,	,	PUNCT
dpc-2075	107	40	and	and	CCONJ
dpc-2075	107	41	therefore	therefore	ADV
dpc-2075	107	42	postoperative	postoperative	ADJ
dpc-2075	107	43	rt	rt	PROPN
dpc-2075	107	44	is	be	AUX
dpc-2075	107	45	not	not	PART
dpc-2075	107	46	necessary	necessary	ADJ
dpc-2075	107	47	if	if	SCONJ
dpc-2075	107	48	no	no	DET
dpc-2075	107	49	such	such	ADJ
dpc-2075	107	50	findings	finding	NOUN
dpc-2075	107	51	occur	occur	VERB
dpc-2075	107	52	[	[	X
dpc-2075	107	53	25	25	NUM
dpc-2075	107	54	]	]	PUNCT
dpc-2075	107	55	.	.	PUNCT
dpc-2075	108	1	cscc	cscc	VERB
dpc-2075	108	2	with	with	ADP
dpc-2075	108	3	cranial	cranial	ADJ
dpc-2075	108	4	nerve	nerve	NOUN
dpc-2075	108	5	invasion	invasion	NOUN
dpc-2075	108	6	,	,	PUNCT
dpc-2075	108	7	on	on	ADP
dpc-2075	108	8	the	the	DET
dpc-2075	108	9	other	other	ADJ
dpc-2075	108	10	hand	hand	NOUN
dpc-2075	108	11	,	,	PUNCT
dpc-2075	108	12	represents	represent	VERB
dpc-2075	108	13	a	a	DET
dpc-2075	108	14	possible	possible	ADJ
dpc-2075	108	15	criterion	criterion	NOUN
dpc-2075	108	16	for	for	ADP
dpc-2075	108	17	choosing	choose	VERB
dpc-2075	108	18	to	to	PART
dpc-2075	108	19	perform	perform	VERB
dpc-2075	108	20	postoperative	postoperative	ADJ
dpc-2075	108	21	rt	rt	PROPN
dpc-2075	109	1	[	[	X
dpc-2075	109	2	26	26	NUM
dpc-2075	109	3	]	]	PUNCT
dpc-2075	109	4	.	.	PUNCT
dpc-2075	110	1	several	several	ADJ
dpc-2075	110	2	rt	rt	PROPN
dpc-2075	110	3	schedules	schedule	NOUN
dpc-2075	110	4	have	have	AUX
dpc-2075	110	5	been	be	AUX
dpc-2075	110	6	used	use	VERB
dpc-2075	110	7	for	for	ADP
dpc-2075	110	8	adjuvant	adjuvant	ADJ
dpc-2075	110	9	treatment	treatment	NOUN
dpc-2075	110	10	of	of	ADP
dpc-2075	110	11	cscc	cscc	NOUN
dpc-2075	110	12	.	.	PUNCT
dpc-2075	111	1	briefly	briefly	ADV
dpc-2075	111	2	,	,	PUNCT
dpc-2075	111	3	the	the	DET
dpc-2075	111	4	proposed	propose	VERB
dpc-2075	111	5	algorithm	algorithm	NOUN
dpc-2075	111	6	by	by	ADP
dpc-2075	111	7	the	the	DET
dpc-2075	111	8	nccn	nccn	NOUN
dpc-2075	111	9	includes	include	VERB
dpc-2075	111	10	doses	dose	NOUN
dpc-2075	111	11	of	of	ADP
dpc-2075	111	12	60	60	NUM
dpc-2075	111	13	-	-	SYM
dpc-2075	111	14	64	64	NUM
dpc-2075	111	15	gy	gy	NOUN
dpc-2075	111	16	over	over	ADP
dpc-2075	111	17	6	6	NUM
dpc-2075	111	18	to	to	PART
dpc-2075	111	19	7	7	NUM
dpc-2075	111	20	weeks	week	NOUN
dpc-2075	111	21	or	or	CCONJ
dpc-2075	111	22	50	50	NUM
dpc-2075	111	23	gy	gy	NOUN
dpc-2075	111	24	over	over	ADP
dpc-2075	111	25	4	4	NUM
dpc-2075	111	26	weeks	week	NOUN
dpc-2075	112	1	[	[	X
dpc-2075	112	2	23	23	NUM
dpc-2075	112	3	]	]	PUNCT
dpc-2075	112	4	.	.	PUNCT
dpc-2075	113	1	4	4	NUM
dpc-2075	113	2	review	review	NOUN
dpc-2075	113	3	|	|	ADV
dpc-2075	113	4	dermatol	dermatol	ADJ
dpc-2075	113	5	pract	pract	NOUN
dpc-2075	113	6	concept	concept	NOUN
dpc-2075	113	7	.	.	PUNCT
dpc-2075	114	1	2021	2021	NUM
dpc-2075	114	2	;	;	PUNCT
dpc-2075	114	3	11(s2	11(s2	NUM
dpc-2075	114	4	):	):	PUNCT
dpc-2075	114	5	e2021168s	e2021168s	PROPN
dpc-2075	114	6	radiotherapy	radiotherapy	NOUN
dpc-2075	114	7	in	in	ADP
dpc-2075	114	8	the	the	DET
dpc-2075	114	9	definitive	definitive	ADJ
dpc-2075	114	10	setting	set	VERB
dpc-2075	114	11	definitive	definitive	ADJ
dpc-2075	114	12	primary	primary	ADJ
dpc-2075	114	13	rt	rt	PROPN
dpc-2075	114	14	represents	represent	VERB
dpc-2075	114	15	a	a	DET
dpc-2075	114	16	curative	curative	ADJ
dpc-2075	114	17	and	and	CCONJ
dpc-2075	114	18	alternative	alternative	ADJ
dpc-2075	114	19	treatment	treatment	NOUN
dpc-2075	114	20	strategy	strategy	NOUN
dpc-2075	114	21	to	to	ADP
dpc-2075	114	22	surgery	surgery	NOUN
dpc-2075	114	23	for	for	ADP
dpc-2075	114	24	cscc	cscc	NOUN
dpc-2075	114	25	.	.	PUNCT
dpc-2075	115	1	rt	rt	PROPN
dpc-2075	115	2	may	may	AUX
dpc-2075	115	3	be	be	AUX
dpc-2075	115	4	considered	consider	VERB
dpc-2075	115	5	as	as	ADP
dpc-2075	115	6	primary	primary	ADJ
dpc-2075	115	7	treatment	treatment	NOUN
dpc-2075	115	8	in	in	ADP
dpc-2075	115	9	patients	patient	NOUN
dpc-2075	115	10	who	who	PRON
dpc-2075	115	11	are	be	AUX
dpc-2075	115	12	not	not	PART
dpc-2075	115	13	candidates	candidate	NOUN
dpc-2075	115	14	for	for	ADP
dpc-2075	115	15	surgery	surgery	NOUN
dpc-2075	115	16	(	(	PUNCT
dpc-2075	115	17	eg	eg	NOUN
dpc-2075	115	18	locally	locally	ADV
dpc-2075	115	19	advanced	advance	VERB
dpc-2075	115	20	cscc	cscc	ADJ
dpc-2075	115	21	,	,	PUNCT
dpc-2075	115	22	comorbidities	comorbiditie	NOUN
dpc-2075	115	23	,	,	PUNCT
dpc-2075	115	24	or	or	CCONJ
dpc-2075	115	25	refusal	refusal	NOUN
dpc-2075	115	26	of	of	ADP
dpc-2075	115	27	surgery	surgery	NOUN
dpc-2075	115	28	)	)	PUNCT
dpc-2075	115	29	or	or	CCONJ
dpc-2075	115	30	in	in	ADP
dpc-2075	115	31	cases	case	NOUN
dpc-2075	115	32	where	where	SCONJ
dpc-2075	115	33	surgery	surgery	NOUN
dpc-2075	115	34	is	be	AUX
dpc-2075	115	35	not	not	PART
dpc-2075	115	36	feasible	feasible	ADJ
dpc-2075	115	37	.	.	PUNCT
dpc-2075	116	1	this	this	PRON
dpc-2075	116	2	may	may	AUX
dpc-2075	116	3	occur	occur	VERB
dpc-2075	116	4	when	when	SCONJ
dpc-2075	116	5	the	the	DET
dpc-2075	116	6	surgical	surgical	ADJ
dpc-2075	116	7	approach	approach	NOUN
dpc-2075	116	8	could	could	AUX
dpc-2075	116	9	result	result	VERB
dpc-2075	116	10	in	in	ADP
dpc-2075	116	11	poor	poor	ADJ
dpc-2075	116	12	functional	functional	ADJ
dpc-2075	116	13	outcomes	outcome	NOUN
dpc-2075	116	14	or	or	CCONJ
dpc-2075	116	15	be	be	AUX
dpc-2075	116	16	disfiguring	disfigure	VERB
dpc-2075	116	17	,	,	PUNCT
dpc-2075	116	18	as	as	ADP
dpc-2075	116	19	in	in	ADP
dpc-2075	116	20	large	large	ADJ
dpc-2075	116	21	cscc	cscc	ADJ
dpc-2075	116	22	lesions	lesion	NOUN
dpc-2075	116	23	located	locate	VERB
dpc-2075	116	24	on	on	ADP
dpc-2075	116	25	the	the	DET
dpc-2075	116	26	face	face	NOUN
dpc-2075	116	27	(	(	PUNCT
dpc-2075	116	28	eg	eg	NOUN
dpc-2075	116	29	eyelids	eyelid	NOUN
dpc-2075	116	30	,	,	PUNCT
dpc-2075	116	31	nose	nose	NOUN
dpc-2075	116	32	,	,	PUNCT
dpc-2075	116	33	and	and	CCONJ
dpc-2075	116	34	lips	lip	NOUN
dpc-2075	116	35	)	)	PUNCT
dpc-2075	116	36	or	or	CCONJ
dpc-2075	116	37	large	large	ADJ
dpc-2075	116	38	lesions	lesion	NOUN
dpc-2075	116	39	on	on	ADP
dpc-2075	116	40	the	the	DET
dpc-2075	116	41	ear	ear	NOUN
dpc-2075	116	42	,	,	PUNCT
dpc-2075	116	43	forehead	forehead	NOUN
dpc-2075	116	44	,	,	PUNCT
dpc-2075	116	45	or	or	CCONJ
dpc-2075	116	46	scalp	scalp	NOUN
dpc-2075	116	47	[	[	X
dpc-2075	116	48	13	13	NUM
dpc-2075	116	49	]	]	PUNCT
dpc-2075	116	50	.	.	PUNCT
dpc-2075	117	1	no	no	DET
dpc-2075	117	2	prospective	prospective	ADJ
dpc-2075	117	3	randomized	randomized	ADJ
dpc-2075	117	4	trials	trial	NOUN
dpc-2075	117	5	comparing	compare	VERB
dpc-2075	117	6	the	the	DET
dpc-2075	117	7	efficacy	efficacy	NOUN
dpc-2075	117	8	of	of	ADP
dpc-2075	117	9	primary	primary	ADJ
dpc-2075	117	10	rt	rt	PROPN
dpc-2075	117	11	in	in	ADP
dpc-2075	117	12	local	local	ADJ
dpc-2075	117	13	tumor	tumor	NOUN
dpc-2075	117	14	control	control	NOUN
dpc-2075	117	15	and	and	CCONJ
dpc-2075	117	16	patient	patient	ADJ
dpc-2075	117	17	survival	survival	NOUN
dpc-2075	117	18	compared	compare	VERB
dpc-2075	117	19	with	with	ADP
dpc-2075	117	20	other	other	ADJ
dpc-2075	117	21	local	local	ADJ
dpc-2075	117	22	therapy	therapy	NOUN
dpc-2075	117	23	modalities	modality	NOUN
dpc-2075	117	24	are	be	AUX
dpc-2075	117	25	available	available	ADJ
dpc-2075	117	26	.	.	PUNCT
dpc-2075	118	1	a	a	DET
dpc-2075	118	2	mean	mean	ADJ
dpc-2075	118	3	local	local	ADJ
dpc-2075	118	4	recurrence	recurrence	NOUN
dpc-2075	118	5	rate	rate	NOUN
dpc-2075	118	6	of	of	ADP
dpc-2075	118	7	6.4	6.4	NUM
dpc-2075	118	8	%	%	NOUN
dpc-2075	118	9	was	be	AUX
dpc-2075	118	10	reported	report	VERB
dpc-2075	118	11	in	in	ADP
dpc-2075	118	12	a	a	DET
dpc-2075	118	13	meta	meta	ADJ
dpc-2075	118	14	-	-	PUNCT
dpc-2075	118	15	analysis	analysis	NOUN
dpc-2075	118	16	analyzing	analyze	VERB
dpc-2075	118	17	1018	1018	NUM
dpc-2075	118	18	csscs	cssc	NOUN
dpc-2075	118	19	,	,	PUNCT
dpc-2075	118	20	including	include	VERB
dpc-2075	118	21	14	14	NUM
dpc-2075	118	22	observational	observational	ADJ
dpc-2075	118	23	rt	rt	PROPN
dpc-2075	118	24	studies	study	NOUN
dpc-2075	118	25	[	[	X
dpc-2075	118	26	1	1	NUM
dpc-2075	118	27	]	]	PUNCT
dpc-2075	118	28	.	.	PUNCT
dpc-2075	119	1	also	also	ADV
dpc-2075	119	2	in	in	ADP
dpc-2075	119	3	the	the	DET
dpc-2075	119	4	exclusive	exclusive	ADJ
dpc-2075	119	5	setting	setting	NOUN
dpc-2075	119	6	,	,	PUNCT
dpc-2075	119	7	rt	rt	PROPN
dpc-2075	119	8	dose	dose	NOUN
dpc-2075	119	9	can	can	AUX
dpc-2075	119	10	be	be	AUX
dpc-2075	119	11	delivered	deliver	VERB
dpc-2075	119	12	as	as	ADP
dpc-2075	119	13	either	either	CCONJ
dpc-2075	119	14	ebrt	ebrt	ADJ
dpc-2075	119	15	or	or	CCONJ
dpc-2075	119	16	brt	brt	PROPN
dpc-2075	119	17	.	.	PROPN
dpc-2075	119	18	ebrt	ebrt	PROPN
dpc-2075	119	19	can	can	AUX
dpc-2075	119	20	use	use	VERB
dpc-2075	119	21	both	both	DET
dpc-2075	119	22	photons	photon	NOUN
dpc-2075	119	23	and	and	CCONJ
dpc-2075	119	24	electrons	electron	NOUN
dpc-2075	119	25	,	,	PUNCT
dpc-2075	119	26	with	with	ADP
dpc-2075	119	27	deeply	deeply	ADV
dpc-2075	119	28	penetrating	penetrate	VERB
dpc-2075	119	29	energies	energy	NOUN
dpc-2075	119	30	in	in	ADP
dpc-2075	119	31	the	the	DET
dpc-2075	119	32	range	range	NOUN
dpc-2075	119	33	of	of	ADP
dpc-2075	119	34	4	4	NUM
dpc-2075	119	35	-	-	SYM
dpc-2075	119	36	10	10	NUM
dpc-2075	119	37	mv	mv	NOUN
dpc-2075	119	38	.	.	PUNCT
dpc-2075	120	1	treatment	treatment	NOUN
dpc-2075	120	2	can	can	AUX
dpc-2075	120	3	be	be	AUX
dpc-2075	120	4	administered	administer	VERB
dpc-2075	120	5	to	to	ADP
dpc-2075	120	6	a	a	DET
dpc-2075	120	7	small	small	ADJ
dpc-2075	120	8	surface	surface	NOUN
dpc-2075	120	9	area	area	NOUN
dpc-2075	120	10	(	(	PUNCT
dpc-2075	120	11	eg	eg	ADP
dpc-2075	120	12	the	the	DET
dpc-2075	120	13	nasal	nasal	ADJ
dpc-2075	120	14	wing	wing	NOUN
dpc-2075	120	15	)	)	PUNCT
dpc-2075	120	16	or	or	CCONJ
dpc-2075	120	17	a	a	DET
dpc-2075	120	18	large	large	ADJ
dpc-2075	120	19	complex	complex	ADJ
dpc-2075	120	20	volume	volume	NOUN
dpc-2075	120	21	(	(	PUNCT
dpc-2075	120	22	eg	eg	VERB
dpc-2075	120	23	the	the	DET
dpc-2075	120	24	entire	entire	ADJ
dpc-2075	120	25	scalp	scalp	NOUN
dpc-2075	120	26	or	or	CCONJ
dpc-2075	120	27	base	base	NOUN
dpc-2075	120	28	of	of	ADP
dpc-2075	120	29	the	the	DET
dpc-2075	120	30	skull	skull	NOUN
dpc-2075	120	31	)	)	PUNCT
dpc-2075	120	32	.	.	PUNCT
dpc-2075	121	1	the	the	DET
dpc-2075	121	2	total	total	ADJ
dpc-2075	121	3	prescribed	prescribed	ADJ
dpc-2075	121	4	dose	dose	NOUN
dpc-2075	121	5	and	and	CCONJ
dpc-2075	121	6	fractionation	fractionation	NOUN
dpc-2075	121	7	should	should	AUX
dpc-2075	121	8	reflect	reflect	VERB
dpc-2075	121	9	differences	difference	NOUN
dpc-2075	121	10	in	in	ADP
dpc-2075	121	11	radiobiologic	radiobiologic	ADJ
dpc-2075	121	12	efficacy	efficacy	NOUN
dpc-2075	121	13	between	between	ADP
dpc-2075	121	14	radiation	radiation	NOUN
dpc-2075	121	15	modalities	modality	NOUN
dpc-2075	121	16	.	.	PUNCT
dpc-2075	122	1	briefly	briefly	NOUN
dpc-2075	122	2	,	,	PUNCT
dpc-2075	122	3	doses	dose	NOUN
dpc-2075	122	4	of	of	ADP
dpc-2075	122	5	45	45	NUM
dpc-2075	122	6	-	-	SYM
dpc-2075	122	7	50	50	NUM
dpc-2075	122	8	gy	gy	NOUN
dpc-2075	122	9	in	in	ADP
dpc-2075	122	10	fractions	fraction	NOUN
dpc-2075	122	11	of	of	ADP
dpc-2075	122	12	2.5	2.5	NUM
dpc-2075	122	13	-	-	SYM
dpc-2075	122	14	3	3	NUM
dpc-2075	122	15	gy	gy	NOUN
dpc-2075	122	16	are	be	AUX
dpc-2075	122	17	recommended	recommend	VERB
dpc-2075	122	18	for	for	ADP
dpc-2075	122	19	tumors	tumor	NOUN
dpc-2075	122	20	<	<	X
dpc-2075	122	21	2	2	NUM
dpc-2075	122	22	cm	cm	NOUN
dpc-2075	122	23	and	and	CCONJ
dpc-2075	122	24	doses	dose	NOUN
dpc-2075	122	25	of	of	ADP
dpc-2075	122	26	60	60	NUM
dpc-2075	122	27	-	-	SYM
dpc-2075	122	28	66	66	NUM
dpc-2075	122	29	gy	gy	NOUN
dpc-2075	122	30	in	in	ADP
dpc-2075	122	31	fractions	fraction	NOUN
dpc-2075	122	32	of	of	ADP
dpc-2075	122	33	2	2	NUM
dpc-2075	122	34	gy	gy	NOUN
dpc-2075	122	35	or	or	CCONJ
dpc-2075	122	36	50	50	NUM
dpc-2075	122	37	-	-	SYM
dpc-2075	122	38	60	60	NUM
dpc-2075	122	39	gy	gy	NOUN
dpc-2075	122	40	in	in	ADP
dpc-2075	122	41	fractions	fraction	NOUN
dpc-2075	122	42	of	of	ADP
dpc-2075	122	43	2.5	2.5	NUM
dpc-2075	122	44	gy	gy	NOUN
dpc-2075	122	45	for	for	ADP
dpc-2075	122	46	tumors	tumor	NOUN
dpc-2075	122	47	>	>	X
dpc-2075	122	48	2	2	NUM
dpc-2075	122	49	cm	cm	NOUN
dpc-2075	123	1	[	[	X
dpc-2075	123	2	1	1	NUM
dpc-2075	123	3	]	]	PUNCT
dpc-2075	123	4	.	.	PUNCT
dpc-2075	124	1	rt	rt	PROPN
dpc-2075	124	2	is	be	AUX
dpc-2075	124	3	an	an	DET
dpc-2075	124	4	overall	overall	ADJ
dpc-2075	124	5	safe	safe	ADJ
dpc-2075	124	6	procedure	procedure	NOUN
dpc-2075	124	7	,	,	PUNCT
dpc-2075	124	8	although	although	SCONJ
dpc-2075	124	9	it	it	PRON
dpc-2075	124	10	can	can	AUX
dpc-2075	124	11	be	be	AUX
dpc-2075	124	12	associated	associate	VERB
dpc-2075	124	13	with	with	ADP
dpc-2075	124	14	both	both	CCONJ
dpc-2075	124	15	acute	acute	ADJ
dpc-2075	124	16	and	and	CCONJ
dpc-2075	124	17	late	late	ADJ
dpc-2075	124	18	toxicities	toxicity	NOUN
dpc-2075	124	19	.	.	PUNCT
dpc-2075	125	1	the	the	DET
dpc-2075	125	2	most	most	ADV
dpc-2075	125	3	frequent	frequent	ADJ
dpc-2075	125	4	acute	acute	NOUN
dpc-2075	125	5	toxicity	toxicity	NOUN
dpc-2075	125	6	may	may	AUX
dpc-2075	125	7	consist	consist	VERB
dpc-2075	125	8	of	of	ADP
dpc-2075	125	9	acute	acute	NOUN
dpc-2075	125	10	,	,	PUNCT
dpc-2075	125	11	often	often	ADV
dpc-2075	125	12	erosive	erosive	VERB
dpc-2075	125	13	dermatitis	dermatitis	NOUN
dpc-2075	125	14	,	,	PUNCT
dpc-2075	125	15	while	while	SCONJ
dpc-2075	125	16	late	late	ADJ
dpc-2075	125	17	onset	onset	NOUN
dpc-2075	125	18	chronic	chronic	ADJ
dpc-2075	125	19	depigmentation	depigmentation	NOUN
dpc-2075	125	20	and	and	CCONJ
dpc-2075	125	21	telangiectasias	telangiectasia	NOUN
dpc-2075	125	22	are	be	AUX
dpc-2075	125	23	more	more	ADV
dpc-2075	125	24	often	often	ADV
dpc-2075	125	25	seen	see	VERB
dpc-2075	125	26	.	.	PUNCT
dpc-2075	126	1	moreover	moreover	ADV
dpc-2075	126	2	,	,	PUNCT
dpc-2075	126	3	rt	rt	PROPN
dpc-2075	126	4	should	should	AUX
dpc-2075	126	5	not	not	PART
dpc-2075	126	6	be	be	AUX
dpc-2075	126	7	recommended	recommend	VERB
dpc-2075	126	8	in	in	ADP
dpc-2075	126	9	younger	young	ADJ
dpc-2075	126	10	(	(	PUNCT
dpc-2075	126	11	<	<	X
dpc-2075	126	12	60	60	NUM
dpc-2075	126	13	years	year	NOUN
dpc-2075	126	14	old	old	ADJ
dpc-2075	126	15	)	)	PUNCT
dpc-2075	126	16	patients	patient	NOUN
dpc-2075	126	17	because	because	SCONJ
dpc-2075	126	18	chronic	chronic	ADJ
dpc-2075	126	19	toxicity	toxicity	NOUN
dpc-2075	126	20	becomes	become	VERB
dpc-2075	126	21	more	more	ADV
dpc-2075	126	22	visible	visible	ADJ
dpc-2075	126	23	with	with	ADP
dpc-2075	126	24	age	age	NOUN
dpc-2075	126	25	.	.	PUNCT
dpc-2075	127	1	higher	high	ADJ
dpc-2075	127	2	doses	dose	NOUN
dpc-2075	127	3	per	per	ADP
dpc-2075	127	4	fraction	fraction	NOUN
dpc-2075	127	5	lead	lead	NOUN
dpc-2075	127	6	to	to	ADP
dpc-2075	127	7	higher	high	ADJ
dpc-2075	127	8	rates	rate	NOUN
dpc-2075	127	9	of	of	ADP
dpc-2075	127	10	late	late	ADJ
dpc-2075	127	11	toxicity	toxicity	NOUN
dpc-2075	127	12	[	[	X
dpc-2075	127	13	27	27	NUM
dpc-2075	127	14	]	]	PUNCT
dpc-2075	127	15	.	.	PUNCT
dpc-2075	128	1	therefore	therefore	ADV
dpc-2075	128	2	,	,	PUNCT
dpc-2075	128	3	accelerated	accelerate	VERB
dpc-2075	128	4	fractionation	fractionation	NOUN
dpc-2075	128	5	schemes	scheme	NOUN
dpc-2075	128	6	(	(	PUNCT
dpc-2075	128	7	acceleration	acceleration	NOUN
dpc-2075	128	8	means	mean	VERB
dpc-2075	128	9	radiation	radiation	NOUN
dpc-2075	128	10	treatment	treatment	NOUN
dpc-2075	128	11	in	in	ADP
dpc-2075	128	12	which	which	PRON
dpc-2075	128	13	the	the	DET
dpc-2075	128	14	total	total	ADJ
dpc-2075	128	15	dose	dose	NOUN
dpc-2075	128	16	of	of	ADP
dpc-2075	128	17	radiation	radiation	NOUN
dpc-2075	128	18	is	be	AUX
dpc-2075	128	19	given	give	VERB
dpc-2075	128	20	over	over	ADP
dpc-2075	128	21	a	a	DET
dpc-2075	128	22	shorter	short	ADJ
dpc-2075	128	23	period	period	NOUN
dpc-2075	128	24	of	of	ADP
dpc-2075	128	25	time	time	NOUN
dpc-2075	128	26	compared	compare	VERB
dpc-2075	128	27	to	to	ADP
dpc-2075	128	28	standard	standard	ADJ
dpc-2075	128	29	radiation	radiation	NOUN
dpc-2075	128	30	therapy	therapy	NOUN
dpc-2075	128	31	)	)	PUNCT
dpc-2075	128	32	should	should	AUX
dpc-2075	128	33	be	be	AUX
dpc-2075	128	34	reserved	reserve	VERB
dpc-2075	128	35	for	for	ADP
dpc-2075	128	36	elderly	elderly	ADJ
dpc-2075	128	37	and	and	CCONJ
dpc-2075	128	38	frail	frail	ADJ
dpc-2075	128	39	patients	patient	NOUN
dpc-2075	128	40	,	,	PUNCT
dpc-2075	128	41	or	or	CCONJ
dpc-2075	128	42	when	when	SCONJ
dpc-2075	128	43	the	the	DET
dpc-2075	128	44	cosmetic	cosmetic	ADJ
dpc-2075	128	45	outcome	outcome	NOUN
dpc-2075	128	46	is	be	AUX
dpc-2075	128	47	less	less	ADV
dpc-2075	128	48	important	important	ADJ
dpc-2075	128	49	.	.	PUNCT
dpc-2075	129	1	the	the	DET
dpc-2075	129	2	volume	volume	NOUN
dpc-2075	129	3	to	to	PART
dpc-2075	129	4	be	be	AUX
dpc-2075	129	5	irradiated	irradiate	VERB
dpc-2075	129	6	in	in	ADP
dpc-2075	129	7	csccs	csccs	PROPN
dpc-2075	129	8	represents	represent	VERB
dpc-2075	129	9	the	the	DET
dpc-2075	129	10	visible	visible	ADJ
dpc-2075	129	11	disease	disease	NOUN
dpc-2075	129	12	gross	gross	ADJ
dpc-2075	129	13	tumor	tumor	NOUN
dpc-2075	129	14	volume	volume	NOUN
dpc-2075	129	15	(	(	PUNCT
dpc-2075	129	16	gtv	gtv	PROPN
dpc-2075	129	17	)	)	PUNCT
dpc-2075	129	18	associated	associate	VERB
dpc-2075	129	19	with	with	ADP
dpc-2075	129	20	microscopic	microscopic	ADJ
dpc-2075	129	21	disease	disease	NOUN
dpc-2075	129	22	and	and	CCONJ
dpc-2075	129	23	possible	possible	ADJ
dpc-2075	129	24	leakage	leakage	NOUN
dpc-2075	129	25	pathways	pathway	NOUN
dpc-2075	129	26	.	.	PUNCT
dpc-2075	130	1	the	the	DET
dpc-2075	130	2	prescribed	prescribed	ADJ
dpc-2075	130	3	dose	dose	NOUN
dpc-2075	130	4	should	should	AUX
dpc-2075	130	5	therefore	therefore	ADV
dpc-2075	130	6	include	include	VERB
dpc-2075	130	7	all	all	DET
dpc-2075	130	8	visible	visible	ADJ
dpc-2075	130	9	tumors	tumor	NOUN
dpc-2075	130	10	plus	plus	CCONJ
dpc-2075	130	11	an	an	DET
dpc-2075	130	12	appropriate	appropriate	ADJ
dpc-2075	130	13	variable	variable	ADJ
dpc-2075	130	14	margin	margin	NOUN
dpc-2075	130	15	(	(	PUNCT
dpc-2075	130	16	clinical	clinical	ADJ
dpc-2075	130	17	target	target	NOUN
dpc-2075	130	18	volume	volume	NOUN
dpc-2075	130	19	)	)	PUNCT
dpc-2075	130	20	,	,	PUNCT
dpc-2075	130	21	sparing	spare	VERB
dpc-2075	130	22	surrounding	surround	VERB
dpc-2075	130	23	healthy	healthy	ADJ
dpc-2075	130	24	structures	structure	NOUN
dpc-2075	130	25	as	as	ADV
dpc-2075	130	26	much	much	ADV
dpc-2075	130	27	as	as	ADP
dpc-2075	130	28	possible	possible	ADJ
dpc-2075	130	29	[	[	X
dpc-2075	130	30	28,29	28,29	NUM
dpc-2075	130	31	]	]	PUNCT
dpc-2075	130	32	.	.	PUNCT
dpc-2075	131	1	dosimetry	dosimetry	NOUN
dpc-2075	131	2	and	and	CCONJ
dpc-2075	131	3	technical	technical	ADJ
dpc-2075	131	4	details	detail	NOUN
dpc-2075	131	5	should	should	AUX
dpc-2075	131	6	be	be	AUX
dpc-2075	131	7	monitored	monitor	VERB
dpc-2075	131	8	by	by	ADP
dpc-2075	131	9	a	a	DET
dpc-2075	131	10	certified	certify	VERB
dpc-2075	131	11	radiation	radiation	NOUN
dpc-2075	131	12	oncologist	oncologist	NOUN
dpc-2075	131	13	,	,	PUNCT
dpc-2075	131	14	for	for	ADP
dpc-2075	131	15	some	some	DET
dpc-2075	131	16	difficult	difficult	ADJ
dpc-2075	131	17	anatomical	anatomical	ADJ
dpc-2075	131	18	sites	site	NOUN
dpc-2075	131	19	there	there	PRON
dpc-2075	131	20	is	be	VERB
dpc-2075	131	21	the	the	DET
dpc-2075	131	22	risk	risk	NOUN
dpc-2075	131	23	to	to	PART
dpc-2075	131	24	undertreat	undertreat	VERB
dpc-2075	131	25	some	some	DET
dpc-2075	131	26	cscc	cscc	NOUN
dpc-2075	131	27	.	.	PUNCT
dpc-2075	132	1	rt	rt	PROPN
dpc-2075	132	2	may	may	AUX
dpc-2075	132	3	be	be	AUX
dpc-2075	132	4	combined	combine	VERB
dpc-2075	132	5	with	with	ADP
dpc-2075	132	6	systemic	systemic	ADJ
dpc-2075	132	7	therapies	therapy	NOUN
dpc-2075	132	8	including	include	VERB
dpc-2075	132	9	chemotherapy	chemotherapy	NOUN
dpc-2075	132	10	(	(	PUNCT
dpc-2075	132	11	chemoradiation	chemoradiation	NOUN
dpc-2075	132	12	)	)	PUNCT
dpc-2075	132	13	or	or	CCONJ
dpc-2075	132	14	cetuximab	cetuximab	NOUN
dpc-2075	132	15	in	in	ADP
dpc-2075	132	16	more	more	ADV
dpc-2075	132	17	advanced	advanced	ADJ
dpc-2075	132	18	cases	case	NOUN
dpc-2075	132	19	(	(	PUNCT
dpc-2075	132	20	for	for	ADP
dpc-2075	132	21	h	h	NOUN
dpc-2075	132	22	/	/	SYM
dpc-2075	132	23	n	n	CCONJ
dpc-2075	132	24	tumours	tumour	NOUN
dpc-2075	132	25	)	)	PUNCT
dpc-2075	132	26	.	.	PUNCT
dpc-2075	133	1	age	age	NOUN
dpc-2075	133	2	is	be	AUX
dpc-2075	133	3	a	a	DET
dpc-2075	133	4	very	very	ADV
dpc-2075	133	5	important	important	ADJ
dpc-2075	133	6	issue	issue	NOUN
dpc-2075	133	7	for	for	ADP
dpc-2075	133	8	dose	dose	NOUN
dpc-2075	133	9	/	/	SYM
dpc-2075	133	10	fractionation	fractionation	NOUN
dpc-2075	133	11	decisions	decision	NOUN
dpc-2075	133	12	:	:	PUNCT
dpc-2075	133	13	as	as	SCONJ
dpc-2075	133	14	mentioned	mention	VERB
dpc-2075	133	15	above	above	ADV
dpc-2075	133	16	,	,	PUNCT
dpc-2075	133	17	there	there	PRON
dpc-2075	133	18	are	be	VERB
dpc-2075	133	19	multiple	multiple	ADJ
dpc-2075	133	20	dose	dose	NOUN
dpc-2075	133	21	fractionation	fractionation	NOUN
dpc-2075	133	22	schedules	schedule	NOUN
dpc-2075	133	23	,	,	PUNCT
dpc-2075	133	24	but	but	CCONJ
dpc-2075	133	25	in	in	ADP
dpc-2075	133	26	patients	patient	NOUN
dpc-2075	133	27	<	<	X
dpc-2075	133	28	50	50	NUM
dpc-2075	133	29	years	year	NOUN
dpc-2075	133	30	old	old	ADJ
dpc-2075	133	31	rt	rt	PROPN
dpc-2075	133	32	fraction	fraction	NOUN
dpc-2075	133	33	sizes	size	NOUN
dpc-2075	133	34	of	of	ADP
dpc-2075	133	35	2	2	NUM
dpc-2075	133	36	-	-	SYM
dpc-2075	133	37	2.5gy	2.5gy	NUM
dpc-2075	133	38	are	be	AUX
dpc-2075	133	39	delivered	deliver	VERB
dpc-2075	133	40	over	over	ADP
dpc-2075	133	41	a	a	DET
dpc-2075	133	42	period	period	NOUN
dpc-2075	133	43	of	of	ADP
dpc-2075	133	44	4	4	NUM
dpc-2075	133	45	-	-	SYM
dpc-2075	133	46	5	5	NUM
dpc-2075	133	47	weeks	week	NOUN
dpc-2075	133	48	,	,	PUNCT
dpc-2075	133	49	with	with	ADP
dpc-2075	133	50	the	the	DET
dpc-2075	133	51	aim	aim	NOUN
dpc-2075	133	52	of	of	ADP
dpc-2075	133	53	achieving	achieve	VERB
dpc-2075	133	54	the	the	DET
dpc-2075	133	55	best	good	ADJ
dpc-2075	133	56	long	long	ADJ
dpc-2075	133	57	-	-	PUNCT
dpc-2075	133	58	term	term	NOUN
dpc-2075	133	59	results	result	NOUN
dpc-2075	133	60	(	(	PUNCT
dpc-2075	133	61	heal	heal	NOUN
dpc-2075	133	62	and	and	CCONJ
dpc-2075	133	63	cosmetic	cosmetic	ADJ
dpc-2075	133	64	outcome	outcome	NOUN
dpc-2075	133	65	)	)	PUNCT
dpc-2075	134	1	[	[	X
dpc-2075	134	2	30	30	NUM
dpc-2075	134	3	]	]	PUNCT
dpc-2075	134	4	.	.	PUNCT
dpc-2075	135	1	when	when	SCONJ
dpc-2075	135	2	deciding	decide	VERB
dpc-2075	135	3	on	on	ADP
dpc-2075	135	4	the	the	DET
dpc-2075	135	5	number	number	NOUN
dpc-2075	135	6	of	of	ADP
dpc-2075	135	7	fractions	fraction	NOUN
dpc-2075	135	8	to	to	PART
dpc-2075	135	9	prescribe	prescribe	VERB
dpc-2075	135	10	for	for	ADP
dpc-2075	135	11	an	an	DET
dpc-2075	135	12	appropriate	appropriate	ADJ
dpc-2075	135	13	course	course	NOUN
dpc-2075	135	14	of	of	ADP
dpc-2075	135	15	radiotherapy	radiotherapy	NOUN
dpc-2075	135	16	,	,	PUNCT
dpc-2075	135	17	age	age	NOUN
dpc-2075	135	18	must	must	AUX
dpc-2075	135	19	be	be	AUX
dpc-2075	135	20	considered	consider	VERB
dpc-2075	135	21	together	together	ADV
dpc-2075	135	22	with	with	ADP
dpc-2075	135	23	the	the	DET
dpc-2075	135	24	patient	patient	NOUN
dpc-2075	135	25	’s	’s	PART
dpc-2075	135	26	medical	medical	ADJ
dpc-2075	135	27	co	co	NOUN
dpc-2075	135	28	-	-	NOUN
dpc-2075	135	29	morbidity	morbidity	NOUN
dpc-2075	135	30	,	,	PUNCT
dpc-2075	135	31	performance	performance	NOUN
dpc-2075	135	32	status	status	NOUN
dpc-2075	135	33	,	,	PUNCT
dpc-2075	135	34	and	and	CCONJ
dpc-2075	135	35	preference	preference	NOUN
dpc-2075	135	36	.	.	PUNCT
dpc-2075	136	1	in	in	ADP
dpc-2075	136	2	older	old	ADJ
dpc-2075	136	3	(	(	PUNCT
dpc-2075	136	4	70	70	NUM
dpc-2075	136	5	-	-	SYM
dpc-2075	136	6	80	80	NUM
dpc-2075	136	7	years	year	NOUN
dpc-2075	136	8	old	old	ADJ
dpc-2075	136	9	)	)	PUNCT
dpc-2075	136	10	patients	patient	NOUN
dpc-2075	136	11	it	it	PRON
dpc-2075	136	12	could	could	AUX
dpc-2075	136	13	be	be	AUX
dpc-2075	136	14	useful	useful	ADJ
dpc-2075	136	15	to	to	PART
dpc-2075	136	16	decrease	decrease	VERB
dpc-2075	136	17	the	the	DET
dpc-2075	136	18	total	total	ADJ
dpc-2075	136	19	duration	duration	NOUN
dpc-2075	136	20	of	of	ADP
dpc-2075	136	21	treatment	treatment	NOUN
dpc-2075	136	22	using	use	VERB
dpc-2075	136	23	daily	daily	ADJ
dpc-2075	136	24	rt	rt	PROPN
dpc-2075	136	25	fraction	fraction	NOUN
dpc-2075	136	26	sizes	size	NOUN
dpc-2075	136	27	of	of	ADP
dpc-2075	136	28	3	3	NUM
dpc-2075	136	29	-	-	PUNCT
dpc-2075	136	30	4gy	4gy	NOUN
dpc-2075	136	31	over	over	ADP
dpc-2075	136	32	a	a	DET
dpc-2075	136	33	period	period	NOUN
dpc-2075	136	34	of	of	ADP
dpc-2075	136	35	2	2	NUM
dpc-2075	136	36	-	-	SYM
dpc-2075	136	37	3	3	NUM
dpc-2075	136	38	weeks	week	NOUN
dpc-2075	136	39	(	(	PUNCT
dpc-2075	136	40	40	40	NUM
dpc-2075	136	41	-	-	PUNCT
dpc-2075	136	42	45gy	45gy	NOUN
dpc-2075	136	43	in	in	ADP
dpc-2075	136	44	10	10	NUM
dpc-2075	136	45	-	-	SYM
dpc-2075	136	46	15	15	NUM
dpc-2075	136	47	fractions	fraction	NOUN
dpc-2075	136	48	)	)	PUNCT
dpc-2075	136	49	.	.	PUNCT
dpc-2075	137	1	in	in	ADP
dpc-2075	137	2	elderly	elderly	ADJ
dpc-2075	137	3	patients	patient	NOUN
dpc-2075	137	4	(	(	PUNCT
dpc-2075	137	5	>	>	SYM
dpc-2075	137	6	80	80	NUM
dpc-2075	137	7	years	year	NOUN
dpc-2075	137	8	old	old	ADJ
dpc-2075	137	9	)	)	PUNCT
dpc-2075	137	10	less	less	ADV
dpc-2075	137	11	frequent	frequent	ADJ
dpc-2075	137	12	(	(	PUNCT
dpc-2075	137	13	1	1	NUM
dpc-2075	137	14	to	to	PART
dpc-2075	137	15	3	3	NUM
dpc-2075	137	16	times	time	NOUN
dpc-2075	137	17	per	per	ADP
dpc-2075	137	18	week	week	NOUN
dpc-2075	137	19	)	)	PUNCT
dpc-2075	137	20	and	and	CCONJ
dpc-2075	137	21	larger	large	ADJ
dpc-2075	137	22	fraction	fraction	NOUN
dpc-2075	137	23	sizes	size	NOUN
dpc-2075	137	24	are	be	AUX
dpc-2075	137	25	recommended	recommend	VERB
dpc-2075	137	26	,	,	PUNCT
dpc-2075	137	27	such	such	ADJ
dpc-2075	137	28	as	as	ADP
dpc-2075	137	29	5	5	NUM
dpc-2075	137	30	-	-	PUNCT
dpc-2075	137	31	7gy	7gy	NOUN
dpc-2075	137	32	in	in	ADP
dpc-2075	137	33	5	5	NUM
dpc-2075	137	34	to	to	PART
dpc-2075	137	35	6	6	NUM
dpc-2075	137	36	fractions	fraction	NOUN
dpc-2075	137	37	[	[	X
dpc-2075	137	38	31	31	NUM
dpc-2075	137	39	]	]	PUNCT
dpc-2075	137	40	.	.	PUNCT
dpc-2075	138	1	hypofractionated	hypofractionate	VERB
dpc-2075	138	2	rt	rt	PROPN
dpc-2075	138	3	delivered	deliver	VERB
dpc-2075	138	4	2	2	NUM
dpc-2075	138	5	-	-	SYM
dpc-2075	138	6	3	3	NUM
dpc-2075	138	7	times	time	NOUN
dpc-2075	138	8	a	a	DET
dpc-2075	138	9	week	week	NOUN
dpc-2075	138	10	or	or	CCONJ
dpc-2075	138	11	once	once	ADV
dpc-2075	138	12	weekly	weekly	ADJ
dpc-2075	138	13	is	be	AUX
dpc-2075	138	14	a	a	DET
dpc-2075	138	15	highly	highly	ADV
dpc-2075	138	16	effective	effective	ADJ
dpc-2075	138	17	option	option	NOUN
dpc-2075	138	18	with	with	ADP
dpc-2075	138	19	tolerable	tolerable	ADJ
dpc-2075	138	20	treatment	treatment	NOUN
dpc-2075	138	21	-	-	PUNCT
dpc-2075	138	22	related	relate	VERB
dpc-2075	138	23	toxicity	toxicity	NOUN
dpc-2075	138	24	(	(	PUNCT
dpc-2075	138	25	figures	figure	NOUN
dpc-2075	138	26	1	1	NUM
dpc-2075	138	27	and	and	CCONJ
dpc-2075	138	28	2	2	NUM
dpc-2075	138	29	)	)	PUNCT
dpc-2075	138	30	.	.	PUNCT
dpc-2075	139	1	two	two	NUM
dpc-2075	139	2	recent	recent	ADJ
dpc-2075	139	3	systematic	systematic	ADJ
dpc-2075	139	4	reviews	review	NOUN
dpc-2075	139	5	of	of	ADP
dpc-2075	139	6	hypofractionated	hypofractionated	ADJ
dpc-2075	139	7	rt	rt	PROPN
dpc-2075	139	8	reported	report	VERB
dpc-2075	139	9	durable	durable	ADJ
dpc-2075	139	10	local	local	ADJ
dpc-2075	139	11	control	control	NOUN
dpc-2075	139	12	rates	rate	NOUN
dpc-2075	139	13	of	of	ADP
dpc-2075	139	14	over	over	ADP
dpc-2075	139	15	90	90	NUM
dpc-2075	139	16	%	%	NOUN
dpc-2075	139	17	and	and	CCONJ
dpc-2075	139	18	acceptable	acceptable	ADJ
dpc-2075	139	19	side	side	NOUN
dpc-2075	139	20	effects	effect	NOUN
dpc-2075	139	21	[	[	X
dpc-2075	139	22	32	32	NUM
dpc-2075	139	23	]	]	PUNCT
dpc-2075	139	24	.	.	PUNCT
dpc-2075	140	1	in	in	ADP
dpc-2075	140	2	a	a	DET
dpc-2075	140	3	systematic	systematic	ADJ
dpc-2075	140	4	review	review	NOUN
dpc-2075	140	5	comprising	comprise	VERB
dpc-2075	140	6	40	40	NUM
dpc-2075	140	7	relevant	relevant	ADJ
dpc-2075	140	8	publications	publication	NOUN
dpc-2075	140	9	(	(	PUNCT
dpc-2075	140	10	external	external	ADJ
dpc-2075	140	11	beam	beam	NOUN
dpc-2075	140	12	rt	rt	PROPN
dpc-2075	140	13	and	and	CCONJ
dpc-2075	140	14	brachytherapy	brachytherapy	NOUN
dpc-2075	140	15	included	include	VERB
dpc-2075	140	16	)	)	PUNCT
dpc-2075	140	17	of	of	ADP
dpc-2075	140	18	over	over	ADP
dpc-2075	140	19	12	12	NUM
dpc-2075	140	20	000	000	NUM
dpc-2075	140	21	nmsc	nmsc	NOUN
dpc-2075	140	22	(	(	PUNCT
dpc-2075	140	23	24	24	NUM
dpc-2075	140	24	%	%	NOUN
dpc-2075	140	25	scc	scc	PROPN
dpc-2075	140	26	)	)	PUNCT
dpc-2075	140	27	,	,	PUNCT
dpc-2075	140	28	local	local	ADJ
dpc-2075	140	29	recurrence	recurrence	NOUN
dpc-2075	140	30	rates	rate	NOUN
dpc-2075	140	31	did	do	AUX
dpc-2075	140	32	not	not	PART
dpc-2075	140	33	exceed	exceed	VERB
dpc-2075	140	34	7.9	7.9	NUM
dpc-2075	140	35	%	%	NOUN
dpc-2075	140	36	.	.	PUNCT
dpc-2075	141	1	the	the	DET
dpc-2075	141	2	authors	author	NOUN
dpc-2075	141	3	concluded	conclude	VERB
dpc-2075	141	4	that	that	SCONJ
dpc-2075	141	5	hypofractionated	hypofractionate	VERB
dpc-2075	141	6	rt	rt	PROPN
dpc-2075	141	7	does	do	AUX
dpc-2075	141	8	not	not	PART
dpc-2075	141	9	confer	confer	VERB
dpc-2075	141	10	no	no	DET
dpc-2075	141	11	obvious	obvious	ADJ
dpc-2075	141	12	disadvantage	disadvantage	NOUN
dpc-2075	141	13	in	in	ADP
dpc-2075	141	14	local	local	ADJ
dpc-2075	141	15	control	control	NOUN
dpc-2075	141	16	when	when	SCONJ
dpc-2075	141	17	compared	compare	VERB
dpc-2075	141	18	with	with	ADP
dpc-2075	141	19	traditional	traditional	ADJ
dpc-2075	141	20	more	more	ADV
dpc-2075	141	21	protracted	protracted	ADJ
dpc-2075	141	22	rt	rt	PROPN
dpc-2075	141	23	schedules	schedule	NOUN
dpc-2075	141	24	[	[	X
dpc-2075	141	25	33	33	NUM
dpc-2075	141	26	]	]	PUNCT
dpc-2075	141	27	.	.	PUNCT
dpc-2075	142	1	rt	rt	PROPN
dpc-2075	142	2	could	could	AUX
dpc-2075	142	3	have	have	VERB
dpc-2075	142	4	also	also	ADV
dpc-2075	142	5	an	an	DET
dpc-2075	142	6	important	important	ADJ
dpc-2075	142	7	role	role	NOUN
dpc-2075	142	8	in	in	ADP
dpc-2075	142	9	palliative	palliative	ADJ
dpc-2075	142	10	setting	setting	NOUN
dpc-2075	142	11	for	for	ADP
dpc-2075	142	12	bleeding	bleed	VERB
dpc-2075	142	13	tumors	tumor	NOUN
dpc-2075	142	14	,	,	PUNCT
dpc-2075	142	15	to	to	PART
dpc-2075	142	16	reduce	reduce	VERB
dpc-2075	142	17	disfiguring	disfigure	VERB
dpc-2075	142	18	or	or	CCONJ
dpc-2075	142	19	symptomatic	symptomatic	ADJ
dpc-2075	142	20	neoplasms	neoplasm	NOUN
dpc-2075	142	21	:	:	PUNCT
dpc-2075	142	22	the	the	DET
dpc-2075	142	23	most	most	ADV
dpc-2075	142	24	used	use	VERB
dpc-2075	142	25	schedules	schedule	NOUN
dpc-2075	142	26	are	be	AUX
dpc-2075	142	27	30	30	NUM
dpc-2075	142	28	gy	gy	NOUN
dpc-2075	142	29	in	in	ADP
dpc-2075	142	30	10	10	NUM
dpc-2075	142	31	daily	daily	ADJ
dpc-2075	142	32	fractions	fraction	NOUN
dpc-2075	142	33	or	or	CCONJ
dpc-2075	142	34	20	20	NUM
dpc-2075	142	35	gy	gy	NOUN
dpc-2075	142	36	in	in	ADP
dpc-2075	142	37	5	5	NUM
dpc-2075	142	38	fractions	fraction	NOUN
dpc-2075	142	39	.	.	PUNCT
dpc-2075	143	1	brachytherapy	brachytherapy	NOUN
dpc-2075	143	2	brachytherapy	brachytherapy	NOUN
dpc-2075	143	3	for	for	ADP
dpc-2075	143	4	cutaneous	cutaneous	ADJ
dpc-2075	143	5	neoplasms	neoplasm	NOUN
dpc-2075	143	6	has	have	VERB
dpc-2075	143	7	solid	solid	ADJ
dpc-2075	143	8	historical	historical	ADJ
dpc-2075	143	9	roots	root	NOUN
dpc-2075	143	10	(	(	PUNCT
dpc-2075	143	11	with	with	ADP
dpc-2075	143	12	the	the	DET
dpc-2075	143	13	first	first	ADJ
dpc-2075	143	14	documented	document	VERB
dpc-2075	143	15	cases	case	NOUN
dpc-2075	143	16	in	in	ADP
dpc-2075	143	17	1896	1896	NUM
dpc-2075	143	18	)	)	PUNCT
dpc-2075	144	1	[	[	X
dpc-2075	144	2	34	34	NUM
dpc-2075	144	3	]	]	PUNCT
dpc-2075	144	4	.	.	PUNCT
dpc-2075	145	1	interest	interest	NOUN
dpc-2075	145	2	in	in	ADP
dpc-2075	145	3	the	the	DET
dpc-2075	145	4	use	use	NOUN
dpc-2075	145	5	of	of	ADP
dpc-2075	145	6	brachytherapy	brachytherapy	NOUN
dpc-2075	145	7	for	for	ADP
dpc-2075	145	8	skin	skin	NOUN
dpc-2075	145	9	cancers	cancer	NOUN
dpc-2075	145	10	has	have	AUX
dpc-2075	145	11	decreased	decrease	VERB
dpc-2075	145	12	with	with	ADP
dpc-2075	145	13	the	the	DET
dpc-2075	145	14	development	development	NOUN
dpc-2075	145	15	of	of	ADP
dpc-2075	145	16	better	well	ADJ
dpc-2075	145	17	surgical	surgical	ADJ
dpc-2075	145	18	techniques	technique	NOUN
dpc-2075	145	19	such	such	ADJ
dpc-2075	145	20	as	as	ADP
dpc-2075	145	21	mohs	mohs	PROPN
dpc-2075	145	22	surgery	surgery	NOUN
dpc-2075	145	23	,	,	PUNCT
dpc-2075	145	24	and	and	CCONJ
dpc-2075	145	25	its	its	PRON
dpc-2075	145	26	application	application	NOUN
dpc-2075	145	27	in	in	ADP
dpc-2075	145	28	skin	skin	NOUN
dpc-2075	145	29	cancer	cancer	NOUN
dpc-2075	145	30	has	have	AUX
dpc-2075	145	31	declined	decline	VERB
dpc-2075	145	32	figure	figure	NOUN
dpc-2075	145	33	1	1	NUM
dpc-2075	145	34	.	.	PUNCT
dpc-2075	145	35	pre	pre	VERB
dpc-2075	146	1	rt	rt	PROPN
dpc-2075	146	2	treatment	treatment	NOUN
dpc-2075	146	3	for	for	ADP
dpc-2075	146	4	a	a	DET
dpc-2075	146	5	cscc	cscc	NOUN
dpc-2075	146	6	.	.	PUNCT
dpc-2075	147	1	review	review	VERB
dpc-2075	147	2	|	|	ADV
dpc-2075	147	3	dermatol	dermatol	ADJ
dpc-2075	147	4	pract	pract	NOUN
dpc-2075	147	5	concept	concept	NOUN
dpc-2075	147	6	.	.	PUNCT
dpc-2075	148	1	2021	2021	NUM
dpc-2075	148	2	;	;	PUNCT
dpc-2075	148	3	11(s2	11(s2	NUM
dpc-2075	148	4	):	):	PUNCT
dpc-2075	148	5	e2021168s	e2021168s	NOUN
dpc-2075	148	6	5	5	NUM
dpc-2075	148	7	significantly	significantly	ADV
dpc-2075	148	8	over	over	ADP
dpc-2075	148	9	the	the	DET
dpc-2075	148	10	years	year	NOUN
dpc-2075	148	11	.	.	PUNCT
dpc-2075	149	1	the	the	DET
dpc-2075	149	2	introduction	introduction	NOUN
dpc-2075	149	3	of	of	ADP
dpc-2075	149	4	the	the	DET
dpc-2075	149	5	highdose	highdose	NOUN
dpc-2075	149	6	-	-	PUNCT
dpc-2075	149	7	rate	rate	NOUN
dpc-2075	149	8	afterloading	afterloading	NOUN
dpc-2075	149	9	technique	technique	NOUN
dpc-2075	149	10	and	and	CCONJ
dpc-2075	149	11	electronic	electronic	ADJ
dpc-2075	149	12	brachytherapy	brachytherapy	NOUN
dpc-2075	149	13	has	have	AUX
dpc-2075	149	14	renewed	renew	VERB
dpc-2075	149	15	interest	interest	NOUN
dpc-2075	149	16	in	in	ADP
dpc-2075	149	17	the	the	DET
dpc-2075	149	18	role	role	NOUN
dpc-2075	149	19	of	of	ADP
dpc-2075	149	20	brachytherapy	brachytherapy	NOUN
dpc-2075	149	21	in	in	ADP
dpc-2075	149	22	cscc	cscc	NOUN
dpc-2075	149	23	.	.	PUNCT
dpc-2075	150	1	compared	compare	VERB
dpc-2075	150	2	with	with	ADP
dpc-2075	150	3	external	external	ADJ
dpc-2075	150	4	beam	beam	NOUN
dpc-2075	150	5	rt	rt	PROPN
dpc-2075	150	6	,	,	PUNCT
dpc-2075	150	7	high	high	ADJ
dpc-2075	150	8	-	-	PUNCT
dpc-2075	150	9	dose	dose	NOUN
dpc-2075	150	10	-	-	PUNCT
dpc-2075	150	11	rate	rate	NOUN
dpc-2075	150	12	brachytherapy	brachytherapy	NOUN
dpc-2075	150	13	demonstrates	demonstrate	VERB
dpc-2075	150	14	some	some	DET
dpc-2075	150	15	advantages	advantage	NOUN
dpc-2075	150	16	,	,	PUNCT
dpc-2075	150	17	such	such	ADJ
dpc-2075	150	18	as	as	ADP
dpc-2075	150	19	delivery	delivery	NOUN
dpc-2075	150	20	of	of	ADP
dpc-2075	150	21	a	a	DET
dpc-2075	150	22	high	high	ADJ
dpc-2075	150	23	dose	dose	NOUN
dpc-2075	150	24	of	of	ADP
dpc-2075	150	25	radiation	radiation	NOUN
dpc-2075	150	26	in	in	ADP
dpc-2075	150	27	the	the	DET
dpc-2075	150	28	clinical	clinical	ADJ
dpc-2075	150	29	target	target	NOUN
dpc-2075	150	30	volume/	volume/	NUM
dpc-2075	150	31	planning	planning	NOUN
dpc-2075	150	32	target	target	NOUN
dpc-2075	150	33	volume	volume	NOUN
dpc-2075	150	34	,	,	PUNCT
dpc-2075	150	35	rapid	rapid	ADJ
dpc-2075	150	36	dose	dose	NOUN
dpc-2075	150	37	decrease	decrease	NOUN
dpc-2075	150	38	at	at	ADP
dpc-2075	150	39	the	the	DET
dpc-2075	150	40	periphery	periphery	NOUN
dpc-2075	150	41	of	of	ADP
dpc-2075	150	42	the	the	DET
dpc-2075	150	43	target	target	NOUN
dpc-2075	150	44	,	,	PUNCT
dpc-2075	150	45	optimal	optimal	ADJ
dpc-2075	150	46	sparing	sparing	NOUN
dpc-2075	150	47	of	of	ADP
dpc-2075	150	48	normal	normal	ADJ
dpc-2075	150	49	tissue	tissue	NOUN
dpc-2075	150	50	in	in	ADP
dpc-2075	150	51	sensitive	sensitive	ADJ
dpc-2075	150	52	structures	structure	NOUN
dpc-2075	150	53	,	,	PUNCT
dpc-2075	150	54	shorter	short	ADJ
dpc-2075	150	55	treatment	treatment	NOUN
dpc-2075	150	56	time	time	NOUN
dpc-2075	150	57	,	,	PUNCT
dpc-2075	150	58	and	and	CCONJ
dpc-2075	150	59	use	use	NOUN
dpc-2075	150	60	of	of	ADP
dpc-2075	150	61	a	a	DET
dpc-2075	150	62	hypofractionated	hypofractionated	ADJ
dpc-2075	150	63	pathway	pathway	NOUN
dpc-2075	150	64	.	.	PUNCT
dpc-2075	151	1	cutaneous	cutaneous	ADJ
dpc-2075	151	2	brachytherapy	brachytherapy	NOUN
dpc-2075	151	3	is	be	AUX
dpc-2075	151	4	advantageous	advantageous	ADJ
dpc-2075	151	5	especially	especially	ADV
dpc-2075	151	6	in	in	ADP
dpc-2075	151	7	curved	curved	ADJ
dpc-2075	151	8	surfaces	surface	NOUN
dpc-2075	151	9	and	and	CCONJ
dpc-2075	151	10	should	should	AUX
dpc-2075	151	11	be	be	AUX
dpc-2075	151	12	considered	consider	VERB
dpc-2075	151	13	instead	instead	ADV
dpc-2075	151	14	of	of	ADP
dpc-2075	151	15	external	external	ADJ
dpc-2075	151	16	beam	beam	NOUN
dpc-2075	151	17	radiation	radiation	NOUN
dpc-2075	151	18	therapy	therapy	NOUN
dpc-2075	151	19	(	(	PUNCT
dpc-2075	151	20	if	if	SCONJ
dpc-2075	151	21	surgical	surgical	ADJ
dpc-2075	151	22	excision	excision	NOUN
dpc-2075	151	23	is	be	AUX
dpc-2075	151	24	not	not	PART
dpc-2075	151	25	possible	possible	ADJ
dpc-2075	151	26	)	)	PUNCT
dpc-2075	151	27	in	in	ADP
dpc-2075	151	28	areas	area	NOUN
dpc-2075	151	29	of	of	ADP
dpc-2075	151	30	poor	poor	ADJ
dpc-2075	151	31	vascularization	vascularization	NOUN
dpc-2075	151	32	,	,	PUNCT
dpc-2075	151	33	such	such	ADJ
dpc-2075	151	34	as	as	ADP
dpc-2075	151	35	the	the	DET
dpc-2075	151	36	back	back	NOUN
dpc-2075	151	37	of	of	ADP
dpc-2075	151	38	the	the	DET
dpc-2075	151	39	hands	hand	NOUN
dpc-2075	151	40	or	or	CCONJ
dpc-2075	151	41	feet	foot	NOUN
dpc-2075	151	42	or	or	CCONJ
dpc-2075	151	43	lower	low	ADJ
dpc-2075	151	44	legs	leg	NOUN
dpc-2075	151	45	.	.	PUNCT
dpc-2075	152	1	it	it	PRON
dpc-2075	152	2	can	can	AUX
dpc-2075	152	3	be	be	AUX
dpc-2075	152	4	administered	administer	VERB
dpc-2075	152	5	,	,	PUNCT
dpc-2075	152	6	for	for	ADP
dpc-2075	152	7	example	example	NOUN
dpc-2075	152	8	,	,	PUNCT
dpc-2075	152	9	in	in	ADP
dpc-2075	152	10	a	a	DET
dpc-2075	152	11	superficial	superficial	ADJ
dpc-2075	152	12	technique	technique	NOUN
dpc-2075	152	13	using	use	VERB
dpc-2075	152	14	dermal	dermal	ADJ
dpc-2075	152	15	applicators	applicator	NOUN
dpc-2075	152	16	with	with	ADP
dpc-2075	152	17	192iridium	192iridium	PROPN
dpc-2075	152	18	[	[	X
dpc-2075	152	19	35	35	NUM
dpc-2075	152	20	]	]	PUNCT
dpc-2075	152	21	.	.	PUNCT
dpc-2075	153	1	interstitial	interstitial	ADJ
dpc-2075	153	2	brachytherapy	brachytherapy	NOUN
dpc-2075	153	3	is	be	AUX
dpc-2075	153	4	another	another	DET
dpc-2075	153	5	option	option	NOUN
dpc-2075	153	6	to	to	PART
dpc-2075	153	7	deliver	deliver	VERB
dpc-2075	153	8	high	high	ADJ
dpc-2075	153	9	dose	dose	NOUN
dpc-2075	153	10	radiation	radiation	NOUN
dpc-2075	153	11	rate	rate	NOUN
dpc-2075	153	12	in	in	ADP
dpc-2075	153	13	thicker	thick	ADJ
dpc-2075	153	14	(	(	PUNCT
dpc-2075	153	15	above	above	ADP
dpc-2075	153	16	5	5	NUM
dpc-2075	153	17	mm	mm	NOUN
dpc-2075	153	18	)	)	PUNCT
dpc-2075	153	19	skin	skin	NOUN
dpc-2075	153	20	lesions	lesion	NOUN
dpc-2075	153	21	with	with	ADP
dpc-2075	153	22	catheters	catheter	NOUN
dpc-2075	153	23	to	to	PART
dpc-2075	153	24	be	be	AUX
dpc-2075	153	25	inserted	insert	VERB
dpc-2075	153	26	under	under	ADP
dpc-2075	153	27	anaesthesia	anaesthesia	NOUN
dpc-2075	153	28	directly	directly	ADV
dpc-2075	153	29	into	into	ADP
dpc-2075	153	30	the	the	DET
dpc-2075	153	31	lesion	lesion	NOUN
dpc-2075	153	32	or	or	CCONJ
dpc-2075	153	33	surgical	surgical	ADJ
dpc-2075	153	34	bed	bed	NOUN
dpc-2075	153	35	in	in	ADP
dpc-2075	153	36	the	the	DET
dpc-2075	153	37	adjuvant	adjuvant	NOUN
dpc-2075	153	38	setting	set	VERB
dpc-2075	153	39	[	[	X
dpc-2075	153	40	36	36	NUM
dpc-2075	153	41	]	]	PUNCT
dpc-2075	153	42	.	.	PUNCT
dpc-2075	154	1	electronic	electronic	ADJ
dpc-2075	154	2	brachytherapy	brachytherapy	NOUN
dpc-2075	154	3	is	be	AUX
dpc-2075	154	4	a	a	DET
dpc-2075	154	5	new	new	ADJ
dpc-2075	154	6	technique	technique	NOUN
dpc-2075	154	7	of	of	ADP
dpc-2075	154	8	rt	rt	PROPN
dpc-2075	154	9	based	base	VERB
dpc-2075	154	10	on	on	ADP
dpc-2075	154	11	a	a	DET
dpc-2075	154	12	miniaturised	miniaturise	VERB
dpc-2075	154	13	x	x	ADJ
dpc-2075	154	14	-	-	NOUN
dpc-2075	154	15	ray	ray	NOUN
dpc-2075	154	16	source	source	NOUN
dpc-2075	154	17	that	that	PRON
dpc-2075	154	18	allows	allow	VERB
dpc-2075	154	19	to	to	PART
dpc-2075	154	20	treat	treat	VERB
dpc-2075	154	21	small	small	ADJ
dpc-2075	154	22	and	and	CCONJ
dpc-2075	154	23	flat	flat	ADJ
dpc-2075	154	24	surfaced	surface	VERB
dpc-2075	154	25	cscc	cscc	NOUN
dpc-2075	155	1	[	[	X
dpc-2075	155	2	37	37	NUM
dpc-2075	155	3	,	,	PUNCT
dpc-2075	155	4	38	38	NUM
dpc-2075	155	5	]	]	PUNCT
dpc-2075	155	6	and	and	CCONJ
dpc-2075	155	7	has	have	AUX
dpc-2075	155	8	attracted	attract	VERB
dpc-2075	155	9	considerable	considerable	ADJ
dpc-2075	155	10	interest	interest	NOUN
dpc-2075	155	11	in	in	ADP
dpc-2075	155	12	recent	recent	ADJ
dpc-2075	155	13	years	year	NOUN
dpc-2075	155	14	in	in	ADP
dpc-2075	155	15	the	the	DET
dpc-2075	155	16	management	management	NOUN
dpc-2075	155	17	of	of	ADP
dpc-2075	155	18	cscc	cscc	NOUN
dpc-2075	156	1	[	[	X
dpc-2075	156	2	39	39	NUM
dpc-2075	156	3	]	]	PUNCT
dpc-2075	156	4	.	.	PUNCT
dpc-2075	157	1	although	although	SCONJ
dpc-2075	157	2	preliminary	preliminary	ADJ
dpc-2075	157	3	data	datum	NOUN
dpc-2075	157	4	on	on	ADP
dpc-2075	157	5	the	the	DET
dpc-2075	157	6	use	use	NOUN
dpc-2075	157	7	of	of	ADP
dpc-2075	157	8	electronic	electronic	ADJ
dpc-2075	157	9	brachytherapy	brachytherapy	NOUN
dpc-2075	157	10	in	in	ADP
dpc-2075	157	11	cscc	cscc	PROPN
dpc-2075	157	12	are	be	AUX
dpc-2075	157	13	promising	promise	VERB
dpc-2075	157	14	,	,	PUNCT
dpc-2075	157	15	there	there	PRON
dpc-2075	157	16	is	be	VERB
dpc-2075	157	17	a	a	DET
dpc-2075	157	18	lack	lack	NOUN
dpc-2075	157	19	of	of	ADP
dpc-2075	157	20	scientific	scientific	ADJ
dpc-2075	157	21	work	work	NOUN
dpc-2075	157	22	designed	design	VERB
dpc-2075	157	23	for	for	ADP
dpc-2075	157	24	direct	direct	ADJ
dpc-2075	157	25	comparison	comparison	NOUN
dpc-2075	157	26	with	with	ADP
dpc-2075	157	27	external	external	ADJ
dpc-2075	157	28	beam	beam	NOUN
dpc-2075	157	29	rt	rt	NOUN
dpc-2075	157	30	or	or	CCONJ
dpc-2075	157	31	radionuclide	radionuclide	NOUN
dpc-2075	157	32	brachytherapy	brachytherapy	NOUN
dpc-2075	157	33	.	.	PUNCT
dpc-2075	158	1	because	because	SCONJ
dpc-2075	158	2	this	this	PRON
dpc-2075	158	3	is	be	AUX
dpc-2075	158	4	a	a	DET
dpc-2075	158	5	relatively	relatively	ADV
dpc-2075	158	6	new	new	ADJ
dpc-2075	158	7	scientific	scientific	ADJ
dpc-2075	158	8	scenario	scenario	NOUN
dpc-2075	158	9	,	,	PUNCT
dpc-2075	158	10	long	long	ADJ
dpc-2075	158	11	-	-	PUNCT
dpc-2075	158	12	term	term	NOUN
dpc-2075	158	13	follow	follow	NOUN
dpc-2075	158	14	-	-	PUNCT
dpc-2075	158	15	up	up	ADP
dpc-2075	158	16	data	datum	NOUN
dpc-2075	158	17	are	be	AUX
dpc-2075	158	18	also	also	ADV
dpc-2075	158	19	missing	miss	VERB
dpc-2075	158	20	.	.	PUNCT
dpc-2075	159	1	the	the	DET
dpc-2075	159	2	american	american	PROPN
dpc-2075	159	3	brachytherapy	brachytherapy	PROPN
dpc-2075	159	4	society	society	PROPN
dpc-2075	159	5	consensus	consensus	NOUN
dpc-2075	159	6	statement	statement	NOUN
dpc-2075	159	7	does	do	AUX
dpc-2075	159	8	not	not	PART
dpc-2075	159	9	endorse	endorse	VERB
dpc-2075	159	10	the	the	DET
dpc-2075	159	11	use	use	NOUN
dpc-2075	159	12	of	of	ADP
dpc-2075	159	13	electronic	electronic	ADJ
dpc-2075	159	14	brachytherapy	brachytherapy	NOUN
dpc-2075	159	15	outside	outside	ADP
dpc-2075	159	16	of	of	ADP
dpc-2075	159	17	prospective	prospective	ADJ
dpc-2075	159	18	clinical	clinical	ADJ
dpc-2075	159	19	studies	study	NOUN
dpc-2075	159	20	.	.	PUNCT
dpc-2075	160	1	[	[	X
dpc-2075	160	2	40	40	NUM
dpc-2075	160	3	]	]	PUNCT
dpc-2075	160	4	.	.	PUNCT
dpc-2075	161	1	rt	rt	PROPN
dpc-2075	161	2	planning	plan	VERB
dpc-2075	161	3	the	the	DET
dpc-2075	161	4	main	main	ADJ
dpc-2075	161	5	treatment	treatment	NOUN
dpc-2075	161	6	planning	planning	NOUN
dpc-2075	161	7	modality	modality	NOUN
dpc-2075	161	8	in	in	ADP
dpc-2075	161	9	a	a	DET
dpc-2075	161	10	modern	modern	ADJ
dpc-2075	161	11	radiation	radiation	NOUN
dpc-2075	161	12	therapy	therapy	NOUN
dpc-2075	161	13	department	department	NOUN
dpc-2075	161	14	is	be	AUX
dpc-2075	161	15	based	base	VERB
dpc-2075	161	16	on	on	ADP
dpc-2075	161	17	computed	compute	VERB
dpc-2075	161	18	tomography	tomography	NOUN
dpc-2075	161	19	.	.	PUNCT
dpc-2075	162	1	computed	compute	VERB
dpc-2075	162	2	tomography	tomography	NOUN
dpc-2075	162	3	is	be	AUX
dpc-2075	162	4	used	use	VERB
dpc-2075	162	5	to	to	PART
dpc-2075	162	6	define	define	VERB
dpc-2075	162	7	the	the	DET
dpc-2075	162	8	clinical	clinical	ADJ
dpc-2075	162	9	target	target	NOUN
dpc-2075	162	10	and	and	CCONJ
dpc-2075	162	11	organs	organ	NOUN
dpc-2075	162	12	at	at	ADP
dpc-2075	162	13	risk	risk	NOUN
dpc-2075	162	14	in	in	ADP
dpc-2075	162	15	photon	photon	NOUN
dpc-2075	162	16	and	and	CCONJ
dpc-2075	162	17	electron	electron	NOUN
dpc-2075	162	18	treatment	treatment	NOUN
dpc-2075	162	19	(	(	PUNCT
dpc-2075	162	20	figures	figure	NOUN
dpc-2075	162	21	3	3	NUM
dpc-2075	162	22	and	and	CCONJ
dpc-2075	162	23	4	4	NUM
dpc-2075	162	24	)	)	PUNCT
dpc-2075	162	25	.	.	PUNCT
dpc-2075	163	1	integration	integration	NOUN
dpc-2075	163	2	with	with	ADP
dpc-2075	163	3	mri	mri	NOUN
dpc-2075	163	4	imaging	imaging	NOUN
dpc-2075	163	5	(	(	PUNCT
dpc-2075	163	6	for	for	ADP
dpc-2075	163	7	increased	increase	VERB
dpc-2075	163	8	figure	figure	NOUN
dpc-2075	163	9	2	2	NUM
dpc-2075	163	10	.	.	X
dpc-2075	163	11	post	post	VERB
dpc-2075	163	12	rt	rt	PROPN
dpc-2075	163	13	treatment	treatment	NOUN
dpc-2075	163	14	for	for	ADP
dpc-2075	163	15	a	a	DET
dpc-2075	163	16	cscc	cscc	NOUN
dpc-2075	163	17	.	.	PUNCT
dpc-2075	164	1	figure	figure	NOUN
dpc-2075	164	2	3	3	NUM
dpc-2075	164	3	.	.	PUNCT
dpc-2075	164	4	treatment	treatment	NOUN
dpc-2075	164	5	electron	electron	NOUN
dpc-2075	164	6	planning	planning	NOUN
dpc-2075	164	7	for	for	ADP
dpc-2075	164	8	a	a	DET
dpc-2075	164	9	cscc	cscc	NOUN
dpc-2075	164	10	.	.	PUNCT
dpc-2075	165	1	figure	figure	NOUN
dpc-2075	165	2	4	4	NUM
dpc-2075	165	3	.	.	PUNCT
dpc-2075	165	4	treatment	treatment	NOUN
dpc-2075	165	5	electron	electron	NOUN
dpc-2075	165	6	planning	planning	NOUN
dpc-2075	165	7	for	for	ADP
dpc-2075	165	8	a	a	DET
dpc-2075	165	9	cscc	cscc	NOUN
dpc-2075	165	10	.	.	PUNCT
dpc-2075	166	1	6	6	NUM
dpc-2075	166	2	review	review	NOUN
dpc-2075	166	3	|	|	ADV
dpc-2075	166	4	dermatol	dermatol	ADJ
dpc-2075	166	5	pract	pract	NOUN
dpc-2075	166	6	concept	concept	NOUN
dpc-2075	166	7	.	.	PUNCT
dpc-2075	167	1	2021	2021	NUM
dpc-2075	167	2	;	;	PUNCT
dpc-2075	167	3	11(s2	11(s2	NUM
dpc-2075	167	4	):	):	PUNCT
dpc-2075	167	5	e2021168s	e2021168s	NOUN
dpc-2075	167	6	reliability	reliability	NOUN
dpc-2075	167	7	for	for	ADP
dpc-2075	167	8	soft	soft	ADJ
dpc-2075	167	9	tissue	tissue	NOUN
dpc-2075	167	10	)	)	PUNCT
dpc-2075	167	11	or	or	CCONJ
dpc-2075	167	12	pet	pet	NOUN
dpc-2075	167	13	(	(	PUNCT
dpc-2075	167	14	for	for	ADP
dpc-2075	167	15	biological	biological	ADJ
dpc-2075	167	16	assessment	assessment	NOUN
dpc-2075	167	17	of	of	ADP
dpc-2075	167	18	disease	disease	NOUN
dpc-2075	167	19	)	)	PUNCT
dpc-2075	167	20	is	be	AUX
dpc-2075	167	21	often	often	ADV
dpc-2075	167	22	necessary	necessary	ADJ
dpc-2075	167	23	.	.	PUNCT
dpc-2075	168	1	radiation	radiation	NOUN
dpc-2075	168	2	therapy	therapy	NOUN
dpc-2075	168	3	results	result	NOUN
dpc-2075	168	4	depend	depend	VERB
dpc-2075	168	5	on	on	ADP
dpc-2075	168	6	accurate	accurate	ADJ
dpc-2075	168	7	coverage	coverage	NOUN
dpc-2075	168	8	of	of	ADP
dpc-2075	168	9	a	a	DET
dpc-2075	168	10	target	target	NOUN
dpc-2075	168	11	volume	volume	NOUN
dpc-2075	168	12	with	with	ADP
dpc-2075	168	13	appropriate	appropriate	ADJ
dpc-2075	168	14	margins	margin	NOUN
dpc-2075	168	15	.	.	PUNCT
dpc-2075	169	1	margins	margin	NOUN
dpc-2075	169	2	that	that	PRON
dpc-2075	169	3	are	be	AUX
dpc-2075	169	4	too	too	ADV
dpc-2075	169	5	narrow	narrow	ADJ
dpc-2075	169	6	can	can	AUX
dpc-2075	169	7	lead	lead	VERB
dpc-2075	169	8	to	to	ADP
dpc-2075	169	9	local	local	ADJ
dpc-2075	169	10	failure	failure	NOUN
dpc-2075	169	11	and	and	CCONJ
dpc-2075	169	12	margins	margin	NOUN
dpc-2075	169	13	that	that	PRON
dpc-2075	169	14	are	be	AUX
dpc-2075	169	15	too	too	ADV
dpc-2075	169	16	wide	wide	ADJ
dpc-2075	169	17	can	can	AUX
dpc-2075	169	18	increase	increase	VERB
dpc-2075	169	19	radiation	radiation	NOUN
dpc-2075	169	20	therapy	therapy	NOUN
dpc-2075	169	21	-	-	PUNCT
dpc-2075	169	22	related	relate	VERB
dpc-2075	169	23	morbidity	morbidity	NOUN
dpc-2075	169	24	.	.	PUNCT
dpc-2075	170	1	delineating	delineate	VERB
dpc-2075	170	2	a	a	DET
dpc-2075	170	3	target	target	NOUN
dpc-2075	170	4	volume	volume	NOUN
dpc-2075	170	5	could	could	AUX
dpc-2075	170	6	be	be	AUX
dpc-2075	170	7	challenging	challenge	VERB
dpc-2075	170	8	,	,	PUNCT
dpc-2075	170	9	particularly	particularly	ADV
dpc-2075	170	10	in	in	ADP
dpc-2075	170	11	superficial	superficial	ADJ
dpc-2075	170	12	and	and	CCONJ
dpc-2075	170	13	small	small	ADJ
dpc-2075	170	14	cscc	cscc	NOUN
dpc-2075	170	15	,	,	PUNCT
dpc-2075	170	16	where	where	SCONJ
dpc-2075	170	17	the	the	DET
dpc-2075	170	18	spatial	spatial	ADJ
dpc-2075	170	19	resolution	resolution	NOUN
dpc-2075	170	20	of	of	ADP
dpc-2075	170	21	computed	compute	VERB
dpc-2075	170	22	tomography	tomography	NOUN
dpc-2075	170	23	limits	limit	VERB
dpc-2075	170	24	the	the	DET
dpc-2075	170	25	visualization	visualization	NOUN
dpc-2075	170	26	of	of	ADP
dpc-2075	170	27	any	any	DET
dpc-2075	170	28	skin	skin	NOUN
dpc-2075	170	29	lesions	lesion	NOUN
dpc-2075	170	30	.	.	PUNCT
dpc-2075	171	1	multidisciplinary	multidisciplinary	ADJ
dpc-2075	171	2	evaluation	evaluation	NOUN
dpc-2075	171	3	with	with	ADP
dpc-2075	171	4	the	the	DET
dpc-2075	171	5	dermatologist	dermatologist	NOUN
dpc-2075	171	6	(	(	PUNCT
dpc-2075	171	7	dermoscopic	dermoscopic	NOUN
dpc-2075	171	8	imaging	imaging	NOUN
dpc-2075	171	9	)	)	PUNCT
dpc-2075	171	10	or	or	CCONJ
dpc-2075	171	11	surgeon	surgeon	NOUN
dpc-2075	171	12	(	(	PUNCT
dpc-2075	171	13	for	for	ADP
dpc-2075	171	14	surgical	surgical	ADJ
dpc-2075	171	15	scar	scar	NOUN
dpc-2075	171	16	margins	margin	NOUN
dpc-2075	171	17	)	)	PUNCT
dpc-2075	171	18	is	be	AUX
dpc-2075	171	19	essential	essential	ADJ
dpc-2075	171	20	for	for	ADP
dpc-2075	171	21	the	the	DET
dpc-2075	171	22	assessment	assessment	NOUN
dpc-2075	171	23	of	of	ADP
dpc-2075	171	24	such	such	ADJ
dpc-2075	171	25	targets	target	NOUN
dpc-2075	171	26	[	[	X
dpc-2075	171	27	41	41	NUM
dpc-2075	171	28	]	]	PUNCT
dpc-2075	171	29	.	.	PUNCT
dpc-2075	172	1	in	in	ADP
dpc-2075	172	2	skin	skin	NOUN
dpc-2075	172	3	rt	rt	PROPN
dpc-2075	172	4	,	,	PUNCT
dpc-2075	172	5	the	the	DET
dpc-2075	172	6	use	use	NOUN
dpc-2075	172	7	of	of	ADP
dpc-2075	172	8	computed	computed	ADJ
dpc-2075	172	9	tomography	tomography	NOUN
dpc-2075	172	10	-	-	PUNCT
dpc-2075	172	11	based	base	VERB
dpc-2075	172	12	planning	planning	NOUN
dpc-2075	172	13	is	be	AUX
dpc-2075	172	14	also	also	ADV
dpc-2075	172	15	linked	link	VERB
dpc-2075	172	16	to	to	ADP
dpc-2075	172	17	cases	case	NOUN
dpc-2075	172	18	of	of	ADP
dpc-2075	172	19	larger	large	ADJ
dpc-2075	172	20	and	and	CCONJ
dpc-2075	172	21	deeply	deeply	ADV
dpc-2075	172	22	invading	invade	VERB
dpc-2075	172	23	cscc	cscc	ADJ
dpc-2075	172	24	,	,	PUNCT
dpc-2075	172	25	nodal	nodal	NOUN
dpc-2075	172	26	basin	basin	NOUN
dpc-2075	172	27	rt	rt	PROPN
dpc-2075	172	28	,	,	PUNCT
dpc-2075	172	29	skin	skin	NOUN
dpc-2075	172	30	brachytherapy	brachytherapy	NOUN
dpc-2075	172	31	planning	planning	NOUN
dpc-2075	172	32	and	and	CCONJ
dpc-2075	172	33	in	in	ADP
dpc-2075	172	34	select	select	ADJ
dpc-2075	172	35	palliative	palliative	ADJ
dpc-2075	172	36	settings	setting	NOUN
dpc-2075	172	37	.	.	PUNCT
dpc-2075	173	1	after	after	ADP
dpc-2075	173	2	the	the	DET
dpc-2075	173	3	clinical	clinical	ADJ
dpc-2075	173	4	target	target	NOUN
dpc-2075	173	5	and	and	CCONJ
dpc-2075	173	6	organs	organ	NOUN
dpc-2075	173	7	at	at	ADP
dpc-2075	173	8	risk	risk	NOUN
dpc-2075	173	9	delineation	delineation	NOUN
dpc-2075	173	10	,	,	PUNCT
dpc-2075	173	11	a	a	DET
dpc-2075	173	12	personalized	personalized	ADJ
dpc-2075	173	13	plan	plan	NOUN
dpc-2075	173	14	is	be	AUX
dpc-2075	173	15	built	build	VERB
dpc-2075	173	16	up	up	ADP
dpc-2075	173	17	by	by	ADP
dpc-2075	173	18	the	the	DET
dpc-2075	173	19	certified	certify	VERB
dpc-2075	173	20	radiation	radiation	NOUN
dpc-2075	173	21	oncologist	oncologist	NOUN
dpc-2075	173	22	in	in	ADP
dpc-2075	173	23	synergy	synergy	NOUN
dpc-2075	173	24	with	with	ADP
dpc-2075	173	25	the	the	DET
dpc-2075	173	26	medical	medical	ADJ
dpc-2075	173	27	physicist	physicist	NOUN
dpc-2075	173	28	,	,	PUNCT
dpc-2075	173	29	respecting	respect	VERB
dpc-2075	173	30	the	the	DET
dpc-2075	173	31	dose	dose	NOUN
dpc-2075	173	32	limits	limit	NOUN
dpc-2075	173	33	of	of	ADP
dpc-2075	173	34	any	any	DET
dpc-2075	173	35	organ	organ	NOUN
dpc-2075	173	36	at	at	ADP
dpc-2075	173	37	risk	risk	NOUN
dpc-2075	173	38	to	to	PART
dpc-2075	173	39	minimize	minimize	VERB
dpc-2075	173	40	the	the	DET
dpc-2075	173	41	side	side	NOUN
dpc-2075	173	42	effects	effect	NOUN
dpc-2075	173	43	of	of	ADP
dpc-2075	173	44	radiation	radiation	NOUN
dpc-2075	173	45	treatment	treatment	NOUN
dpc-2075	173	46	.	.	PUNCT
dpc-2075	174	1	conclusions	conclusion	NOUN
dpc-2075	174	2	radiotherapy	radiotherapy	NOUN
dpc-2075	174	3	could	could	AUX
dpc-2075	174	4	be	be	AUX
dpc-2075	174	5	an	an	DET
dpc-2075	174	6	optimal	optimal	ADJ
dpc-2075	174	7	therapeutic	therapeutic	ADJ
dpc-2075	174	8	option	option	NOUN
dpc-2075	174	9	for	for	ADP
dpc-2075	174	10	cscc	cscc	NOUN
dpc-2075	174	11	.	.	PUNCT
dpc-2075	175	1	it	it	PRON
dpc-2075	175	2	could	could	AUX
dpc-2075	175	3	be	be	AUX
dpc-2075	175	4	used	use	VERB
dpc-2075	175	5	for	for	ADP
dpc-2075	175	6	non	non	ADJ
dpc-2075	175	7	-	-	ADJ
dpc-2075	175	8	surgical	surgical	ADJ
dpc-2075	175	9	candidates	candidate	NOUN
dpc-2075	175	10	as	as	ADP
dpc-2075	175	11	exclusive	exclusive	ADJ
dpc-2075	175	12	therapy	therapy	NOUN
dpc-2075	175	13	,	,	PUNCT
dpc-2075	175	14	in	in	ADP
dpc-2075	175	15	adjuvant	adjuvant	ADJ
dpc-2075	175	16	high	high	ADJ
dpc-2075	175	17	risk	risk	NOUN
dpc-2075	175	18	patients	patient	NOUN
dpc-2075	175	19	or	or	CCONJ
dpc-2075	175	20	to	to	PART
dpc-2075	175	21	decrease	decrease	VERB
dpc-2075	175	22	pain	pain	NOUN
dpc-2075	175	23	and	and	CCONJ
dpc-2075	175	24	bleeding	bleeding	NOUN
dpc-2075	175	25	.	.	PUNCT
dpc-2075	176	1	several	several	ADJ
dpc-2075	176	2	dose	dose	NOUN
dpc-2075	176	3	schedules	schedule	NOUN
dpc-2075	176	4	and	and	CCONJ
dpc-2075	176	5	techniques	technique	NOUN
dpc-2075	176	6	have	have	AUX
dpc-2075	176	7	been	be	AUX
dpc-2075	176	8	proposed	propose	VERB
dpc-2075	176	9	both	both	CCONJ
dpc-2075	176	10	for	for	ADP
dpc-2075	176	11	ebrt	ebrt	ADJ
dpc-2075	176	12	(	(	PUNCT
dpc-2075	176	13	external	external	ADJ
dpc-2075	176	14	beam	beam	NOUN
dpc-2075	176	15	radiotherapy	radiotherapy	NOUN
dpc-2075	176	16	)	)	PUNCT
dpc-2075	176	17	than	than	ADP
dpc-2075	176	18	for	for	ADP
dpc-2075	176	19	brt	brt	PROPN
dpc-2075	176	20	(	(	PUNCT
dpc-2075	176	21	brachytherapy	brachytherapy	NOUN
dpc-2075	176	22	)	)	PUNCT
dpc-2075	176	23	.	.	PUNCT
dpc-2075	177	1	multidisciplinary	multidisciplinary	ADJ
dpc-2075	177	2	assessment	assessment	NOUN
dpc-2075	177	3	is	be	AUX
dpc-2075	177	4	a	a	DET
dpc-2075	177	5	main	main	ADJ
dpc-2075	177	6	issue	issue	NOUN
dpc-2075	177	7	in	in	ADP
dpc-2075	177	8	this	this	DET
dpc-2075	177	9	subset	subset	NOUN
dpc-2075	177	10	of	of	ADP
dpc-2075	177	11	patients	patient	NOUN
dpc-2075	177	12	.	.	PUNCT
dpc-2075	178	1	references	reference	NOUN
dpc-2075	178	2	1	1	NUM
dpc-2075	178	3	.	.	PUNCT
dpc-2075	179	1	lansbury	lansbury	PROPN
dpc-2075	179	2	l	l	PROPN
dpc-2075	179	3	,	,	PUNCT
dpc-2075	179	4	bath	bath	NOUN
dpc-2075	179	5	-	-	PUNCT
dpc-2075	179	6	hextall	hextall	NOUN
dpc-2075	179	7	f	f	PROPN
dpc-2075	179	8	,	,	PUNCT
dpc-2075	179	9	perkins	perkins	PROPN
dpc-2075	179	10	w	w	PROPN
dpc-2075	179	11	,	,	PUNCT
dpc-2075	179	12	stanton	stanton	PROPN
dpc-2075	179	13	w	w	PROPN
dpc-2075	179	14	,	,	PUNCT
dpc-2075	179	15	leonardi	leonardi	PROPN
dpc-2075	179	16	-	-	PUNCT
dpc-2075	179	17	bee	bee	PROPN
dpc-2075	179	18	j.	j.	PROPN
dpc-2075	179	19	interventions	intervention	NOUN
dpc-2075	179	20	for	for	ADP
dpc-2075	179	21	non	non	ADJ
dpc-2075	179	22	-	-	ADJ
dpc-2075	179	23	metastatic	metastatic	ADJ
dpc-2075	179	24	squamous	squamous	ADJ
dpc-2075	179	25	cell	cell	NOUN
dpc-2075	179	26	carcinoma	carcinoma	NOUN
dpc-2075	179	27	of	of	ADP
dpc-2075	179	28	the	the	DET
dpc-2075	179	29	skin	skin	NOUN
dpc-2075	179	30	:	:	PUNCT
dpc-2075	179	31	systematic	systematic	ADJ
dpc-2075	179	32	review	review	NOUN
dpc-2075	179	33	and	and	CCONJ
dpc-2075	179	34	pooled	pool	VERB
dpc-2075	179	35	analysis	analysis	NOUN
dpc-2075	179	36	of	of	ADP
dpc-2075	179	37	observational	observational	ADJ
dpc-2075	179	38	studies	study	NOUN
dpc-2075	179	39	.	.	PUNCT
dpc-2075	180	1	bmj	bmj	PROPN
dpc-2075	180	2	.	.	PUNCT
dpc-2075	181	1	2013;34	2013;34	NUM
dpc-2075	181	2	:	:	PUNCT
dpc-2075	181	3	f6153	f6153	VERB
dpc-2075	181	4	.	.	PUNCT
dpc-2075	182	1	doi	doi	NOUN
dpc-2075	182	2	:	:	PUNCT
dpc-2075	182	3	10.1136	10.1136	NUM
dpc-2075	182	4	/	/	SYM
dpc-2075	182	5	bmj.f6153	bmj.f6153	NOUN
dpc-2075	182	6	.	.	PUNCT
dpc-2075	183	1	pmid	pmid	NOUN
dpc-2075	183	2	:	:	PUNCT
dpc-2075	183	3	24191270	24191270	NUM
dpc-2075	183	4	.	.	PUNCT
dpc-2075	184	1	2	2	X
dpc-2075	184	2	.	.	X
dpc-2075	184	3	lomas	lomas	PROPN
dpc-2075	184	4	a	a	DET
dpc-2075	184	5	,	,	PUNCT
dpc-2075	184	6	leonardi	leonardi	PROPN
dpc-2075	184	7	-	-	PUNCT
dpc-2075	184	8	bee	bee	PROPN
dpc-2075	184	9	j	j	PROPN
dpc-2075	184	10	,	,	PUNCT
dpc-2075	184	11	bath	bath	NOUN
dpc-2075	184	12	-	-	PUNCT
dpc-2075	184	13	hextall	hextall	NOUN
dpc-2075	184	14	f.	f.	PROPN
dpc-2075	184	15	a	a	DET
dpc-2075	184	16	systematic	systematic	ADJ
dpc-2075	184	17	review	review	NOUN
dpc-2075	184	18	of	of	ADP
dpc-2075	184	19	worldwide	worldwide	ADJ
dpc-2075	184	20	incidence	incidence	NOUN
dpc-2075	184	21	of	of	ADP
dpc-2075	184	22	nonmelanoma	nonmelanoma	ADJ
dpc-2075	184	23	skin	skin	NOUN
dpc-2075	184	24	cancer	cancer	NOUN
dpc-2075	184	25	.	.	PUNCT
dpc-2075	185	1	br	br	PROPN
dpc-2075	185	2	j	j	PROPN
dpc-2075	185	3	dermatol	dermatol	NOUN
dpc-2075	185	4	.	.	PUNCT
dpc-2075	186	1	2012;166(5):1069–1080	2012;166(5):1069–1080	NUM
dpc-2075	186	2	.	.	PUNCT
dpc-2075	187	1	doi	doi	NOUN
dpc-2075	187	2	:	:	PUNCT
dpc-2075	187	3	10.1111	10.1111	NUM
dpc-2075	187	4	/	/	SYM
dpc-2075	187	5	j.13652133.2012.10830.x	j.13652133.2012.10830.x	PROPN
dpc-2075	187	6	.	.	PUNCT
dpc-2075	188	1	pmid	pmid	NOUN
dpc-2075	188	2	:	:	PUNCT
dpc-2075	188	3	22251204	22251204	NUM
dpc-2075	188	4	.	.	PUNCT
dpc-2075	189	1	3	3	X
dpc-2075	189	2	.	.	X
dpc-2075	189	3	kallini	kallini	PROPN
dpc-2075	189	4	jr	jr	PROPN
dpc-2075	189	5	,	,	PUNCT
dpc-2075	189	6	hamed	hamed	PROPN
dpc-2075	189	7	n	n	CCONJ
dpc-2075	189	8	,	,	PUNCT
dpc-2075	189	9	khachemoune	khachemoune	PROPN
dpc-2075	189	10	a.	a.	PROPN
dpc-2075	189	11	squamous	squamous	PROPN
dpc-2075	189	12	cell	cell	NOUN
dpc-2075	189	13	carcinoma	carcinoma	NOUN
dpc-2075	189	14	of	of	ADP
dpc-2075	189	15	the	the	DET
dpc-2075	189	16	skin	skin	NOUN
dpc-2075	189	17	:	:	PUNCT
dpc-2075	189	18	epidemiology	epidemiology	NOUN
dpc-2075	189	19	,	,	PUNCT
dpc-2075	189	20	classification	classification	NOUN
dpc-2075	189	21	,	,	PUNCT
dpc-2075	189	22	management	management	NOUN
dpc-2075	189	23	,	,	PUNCT
dpc-2075	189	24	and	and	CCONJ
dpc-2075	189	25	novel	novel	ADJ
dpc-2075	189	26	trends	trend	NOUN
dpc-2075	189	27	.	.	PUNCT
dpc-2075	190	1	int	int	NOUN
dpc-2075	190	2	j	j	PROPN
dpc-2075	190	3	dermatol.2015;54(2):130–140	dermatol.2015;54(2):130–140	PROPN
dpc-2075	190	4	.	.	PUNCT
dpc-2075	191	1	doi	doi	NOUN
dpc-2075	191	2	:	:	PUNCT
dpc-2075	191	3	10.1111/	10.1111/	NUM
dpc-2075	191	4	ijd.12553.pmid	ijd.12553.pmid	NOUN
dpc-2075	191	5	:	:	PUNCT
dpc-2075	191	6	25428226	25428226	NUM
dpc-2075	191	7	.	.	PUNCT
dpc-2075	192	1	4	4	X
dpc-2075	192	2	.	.	X
dpc-2075	192	3	veness	veness	PROPN
dpc-2075	192	4	mj	mj	PROPN
dpc-2075	192	5	,	,	PUNCT
dpc-2075	192	6	delishaj	delishaj	PROPN
dpc-2075	192	7	d	d	PROPN
dpc-2075	192	8	,	,	PUNCT
dpc-2075	192	9	barnes	barnes	PROPN
dpc-2075	192	10	ea	ea	PROPN
dpc-2075	192	11	,	,	PUNCT
dpc-2075	192	12	bezugly	bezugly	ADV
dpc-2075	192	13	a	a	PRON
dpc-2075	192	14	,	,	PUNCT
dpc-2075	192	15	rembielak	rembielak	ADJ
dpc-2075	192	16	a.	a.	NOUN
dpc-2075	192	17	current	current	ADJ
dpc-2075	192	18	role	role	NOUN
dpc-2075	192	19	of	of	ADP
dpc-2075	192	20	radiotherapy	radiotherapy	NOUN
dpc-2075	192	21	in	in	ADP
dpc-2075	192	22	non	non	ADJ
dpc-2075	192	23	-	-	ADJ
dpc-2075	192	24	melanoma	melanoma	ADJ
dpc-2075	192	25	skin	skin	NOUN
dpc-2075	192	26	cancer	cancer	NOUN
dpc-2075	192	27	.	.	PUNCT
dpc-2075	193	1	clin	clin	PROPN
dpc-2075	193	2	oncol	oncol	PROPN
dpc-2075	193	3	(	(	PUNCT
dpc-2075	193	4	r	r	PROPN
dpc-2075	193	5	coll	coll	PROPN
dpc-2075	193	6	radiol).2019	radiol).2019	PROPN
dpc-2075	193	7	;	;	PUNCT
dpc-2075	193	8	31(11	31(11	NUM
dpc-2075	193	9	):	):	PUNCT
dpc-2075	193	10	749–758	749–758	NUM
dpc-2075	193	11	.	.	PUNCT
dpc-2075	194	1	doi	doi	NOUN
dpc-2075	194	2	:	:	PUNCT
dpc-2075	194	3	10.1016	10.1016	NUM
dpc-2075	194	4	/	/	SYM
dpc-2075	194	5	j.	j.	PROPN
dpc-2075	194	6	clon.2019.08.004.pmid	clon.2019.08.004.pmid	PROPN
dpc-2075	194	7	:	:	PUNCT
dpc-2075	194	8	31447088	31447088	NUM
dpc-2075	194	9	.	.	PUNCT
dpc-2075	195	1	5	5	X
dpc-2075	195	2	.	.	PUNCT
dpc-2075	196	1	[	[	X
dpc-2075	196	2	5	5	X
dpc-2075	196	3	]	]	X
dpc-2075	196	4	kwan	kwan	PROPN
dpc-2075	196	5	w	w	PROPN
dpc-2075	196	6	,	,	PUNCT
dpc-2075	196	7	wilson	wilson	PROPN
dpc-2075	196	8	d	d	PROPN
dpc-2075	196	9	,	,	PUNCT
dpc-2075	196	10	moravan	moravan	NOUN
dpc-2075	196	11	v.radiotherapy	v.radiotherapy	NOUN
dpc-2075	196	12	for	for	ADP
dpc-2075	196	13	locally	locally	ADV
dpc-2075	196	14	advanced	advance	VERB
dpc-2075	196	15	basal	basal	NOUN
dpc-2075	196	16	cell	cell	NOUN
dpc-2075	196	17	and	and	CCONJ
dpc-2075	196	18	squamous	squamous	ADJ
dpc-2075	196	19	cell	cell	NOUN
dpc-2075	196	20	carcinomas	carcinoma	NOUN
dpc-2075	196	21	of	of	ADP
dpc-2075	196	22	the	the	DET
dpc-2075	196	23	skin	skin	NOUN
dpc-2075	196	24	.	.	PUNCT
dpc-2075	197	1	int	int	PROPN
dpc-2075	197	2	j	j	PROPN
dpc-2075	197	3	radiat	radiat	PROPN
dpc-2075	197	4	oncol	oncol	ADJ
dpc-2075	197	5	biol	biol	PROPN
dpc-2075	197	6	phys	phy	NOUN
dpc-2075	197	7	.	.	PUNCT
dpc-2075	198	1	2004;60(2):406–411	2004;60(2):406–411	X
dpc-2075	198	2	.	.	X
dpc-2075	198	3	doi	doi	NOUN
dpc-2075	198	4	:	:	PUNCT
dpc-2075	198	5	10.1016	10.1016	NUM
dpc-2075	198	6	/	/	SYM
dpc-2075	198	7	j.	j.	PROPN
dpc-2075	198	8	ijrobp.2004.03.006.pmid	ijrobp.2004.03.006.pmid	PROPN
dpc-2075	198	9	:	:	PUNCT
dpc-2075	198	10	15380573	15380573	NUM
dpc-2075	198	11	.	.	PUNCT
dpc-2075	199	1	6	6	NUM
dpc-2075	199	2	.	.	X
dpc-2075	199	3	rong	rong	PROPN
dpc-2075	199	4	y	y	PROPN
dpc-2075	199	5	,	,	PUNCT
dpc-2075	199	6	zuo	zuo	PROPN
dpc-2075	199	7	l	l	PROPN
dpc-2075	199	8	,	,	PUNCT
dpc-2075	199	9	shang	shang	PROPN
dpc-2075	199	10	l	l	PROPN
dpc-2075	199	11	,	,	PUNCT
dpc-2075	199	12	bazan	bazan	PROPN
dpc-2075	199	13	jg	jg	PROPN
dpc-2075	199	14	.	.	PUNCT
dpc-2075	200	1	radiotherapy	radiotherapy	PROPN
dpc-2075	200	2	treatment	treatment	NOUN
dpc-2075	200	3	for	for	ADP
dpc-2075	200	4	nonmelanoma	nonmelanoma	ADJ
dpc-2075	200	5	skin	skin	NOUN
dpc-2075	200	6	cancer	cancer	NOUN
dpc-2075	200	7	.	.	PUNCT
dpc-2075	201	1	expert	expert	NOUN
dpc-2075	201	2	rev	rev	PROPN
dpc-2075	201	3	anticancer	anticancer	NOUN
dpc-2075	201	4	ther.2015	ther.2015	PROPN
dpc-2075	201	5	;	;	PUNCT
dpc-2075	201	6	15(7	15(7	NUM
dpc-2075	201	7	):	):	PUNCT
dpc-2075	201	8	765–776.doi	765–776.doi	NUM
dpc-2075	201	9	:	:	PUNCT
dpc-2075	201	10	10.1586/14737140.2015.1042865.pmid	10.1586/14737140.2015.1042865.pmid	NUM
dpc-2075	201	11	:	:	SYM
dpc-2075	201	12	25955383	25955383	NUM
dpc-2075	201	13	.	.	PUNCT
dpc-2075	202	1	7	7	X
dpc-2075	202	2	.	.	X
dpc-2075	202	3	lee	lee	PROPN
dpc-2075	202	4	da	da	PROPN
dpc-2075	202	5	,	,	PUNCT
dpc-2075	202	6	miller	miller	PROPN
dpc-2075	202	7	sj	sj	PROPN
dpc-2075	202	8	.	.	PUNCT
dpc-2075	202	9	nonmelanoma	nonmelanoma	PROPN
dpc-2075	202	10	skin	skin	NOUN
dpc-2075	202	11	cancer	cancer	NOUN
dpc-2075	202	12	.	.	PUNCT
dpc-2075	203	1	facial	facial	ADJ
dpc-2075	203	2	plast	plast	PROPN
dpc-2075	203	3	surg	surg	PROPN
dpc-2075	203	4	clin	clin	PROPN
dpc-2075	203	5	north	north	PROPN
dpc-2075	203	6	am	am	PROPN
dpc-2075	203	7	.	.	PUNCT
dpc-2075	204	1	2009;17(3):309–324	2009;17(3):309–324	X
dpc-2075	204	2	.	.	PUNCT
dpc-2075	204	3	doi	doi	NOUN
dpc-2075	204	4	:	:	PUNCT
dpc-2075	204	5	10.1016	10.1016	NUM
dpc-2075	204	6	/	/	SYM
dpc-2075	204	7	j.	j.	PROPN
dpc-2075	204	8	fsc.2009.04.004.pmid	fsc.2009.04.004.pmid	PROPN
dpc-2075	204	9	:	:	PUNCT
dpc-2075	204	10	19698913	19698913	NUM
dpc-2075	204	11	.	.	PUNCT
dpc-2075	205	1	8	8	X
dpc-2075	205	2	.	.	X
dpc-2075	205	3	strom	strom	PROPN
dpc-2075	205	4	t	t	PROPN
dpc-2075	205	5	,	,	PUNCT
dpc-2075	205	6	harrison	harrison	PROPN
dpc-2075	205	7	lb	lb	PROPN
dpc-2075	205	8	.	.	PUNCT
dpc-2075	205	9	radiotherapy	radiotherapy	NOUN
dpc-2075	205	10	for	for	ADP
dpc-2075	205	11	management	management	NOUN
dpc-2075	205	12	of	of	ADP
dpc-2075	205	13	basal	basal	ADJ
dpc-2075	205	14	and	and	CCONJ
dpc-2075	205	15	squamous	squamous	ADJ
dpc-2075	205	16	cell	cell	NOUN
dpc-2075	205	17	carcinoma	carcinoma	NOUN
dpc-2075	205	18	.	.	PUNCT
dpc-2075	206	1	curr	curr	PROPN
dpc-2075	206	2	probl	probl	PROPN
dpc-2075	206	3	cancer	cancer	NOUN
dpc-2075	206	4	.	.	PUNCT
dpc-2075	207	1	2015	2015	NUM
dpc-2075	207	2	;	;	PUNCT
dpc-2075	208	1	39(4):237–247	39(4):237–247	X
dpc-2075	208	2	.	.	PUNCT
dpc-2075	209	1	doi	doi	NOUN
dpc-2075	209	2	:	:	PUNCT
dpc-2075	209	3	10.1016	10.1016	NUM
dpc-2075	209	4	/	/	SYM
dpc-2075	209	5	j.currproblcancer.2015.07.003	j.currproblcancer.2015.07.003	PROPN
dpc-2075	209	6	.	.	PROPN
dpc-2075	210	1	pmid	pmid	PROPN
dpc-2075	210	2	:	:	PUNCT
dpc-2075	210	3	26364698	26364698	NUM
dpc-2075	210	4	.	.	PUNCT
dpc-2075	211	1	9	9	X
dpc-2075	211	2	.	.	X
dpc-2075	211	3	kramkimel	kramkimel	PROPN
dpc-2075	211	4	n	n	PART
dpc-2075	211	5	,	,	PUNCT
dpc-2075	211	6	dendale	dendale	ADJ
dpc-2075	211	7	r	r	NOUN
dpc-2075	211	8	,	,	PUNCT
dpc-2075	211	9	bolle	bolle	PROPN
dpc-2075	211	10	s	s	PROPN
dpc-2075	211	11	,	,	PUNCT
dpc-2075	211	12	zefkili	zefkili	NOUN
dpc-2075	211	13	s	s	PROPN
dpc-2075	211	14	,	,	PUNCT
dpc-2075	211	15	fourquet	fourquet	VERB
dpc-2075	211	16	a	a	PRON
dpc-2075	211	17	,	,	PUNCT
dpc-2075	211	18	kirova	kirova	PROPN
dpc-2075	211	19	ym	ym	PROPN
dpc-2075	211	20	.	.	PUNCT
dpc-2075	212	1	management	management	NOUN
dpc-2075	212	2	of	of	ADP
dpc-2075	212	3	advanced	advanced	ADJ
dpc-2075	212	4	non	non	ADJ
dpc-2075	212	5	-	-	ADJ
dpc-2075	212	6	melanoma	melanoma	ADJ
dpc-2075	212	7	skin	skin	NOUN
dpc-2075	212	8	cancers	cancer	NOUN
dpc-2075	212	9	using	use	VERB
dpc-2075	212	10	helical	helical	ADJ
dpc-2075	212	11	tomotherapy	tomotherapy	NOUN
dpc-2075	212	12	.	.	PUNCT
dpc-2075	213	1	j	j	PROPN
dpc-2075	213	2	eur	eur	PROPN
dpc-2075	213	3	acad	acad	PROPN
dpc-2075	213	4	dermatol	dermatol	NOUN
dpc-2075	213	5	venereol	venereol	NOUN
dpc-2075	213	6	.	.	PUNCT
dpc-2075	214	1	2014;28(5);641–650	2014;28(5);641–650	X
dpc-2075	214	2	.	.	PUNCT
dpc-2075	214	3	doi	doi	PROPN
dpc-2075	214	4	:	:	PUNCT
dpc-2075	214	5	10.1111	10.1111	NUM
dpc-2075	214	6	/	/	SYM
dpc-2075	214	7	jdv.12152	jdv.12152	PROPN
dpc-2075	214	8	.	.	PUNCT
dpc-2075	215	1	pmid	pmid	NOUN
dpc-2075	215	2	:	:	PUNCT
dpc-2075	215	3	23560525	23560525	NUM
dpc-2075	215	4	.	.	PUNCT
dpc-2075	216	1	10	10	NUM
dpc-2075	216	2	.	.	PUNCT
dpc-2075	217	1	gb	gb	PRON
dpc-2075	217	2	f	f	PROPN
dpc-2075	217	3	,	,	PUNCT
dpc-2075	217	4	christie	christie	PROPN
dpc-2075	217	5	d	d	PROPN
dpc-2075	217	6	,	,	PUNCT
dpc-2075	217	7	spelman	spelman	PROPN
dpc-2075	217	8	lj	lj	PROPN
dpc-2075	217	9	,	,	PUNCT
dpc-2075	217	10	supranowicz	supranowicz	PROPN
dpc-2075	217	11	mj	mj	PROPN
dpc-2075	217	12	,	,	PUNCT
dpc-2075	217	13	sinclair	sinclair	PROPN
dpc-2075	217	14	rj	rj	PROPN
dpc-2075	217	15	.	.	PROPN
dpc-2075	218	1	can	can	AUX
dpc-2075	218	2	modern	modern	ADJ
dpc-2075	218	3	radiotherapy	radiotherapy	NOUN
dpc-2075	218	4	be	be	AUX
dpc-2075	218	5	used	use	VERB
dpc-2075	218	6	for	for	ADP
dpc-2075	218	7	extensive	extensive	ADJ
dpc-2075	218	8	skin	skin	NOUN
dpc-2075	218	9	field	field	NOUN
dpc-2075	218	10	cancerisation	cancerisation	NOUN
dpc-2075	218	11	an	an	DET
dpc-2075	218	12	update	update	NOUN
dpc-2075	218	13	on	on	ADP
dpc-2075	218	14	current	current	ADJ
dpc-2075	218	15	treatment	treatment	NOUN
dpc-2075	218	16	options	option	NOUN
dpc-2075	218	17	.	.	PUNCT
dpc-2075	219	1	biomedical	biomedical	ADJ
dpc-2075	219	2	journal	journal	PROPN
dpc-2075	219	3	of	of	ADP
dpc-2075	219	4	scientific	scientific	PROPN
dpc-2075	219	5	&	&	CCONJ
dpc-2075	219	6	technical	technical	ADJ
dpc-2075	219	7	research	research	NOUN
dpc-2075	219	8	.	.	PUNCT
dpc-2075	220	1	2018;4(1):3719–3726	2018;4(1):3719–3726	X
dpc-2075	220	2	.	.	PUNCT
dpc-2075	220	3	doi:10.26717	doi:10.26717	PROPN
dpc-2075	220	4	/	/	SYM
dpc-2075	220	5	bjstr.2018.04.000998	bjstr.2018.04.000998	PROPN
dpc-2075	220	6	.	.	PROPN
dpc-2075	221	1	11	11	NUM
dpc-2075	221	2	.	.	PUNCT
dpc-2075	222	1	mendenhall	mendenhall	PROPN
dpc-2075	222	2	wm	wm	PROPN
dpc-2075	222	3	,	,	PUNCT
dpc-2075	222	4	amdur	amdur	PROPN
dpc-2075	222	5	rj	rj	PROPN
dpc-2075	222	6	,	,	PUNCT
dpc-2075	222	7	hinerman	hinerman	PROPN
dpc-2075	222	8	rw	rw	NOUN
dpc-2075	222	9	,	,	PUNCT
dpc-2075	222	10	cognetta	cognetta	PROPN
dpc-2075	222	11	ab	ab	PROPN
dpc-2075	222	12	,	,	PUNCT
dpc-2075	222	13	mendenhall	mendenhall	NOUN
dpc-2075	222	14	p.radiotherapy	p.radiotherapy	NOUN
dpc-2075	222	15	for	for	ADP
dpc-2075	222	16	cutaneous	cutaneous	ADJ
dpc-2075	222	17	squamous	squamous	ADJ
dpc-2075	222	18	and	and	CCONJ
dpc-2075	222	19	basal	basal	ADJ
dpc-2075	222	20	cell	cell	NOUN
dpc-2075	222	21	carcinomas	carcinoma	NOUN
dpc-2075	222	22	of	of	ADP
dpc-2075	222	23	the	the	DET
dpc-2075	222	24	head	head	NOUN
dpc-2075	222	25	and	and	CCONJ
dpc-2075	222	26	neck	neck	NOUN
dpc-2075	222	27	.	.	PUNCT
dpc-2075	223	1	laryngoscope	laryngoscope	NOUN
dpc-2075	223	2	.	.	PUNCT
dpc-2075	224	1	2009;119(10):1994–1999	2009;119(10):1994–1999	NUM
dpc-2075	224	2	.	.	PUNCT
dpc-2075	225	1	doi	doi	NOUN
dpc-2075	225	2	:	:	PUNCT
dpc-2075	225	3	10.1002	10.1002	NUM
dpc-2075	225	4	/	/	SYM
dpc-2075	225	5	lary.20608	lary.20608	PROPN
dpc-2075	225	6	.	.	PUNCT
dpc-2075	226	1	pmid	pmid	PROPN
dpc-2075	226	2	:	:	PUNCT
dpc-2075	226	3	19688856	19688856	NUM
dpc-2075	226	4	.	.	PUNCT
dpc-2075	227	1	12	12	NUM
dpc-2075	227	2	.	.	PUNCT
dpc-2075	227	3	pampena	pampena	NOUN
dpc-2075	227	4	r	r	NOUN
dpc-2075	227	5	et	et	PROPN
dpc-2075	227	6	al	al	PROPN
dpc-2075	227	7	.	.	PUNCT
dpc-2075	228	1	orthovoltage	orthovoltage	PROPN
dpc-2075	228	2	radiotherapy	radiotherapy	NOUN
dpc-2075	228	3	for	for	ADP
dpc-2075	228	4	nonmelanoma	nonmelanoma	ADJ
dpc-2075	228	5	skin	skin	NOUN
dpc-2075	228	6	cancer	cancer	NOUN
dpc-2075	228	7	(	(	PUNCT
dpc-2075	228	8	nmsc	nmsc	NOUN
dpc-2075	228	9	):	):	PUNCT
dpc-2075	228	10	comparison	comparison	NOUN
dpc-2075	228	11	between	between	ADP
dpc-2075	228	12	2	2	NUM
dpc-2075	228	13	different	different	ADJ
dpc-2075	228	14	schedules	schedule	NOUN
dpc-2075	228	15	.	.	PUNCT
dpc-2075	229	1	j	j	PROPN
dpc-2075	229	2	am	be	AUX
dpc-2075	229	3	acad	acad	ADJ
dpc-2075	229	4	dermato	dermato	NOUN
dpc-2075	229	5	.	.	PUNCT
dpc-2075	230	1	2016;74(2):341–347	2016;74(2):341–347	NUM
dpc-2075	230	2	.	.	PUNCT
dpc-2075	230	3	doi	doi	NOUN
dpc-2075	230	4	:	:	PUNCT
dpc-2075	230	5	10.1016	10.1016	NUM
dpc-2075	230	6	/	/	SYM
dpc-2075	230	7	j.	j.	PROPN
dpc-2075	230	8	jaad.2015.09.031.pmid	jaad.2015.09.031.pmid	PROPN
dpc-2075	230	9	:	:	PUNCT
dpc-2075	230	10	26589877	26589877	NUM
dpc-2075	230	11	.	.	PUNCT
dpc-2075	231	1	13	13	NUM
dpc-2075	231	2	.	.	PUNCT
dpc-2075	231	3	stratigos	stratigos	PROPN
dpc-2075	231	4	aj	aj	PROPN
dpc-2075	231	5	et	et	PROPN
dpc-2075	231	6	al	al	PROPN
dpc-2075	231	7	.	.	PUNCT
dpc-2075	231	8	european	european	ADJ
dpc-2075	231	9	interdisciplinary	interdisciplinary	ADJ
dpc-2075	231	10	guideline	guideline	NOUN
dpc-2075	231	11	on	on	ADP
dpc-2075	231	12	invasive	invasive	ADJ
dpc-2075	231	13	squamous	squamous	ADJ
dpc-2075	231	14	cell	cell	NOUN
dpc-2075	231	15	carcinoma	carcinoma	NOUN
dpc-2075	231	16	of	of	ADP
dpc-2075	231	17	the	the	DET
dpc-2075	231	18	skin	skin	NOUN
dpc-2075	231	19	:	:	PUNCT
dpc-2075	231	20	part	part	NOUN
dpc-2075	231	21	2	2	NUM
dpc-2075	231	22	.	.	PUNCT
dpc-2075	231	23	treatment	treatment	NOUN
dpc-2075	231	24	.	.	PUNCT
dpc-2075	232	1	european	european	PROPN
dpc-2075	232	2	journal	journal	PROPN
dpc-2075	232	3	of	of	ADP
dpc-2075	232	4	cancer	cancer	NOUN
dpc-2075	232	5	.	.	PUNCT
dpc-2075	233	1	2020;128:83–102	2020;128:83–102	X
dpc-2075	233	2	.	.	PUNCT
dpc-2075	233	3	doi	doi	NOUN
dpc-2075	233	4	:	:	PUNCT
dpc-2075	233	5	10.1016	10.1016	NUM
dpc-2075	233	6	/	/	SYM
dpc-2075	233	7	j.	j.	PROPN
dpc-2075	233	8	ejca.2020.01.008	ejca.2020.01.008	PROPN
dpc-2075	233	9	.	.	PUNCT
dpc-2075	234	1	pmid	pmid	NOUN
dpc-2075	234	2	:	:	PUNCT
dpc-2075	234	3	32113942	32113942	NUM
dpc-2075	234	4	.	.	PUNCT
dpc-2075	235	1	14	14	NUM
dpc-2075	235	2	.	.	PUNCT
dpc-2075	236	1	thompson	thompson	PROPN
dpc-2075	236	2	ak	ak	PROPN
dpc-2075	236	3	,	,	PUNCT
dpc-2075	236	4	kelley	kelley	PROPN
dpc-2075	236	5	bf	bf	PROPN
dpc-2075	236	6	,	,	PUNCT
dpc-2075	236	7	prokop	prokop	PROPN
dpc-2075	236	8	lj	lj	PROPN
dpc-2075	236	9	,	,	PUNCT
dpc-2075	236	10	murad	murad	PROPN
dpc-2075	236	11	mh	mh	PROPN
dpc-2075	236	12	,	,	PUNCT
dpc-2075	236	13	baum	baum	PROPN
dpc-2075	236	14	cl	cl	PROPN
dpc-2075	236	15	.	.	PUNCT
dpc-2075	237	1	risk	risk	NOUN
dpc-2075	237	2	factors	factor	NOUN
dpc-2075	237	3	for	for	ADP
dpc-2075	237	4	cutaneous	cutaneous	ADJ
dpc-2075	237	5	squamous	squamous	ADJ
dpc-2075	237	6	cell	cell	NOUN
dpc-2075	237	7	carcinoma	carcinoma	NOUN
dpc-2075	237	8	recurrence	recurrence	NOUN
dpc-2075	237	9	,	,	PUNCT
dpc-2075	237	10	metastasis	metastasis	NOUN
dpc-2075	237	11	,	,	PUNCT
dpc-2075	237	12	and	and	CCONJ
dpc-2075	237	13	disease	disease	NOUN
dpc-2075	237	14	-	-	PUNCT
dpc-2075	237	15	specific	specific	ADJ
dpc-2075	237	16	death	death	NOUN
dpc-2075	237	17	:	:	PUNCT
dpc-2075	237	18	a	a	DET
dpc-2075	237	19	systematic	systematic	ADJ
dpc-2075	237	20	review	review	NOUN
dpc-2075	237	21	and	and	CCONJ
dpc-2075	237	22	meta	meta	ADJ
dpc-2075	237	23	-	-	PUNCT
dpc-2075	237	24	analysis	analysis	NOUN
dpc-2075	237	25	.	.	PUNCT
dpc-2075	238	1	jama	jama	PROPN
dpc-2075	238	2	dermatol.2016;152(4):419–428	dermatol.2016;152(4):419–428	PROPN
dpc-2075	238	3	.	.	PUNCT
dpc-2075	239	1	doi	doi	NOUN
dpc-2075	239	2	:	:	PUNCT
dpc-2075	239	3	10.1001	10.1001	NUM
dpc-2075	239	4	/	/	SYM
dpc-2075	239	5	jamadermatol.2015.4994	jamadermatol.2015.4994	ADJ
dpc-2075	239	6	.	.	PUNCT
dpc-2075	240	1	pmid	pmid	NOUN
dpc-2075	240	2	:	:	PUNCT
dpc-2075	240	3	26762219	26762219	NUM
dpc-2075	240	4	.	.	PUNCT
dpc-2075	241	1	15	15	NUM
dpc-2075	241	2	.	.	PUNCT
dpc-2075	241	3	han	han	PROPN
dpc-2075	241	4	a	a	PROPN
dpc-2075	241	5	,	,	PUNCT
dpc-2075	241	6	ratner	ratner	PROPN
dpc-2075	241	7	d.	d.	PROPN
dpc-2075	241	8	what	what	PRON
dpc-2075	241	9	is	be	AUX
dpc-2075	241	10	the	the	DET
dpc-2075	241	11	role	role	NOUN
dpc-2075	241	12	of	of	ADP
dpc-2075	241	13	adjuvant	adjuvant	ADJ
dpc-2075	241	14	radiotherapy	radiotherapy	NOUN
dpc-2075	241	15	in	in	ADP
dpc-2075	241	16	the	the	DET
dpc-2075	241	17	treatment	treatment	NOUN
dpc-2075	241	18	of	of	ADP
dpc-2075	241	19	cutaneous	cutaneous	ADJ
dpc-2075	241	20	squamous	squamous	ADJ
dpc-2075	241	21	cell	cell	NOUN
dpc-2075	241	22	carcinoma	carcinoma	NOUN
dpc-2075	241	23	with	with	ADP
dpc-2075	241	24	perineural	perineural	ADJ
dpc-2075	241	25	invasion?.cancer	invasion?.cancer	NOUN
dpc-2075	241	26	.	.	PUNCT
dpc-2075	242	1	2007	2007	NUM
dpc-2075	242	2	;	;	PUNCT
dpc-2075	242	3	109(6):1053–1059	109(6):1053–1059	X
dpc-2075	242	4	.	.	X
dpc-2075	242	5	doi	doi	NOUN
dpc-2075	242	6	:	:	PUNCT
dpc-2075	242	7	10.1002/	10.1002/	NUM
dpc-2075	242	8	cncr.22509	cncr.22509	PROPN
dpc-2075	242	9	.	.	PUNCT
dpc-2075	243	1	pmid	pmid	PROPN
dpc-2075	243	2	:	:	PUNCT
dpc-2075	243	3	17279578	17279578	NUM
dpc-2075	243	4	.	.	PUNCT
dpc-2075	244	1	16	16	NUM
dpc-2075	244	2	.	.	PUNCT
dpc-2075	245	1	khan	khan	PROPN
dpc-2075	245	2	aa	aa	PROPN
dpc-2075	245	3	et	et	PROPN
dpc-2075	245	4	al	al	PROPN
dpc-2075	245	5	.	.	PROPN
dpc-2075	245	6	guidelines	guideline	NOUN
dpc-2075	245	7	for	for	ADP
dpc-2075	245	8	the	the	DET
dpc-2075	245	9	excision	excision	NOUN
dpc-2075	245	10	of	of	ADP
dpc-2075	245	11	cutaneous	cutaneous	ADJ
dpc-2075	245	12	squamous	squamous	ADJ
dpc-2075	245	13	cell	cell	NOUN
dpc-2075	245	14	cancers	cancer	NOUN
dpc-2075	245	15	in	in	ADP
dpc-2075	245	16	the	the	DET
dpc-2075	245	17	united	united	ADJ
dpc-2075	245	18	kingdom	kingdom	PROPN
dpc-2075	245	19	:	:	PUNCT
dpc-2075	245	20	the	the	DET
dpc-2075	245	21	best	good	ADJ
dpc-2075	245	22	cut	cut	NOUN
dpc-2075	245	23	is	be	AUX
dpc-2075	245	24	the	the	DET
dpc-2075	245	25	deepest	deep	ADJ
dpc-2075	245	26	.	.	PUNCT
dpc-2075	246	1	j	j	PROPN
dpc-2075	246	2	plast	plast	PROPN
dpc-2075	246	3	reconstr	reconstr	PROPN
dpc-2075	246	4	aesthet	aesthet	PROPN
dpc-2075	246	5	surg	surg	PROPN
dpc-2075	246	6	.	.	PUNCT
dpc-2075	247	1	2013;66(4	2013;66(4	NUM
dpc-2075	247	2	):	):	PUNCT
dpc-2075	247	3	467–471	467–471	NUM
dpc-2075	247	4	.	.	PUNCT
dpc-2075	248	1	doi	doi	NOUN
dpc-2075	248	2	:	:	PUNCT
dpc-2075	248	3	10.1016	10.1016	NUM
dpc-2075	248	4	/	/	SYM
dpc-2075	248	5	j.bjps.2012.12.016	j.bjps.2012.12.016	PROPN
dpc-2075	248	6	.	.	PUNCT
dpc-2075	249	1	pmid	pmid	NOUN
dpc-2075	249	2	:	:	PUNCT
dpc-2075	249	3	23352886	23352886	NUM
dpc-2075	249	4	.	.	PUNCT
dpc-2075	250	1	17	17	NUM
dpc-2075	250	2	.	.	PUNCT
dpc-2075	251	1	mirshams	mirshams	PROPN
dpc-2075	251	2	m	m	PROPN
dpc-2075	251	3	,	,	PUNCT
dpc-2075	251	4	razzaghi	razzaghi	PROPN
dpc-2075	251	5	m	m	PROPN
dpc-2075	251	6	,	,	PUNCT
dpc-2075	251	7	noormohammadpour	noormohammadpour	PROPN
dpc-2075	251	8	p	p	X
dpc-2075	251	9	,	,	PUNCT
dpc-2075	251	10	naraghi	naraghi	PROPN
dpc-2075	251	11	z	z	PROPN
dpc-2075	251	12	,	,	PUNCT
dpc-2075	251	13	kamyab	kamyab	X
dpc-2075	251	14	k	k	PROPN
dpc-2075	251	15	,	,	PUNCT
dpc-2075	251	16	sabouri	sabouri	PROPN
dpc-2075	251	17	rad	rad	PROPN
dpc-2075	251	18	s.	s.	PROPN
dpc-2075	251	19	incidence	incidence	NOUN
dpc-2075	251	20	of	of	ADP
dpc-2075	251	21	incomplete	incomplete	ADJ
dpc-2075	251	22	excision	excision	NOUN
dpc-2075	251	23	in	in	ADP
dpc-2075	251	24	surgically	surgically	ADV
dpc-2075	251	25	treated	treat	VERB
dpc-2075	251	26	cutaneous	cutaneous	ADJ
dpc-2075	251	27	squamous	squamous	ADJ
dpc-2075	251	28	cell	cell	NOUN
dpc-2075	251	29	carcinoma	carcinoma	NOUN
dpc-2075	251	30	and	and	CCONJ
dpc-2075	251	31	identification	identification	NOUN
dpc-2075	251	32	of	of	ADP
dpc-2075	251	33	the	the	DET
dpc-2075	251	34	related	related	ADJ
dpc-2075	251	35	risk	risk	NOUN
dpc-2075	251	36	factors	factor	NOUN
dpc-2075	251	37	.	.	PUNCT
dpc-2075	252	1	acta	acta	PROPN
dpc-2075	252	2	med	med	PROPN
dpc-2075	252	3	iran	iran	PROPN
dpc-2075	252	4	.	.	PUNCT
dpc-2075	253	1	2011	2011	NUM
dpc-2075	253	2	;	;	PUNCT
dpc-2075	253	3	49(12	49(12	NUM
dpc-2075	253	4	):	):	PUNCT
dpc-2075	253	5	806–809	806–809	NUM
dpc-2075	253	6	.	.	PUNCT
dpc-2075	254	1	18	18	NUM
dpc-2075	254	2	.	.	PUNCT
dpc-2075	254	3	cañueto	cañueto	PROPN
dpc-2075	254	4	j	j	PROPN
dpc-2075	254	5	,	,	PUNCT
dpc-2075	254	6	jaka	jaka	PROPN
dpc-2075	254	7	a	a	PRON
dpc-2075	254	8	,	,	PUNCT
dpc-2075	254	9	toll	toll	NOUN
dpc-2075	254	10	a.	a.	NOUN
dpc-2075	254	11	the	the	DET
dpc-2075	254	12	value	value	NOUN
dpc-2075	254	13	of	of	ADP
dpc-2075	254	14	adjuvant	adjuvant	ADJ
dpc-2075	254	15	radiotherapy	radiotherapy	NOUN
dpc-2075	254	16	in	in	ADP
dpc-2075	254	17	cutaneous	cutaneous	ADJ
dpc-2075	254	18	squamous	squamous	ADJ
dpc-2075	254	19	cell	cell	NOUN
dpc-2075	254	20	carcinoma	carcinoma	NOUN
dpc-2075	254	21	:	:	PUNCT
dpc-2075	254	22	a	a	DET
dpc-2075	254	23	review	review	NOUN
dpc-2075	254	24	.	.	PUNCT
dpc-2075	255	1	actas	actas	PROPN
dpc-2075	255	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-2075	255	3	.	.	PUNCT
dpc-2075	256	1	2018;109(6	2018;109(6	X
dpc-2075	256	2	):	):	PUNCT
dpc-2075	256	3	476–484	476–484	NUM
dpc-2075	256	4	.	.	PUNCT
dpc-2075	257	1	doi	doi	NOUN
dpc-2075	257	2	:	:	PUNCT
dpc-2075	257	3	10.1016	10.1016	NUM
dpc-2075	257	4	/	/	SYM
dpc-2075	257	5	j.ad.2018.03.007	j.ad.2018.03.007	PROPN
dpc-2075	257	6	.	.	PUNCT
dpc-2075	258	1	pmid	pmid	NOUN
dpc-2075	258	2	:	:	PUNCT
dpc-2075	258	3	29759308	29759308	NUM
dpc-2075	258	4	.	.	PUNCT
dpc-2075	259	1	19	19	NUM
dpc-2075	259	2	.	.	PUNCT
dpc-2075	259	3	housman	housman	PROPN
dpc-2075	259	4	ts	ts	ADP
dpc-2075	259	5	et	et	PROPN
dpc-2075	259	6	al	al	PROPN
dpc-2075	259	7	.	.	PROPN
dpc-2075	259	8	skin	skin	NOUN
dpc-2075	259	9	cancer	cancer	NOUN
dpc-2075	259	10	is	be	AUX
dpc-2075	259	11	among	among	ADP
dpc-2075	259	12	the	the	DET
dpc-2075	259	13	most	most	ADV
dpc-2075	259	14	costly	costly	ADJ
dpc-2075	259	15	of	of	ADP
dpc-2075	259	16	all	all	DET
dpc-2075	259	17	cancers	cancer	NOUN
dpc-2075	259	18	to	to	PART
dpc-2075	259	19	treat	treat	VERB
dpc-2075	259	20	for	for	ADP
dpc-2075	259	21	the	the	DET
dpc-2075	259	22	medicare	medicare	PROPN
dpc-2075	259	23	population	population	NOUN
dpc-2075	259	24	.	.	PUNCT
dpc-2075	260	1	j	j	PROPN
dpc-2075	260	2	am	be	AUX
dpc-2075	260	3	acad	acad	ADJ
dpc-2075	260	4	dermatol	dermatol	NOUN
dpc-2075	260	5	,	,	PUNCT
dpc-2075	260	6	.	.	PUNCT
dpc-2075	261	1	2003;48(3):425–429	2003;48(3):425–429	NUM
dpc-2075	261	2	.	.	PUNCT
dpc-2075	261	3	doi	doi	NOUN
dpc-2075	261	4	:	:	PUNCT
dpc-2075	261	5	10.1067	10.1067	NUM
dpc-2075	261	6	/	/	SYM
dpc-2075	261	7	mjd.2003.186	mjd.2003.186	PROPN
dpc-2075	261	8	.	.	PUNCT
dpc-2075	262	1	pmid	pmid	NOUN
dpc-2075	262	2	:	:	PUNCT
dpc-2075	262	3	12637924	12637924	NUM
dpc-2075	262	4	.	.	PUNCT
dpc-2075	263	1	20	20	NUM
dpc-2075	263	2	.	.	PUNCT
dpc-2075	264	1	babington	babington	PROPN
dpc-2075	264	2	s	s	PROPN
dpc-2075	264	3	,	,	PUNCT
dpc-2075	264	4	veness	veness	PROPN
dpc-2075	264	5	mj	mj	PROPN
dpc-2075	264	6	,	,	PUNCT
dpc-2075	264	7	cakir	cakir	PROPN
dpc-2075	264	8	b	b	PROPN
dpc-2075	264	9	,	,	PUNCT
dpc-2075	264	10	gebski	gebski	PROPN
dpc-2075	264	11	vj	vj	PROPN
dpc-2075	264	12	,	,	PUNCT
dpc-2075	264	13	morgan	morgan	PROPN
dpc-2075	264	14	gj	gj	PROPN
dpc-2075	264	15	.	.	PROPN
dpc-2075	264	16	squamous	squamous	ADJ
dpc-2075	264	17	cell	cell	NOUN
dpc-2075	264	18	carcinoma	carcinoma	NOUN
dpc-2075	264	19	of	of	ADP
dpc-2075	264	20	the	the	DET
dpc-2075	264	21	lip	lip	NOUN
dpc-2075	264	22	:	:	PUNCT
dpc-2075	264	23	is	be	AUX
dpc-2075	264	24	there	there	PRON
dpc-2075	264	25	a	a	DET
dpc-2075	264	26	role	role	NOUN
dpc-2075	264	27	for	for	ADP
dpc-2075	264	28	adjuvant	adjuvant	ADJ
dpc-2075	264	29	rareview	rareview	NOUN
dpc-2075	264	30	|	|	ADV
dpc-2075	264	31	dermatol	dermatol	ADJ
dpc-2075	264	32	pract	pract	NOUN
dpc-2075	264	33	concept	concept	NOUN
dpc-2075	264	34	.	.	PUNCT
dpc-2075	265	1	2021	2021	NUM
dpc-2075	265	2	;	;	PUNCT
dpc-2075	265	3	11(s2	11(s2	NUM
dpc-2075	265	4	):	):	PUNCT
dpc-2075	265	5	e2021168s	e2021168s	PROPN
dpc-2075	265	6	7	7	PROPN
dpc-2075	265	7	diotherapy	diotherapy	NOUN
dpc-2075	265	8	in	in	ADP
dpc-2075	265	9	improving	improve	VERB
dpc-2075	265	10	local	local	ADJ
dpc-2075	265	11	control	control	NOUN
dpc-2075	265	12	following	follow	VERB
dpc-2075	265	13	incomplete	incomplete	ADJ
dpc-2075	265	14	or	or	CCONJ
dpc-2075	265	15	inadequate	inadequate	ADJ
dpc-2075	265	16	excision	excision	NOUN
dpc-2075	265	17	?	?	PUNCT
dpc-2075	266	1	anz	anz	PROPN
dpc-2075	266	2	j	j	PROPN
dpc-2075	266	3	surg	surg	PROPN
dpc-2075	266	4	.	.	PUNCT
dpc-2075	267	1	2003	2003	NUM
dpc-2075	267	2	;	;	PUNCT
dpc-2075	268	1	73(8):621–625	73(8):621–625	X
dpc-2075	268	2	.	.	PUNCT
dpc-2075	269	1	doi	doi	NOUN
dpc-2075	269	2	:	:	PUNCT
dpc-2075	269	3	10.1046	10.1046	NUM
dpc-2075	269	4	/	/	SYM
dpc-2075	269	5	j.1445	j.1445	NOUN
dpc-2075	269	6	-	-	PUNCT
dpc-2075	269	7	2197.2003.t01	2197.2003.t01	NOUN
dpc-2075	269	8	-	-	PUNCT
dpc-2075	269	9	1	1	NUM
dpc-2075	269	10	-	-	PUNCT
dpc-2075	269	11	02710.x	02710.x	PROPN
dpc-2075	269	12	.	.	PUNCT
dpc-2075	270	1	pmid	pmid	NOUN
dpc-2075	270	2	:	:	PUNCT
dpc-2075	270	3	12887533	12887533	NUM
dpc-2075	270	4	.	.	PUNCT
dpc-2075	271	1	21	21	NUM
dpc-2075	271	2	.	.	PUNCT
dpc-2075	271	3	carter	carter	PROPN
dpc-2075	271	4	jb	jb	PROPN
dpc-2075	271	5	,	,	PUNCT
dpc-2075	271	6	johnson	johnson	PROPN
dpc-2075	271	7	mm	mm	PROPN
dpc-2075	271	8	,	,	PUNCT
dpc-2075	271	9	chua	chua	PROPN
dpc-2075	271	10	tl	tl	PROPN
dpc-2075	271	11	,	,	PUNCT
dpc-2075	271	12	karia	karia	PROPN
dpc-2075	271	13	ps	ps	PROPN
dpc-2075	271	14	,	,	PUNCT
dpc-2075	271	15	schmults	schmults	PROPN
dpc-2075	271	16	cd	cd	PROPN
dpc-2075	271	17	.	.	PUNCT
dpc-2075	272	1	outcomes	outcome	NOUN
dpc-2075	272	2	of	of	ADP
dpc-2075	272	3	primary	primary	ADJ
dpc-2075	272	4	cutaneous	cutaneous	ADJ
dpc-2075	272	5	squamous	squamous	ADJ
dpc-2075	272	6	cell	cell	NOUN
dpc-2075	272	7	carcinoma	carcinoma	NOUN
dpc-2075	272	8	with	with	ADP
dpc-2075	272	9	perineural	perineural	ADJ
dpc-2075	272	10	invasion	invasion	NOUN
dpc-2075	272	11	:	:	PUNCT
dpc-2075	272	12	an	an	DET
dpc-2075	272	13	11	11	NUM
dpc-2075	272	14	-	-	PUNCT
dpc-2075	272	15	year	year	NOUN
dpc-2075	272	16	cohort	cohort	NOUN
dpc-2075	272	17	study	study	NOUN
dpc-2075	272	18	.	.	PUNCT
dpc-2075	273	1	jama	jama	PROPN
dpc-2075	273	2	dermatol	dermatol	NOUN
dpc-2075	273	3	.	.	PUNCT
dpc-2075	274	1	2013	2013	NUM
dpc-2075	274	2	;	;	PUNCT
dpc-2075	274	3	149(1):35–41	149(1):35–41	NUM
dpc-2075	274	4	.	.	PUNCT
dpc-2075	275	1	doi	doi	NOUN
dpc-2075	275	2	:	:	PUNCT
dpc-2075	275	3	10.1001	10.1001	NUM
dpc-2075	275	4	/	/	SYM
dpc-2075	275	5	jamadermatol.2013.746	jamadermatol.2013.746	PROPN
dpc-2075	275	6	.	.	PUNCT
dpc-2075	276	1	pmid	pmid	NOUN
dpc-2075	276	2	:	:	PUNCT
dpc-2075	276	3	23324754	23324754	NUM
dpc-2075	276	4	.	.	PUNCT
dpc-2075	277	1	22	22	NUM
dpc-2075	277	2	.	.	PUNCT
dpc-2075	278	1	rowe	rowe	PROPN
dpc-2075	278	2	de	de	PROPN
dpc-2075	278	3	,	,	PUNCT
dpc-2075	278	4	carroll	carroll	PROPN
dpc-2075	278	5	rj	rj	PROPN
dpc-2075	278	6	,	,	PUNCT
dpc-2075	278	7	day	day	PROPN
dpc-2075	278	8	cl	cl	NOUN
dpc-2075	278	9	.	.	PUNCT
dpc-2075	279	1	prognostic	prognostic	ADJ
dpc-2075	279	2	factors	factor	NOUN
dpc-2075	279	3	for	for	ADP
dpc-2075	279	4	local	local	ADJ
dpc-2075	279	5	recurrence	recurrence	NOUN
dpc-2075	279	6	,	,	PUNCT
dpc-2075	279	7	metastasis	metastasis	NOUN
dpc-2075	279	8	,	,	PUNCT
dpc-2075	279	9	and	and	CCONJ
dpc-2075	279	10	survival	survival	NOUN
dpc-2075	279	11	rates	rate	NOUN
dpc-2075	279	12	in	in	ADP
dpc-2075	279	13	squamous	squamous	ADJ
dpc-2075	279	14	cell	cell	NOUN
dpc-2075	279	15	carcinoma	carcinoma	NOUN
dpc-2075	279	16	of	of	ADP
dpc-2075	279	17	the	the	DET
dpc-2075	279	18	skin	skin	NOUN
dpc-2075	279	19	,	,	PUNCT
dpc-2075	279	20	ear	ear	NOUN
dpc-2075	279	21	,	,	PUNCT
dpc-2075	279	22	and	and	CCONJ
dpc-2075	279	23	lip	lip	NOUN
dpc-2075	279	24	.	.	PUNCT
dpc-2075	280	1	implications	implication	NOUN
dpc-2075	280	2	for	for	ADP
dpc-2075	280	3	treatment	treatment	NOUN
dpc-2075	280	4	modality	modality	NOUN
dpc-2075	280	5	selection	selection	NOUN
dpc-2075	280	6	.	.	PUNCT
dpc-2075	281	1	j	j	PROPN
dpc-2075	281	2	am	be	AUX
dpc-2075	281	3	acad	acad	ADJ
dpc-2075	281	4	dermatol	dermatol	NOUN
dpc-2075	281	5	.	.	PUNCT
dpc-2075	282	1	1992;26(6):976–990	1992;26(6):976–990	X
dpc-2075	282	2	.	.	X
dpc-2075	282	3	doi	doi	PROPN
dpc-2075	282	4	:	:	PUNCT
dpc-2075	282	5	10.1016/0190	10.1016/0190	NUM
dpc-2075	282	6	-	-	SYM
dpc-2075	282	7	9622(92)70144	9622(92)70144	NUM
dpc-2075	282	8	-	-	SYM
dpc-2075	282	9	5	5	NUM
dpc-2075	282	10	.	.	NOUN
dpc-2075	282	11	23	23	NUM
dpc-2075	282	12	.	.	PUNCT
dpc-2075	283	1	nccn	nccn	PROPN
dpc-2075	283	2	guidelines.nccn	guidelines.nccn	PROPN
dpc-2075	283	3	guidelines	guideline	VERB
dpc-2075	283	4	squamous	squamous	ADJ
dpc-2075	283	5	cell	cell	NOUN
dpc-2075	283	6	caricinoma	caricinoma	PROPN
dpc-2075	283	7	.	.	PUNCT
dpc-2075	284	1	accessed	access	VERB
dpc-2075	284	2	:	:	PUNCT
dpc-2075	284	3	june	june	PROPN
dpc-2075	284	4	2021	2021	NUM
dpc-2075	284	5	.	.	PUNCT
dpc-2075	285	1	www.nccn.org	www.nccn.org	NOUN
dpc-2075	285	2	in	in	ADP
dpc-2075	285	3	.	.	PUNCT
dpc-2075	286	1	24	24	NUM
dpc-2075	286	2	.	.	PUNCT
dpc-2075	286	3	martorell	martorell	NOUN
dpc-2075	286	4	-	-	PUNCT
dpc-2075	286	5	calatayud	calatayud	NOUN
dpc-2075	286	6	a	a	PRON
dpc-2075	286	7	,	,	PUNCT
dpc-2075	286	8	sanmartín	sanmartín	NOUN
dpc-2075	286	9	jimenez	jimenez	PROPN
dpc-2075	286	10	o	o	PROPN
dpc-2075	286	11	,	,	PUNCT
dpc-2075	286	12	cruz	cruz	PROPN
dpc-2075	286	13	mojarrieta	mojarrieta	PROPN
dpc-2075	286	14	j	j	PROPN
dpc-2075	286	15	,	,	PUNCT
dpc-2075	286	16	guillén	guillén	PROPN
dpc-2075	286	17	barona	barona	PROPN
dpc-2075	286	18	c.	c.	PROPN
dpc-2075	286	19	cutaneous	cutaneous	ADJ
dpc-2075	286	20	squamous	squamous	ADJ
dpc-2075	286	21	cell	cell	NOUN
dpc-2075	286	22	carcinoma	carcinoma	NOUN
dpc-2075	286	23	:	:	PUNCT
dpc-2075	286	24	defining	define	VERB
dpc-2075	286	25	the	the	DET
dpc-2075	286	26	high	high	ADJ
dpc-2075	286	27	-	-	PUNCT
dpc-2075	286	28	risk	risk	NOUN
dpc-2075	286	29	variant	variant	NOUN
dpc-2075	286	30	.	.	PUNCT
dpc-2075	287	1	actas	actas	NOUN
dpc-2075	287	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-2075	287	3	.	.	PUNCT
dpc-2075	288	1	2013;104(5):367	2013;104(5):367	NUM
dpc-2075	288	2	–	–	PUNCT
dpc-2075	288	3	379	379	NUM
dpc-2075	288	4	.	.	PUNCT
dpc-2075	289	1	doi	doi	NOUN
dpc-2075	289	2	:	:	PUNCT
dpc-2075	289	3	10.1016	10.1016	NUM
dpc-2075	289	4	/	/	SYM
dpc-2075	289	5	j.adengl.2011.12.012.pmid	j.adengl.2011.12.012.pmid	NOUN
dpc-2075	289	6	:	:	PUNCT
dpc-2075	289	7	23683506	23683506	NUM
dpc-2075	289	8	.	.	PUNCT
dpc-2075	290	1	25	25	NUM
dpc-2075	290	2	.	.	PUNCT
dpc-2075	291	1	[	[	X
dpc-2075	291	2	25	25	NUM
dpc-2075	291	3	]	]	X
dpc-2075	291	4	jambusaria	jambusaria	NOUN
dpc-2075	291	5	-	-	PUNCT
dpc-2075	291	6	pahlajani	pahlajani	PROPN
dpc-2075	291	7	a	a	PRON
dpc-2075	291	8	,	,	PUNCT
dpc-2075	291	9	miller	miller	PROPN
dpc-2075	291	10	cj	cj	PROPN
dpc-2075	291	11	,	,	PUNCT
dpc-2075	291	12	quon	quon	PROPN
dpc-2075	291	13	h	h	PROPN
dpc-2075	291	14	,	,	PUNCT
dpc-2075	291	15	smith	smith	PROPN
dpc-2075	291	16	n	n	CCONJ
dpc-2075	291	17	,	,	PUNCT
dpc-2075	291	18	klein	klein	PROPN
dpc-2075	291	19	rq	rq	PROPN
dpc-2075	291	20	,	,	PUNCT
dpc-2075	291	21	schmults	schmults	PROPN
dpc-2075	291	22	cd	cd	PROPN
dpc-2075	291	23	.	.	PUNCT
dpc-2075	292	1	surgical	surgical	ADJ
dpc-2075	292	2	monotherapy	monotherapy	NOUN
dpc-2075	292	3	versus	versus	ADP
dpc-2075	292	4	surgery	surgery	NOUN
dpc-2075	292	5	plus	plus	CCONJ
dpc-2075	292	6	adjuvant	adjuvant	ADJ
dpc-2075	292	7	radiotherapy	radiotherapy	NOUN
dpc-2075	292	8	in	in	ADP
dpc-2075	292	9	high	high	ADJ
dpc-2075	292	10	-	-	PUNCT
dpc-2075	292	11	risk	risk	NOUN
dpc-2075	292	12	cutaneous	cutaneous	ADJ
dpc-2075	292	13	squamous	squamous	ADJ
dpc-2075	292	14	cell	cell	NOUN
dpc-2075	292	15	carcinoma	carcinoma	NOUN
dpc-2075	292	16	:	:	PUNCT
dpc-2075	292	17	a	a	DET
dpc-2075	292	18	systematic	systematic	ADJ
dpc-2075	292	19	review	review	NOUN
dpc-2075	292	20	of	of	ADP
dpc-2075	292	21	outcomes	outcome	NOUN
dpc-2075	292	22	.	.	PUNCT
dpc-2075	293	1	dermatol	dermatol	NOUN
dpc-2075	293	2	surg	surg	NOUN
dpc-2075	293	3	.	.	PUNCT
dpc-2075	294	1	2009	2009	NUM
dpc-2075	294	2	;	;	PUNCT
dpc-2075	294	3	35(4):574	35(4):574	NUM
dpc-2075	294	4	–	–	PUNCT
dpc-2075	294	5	585	585	NUM
dpc-2075	294	6	.	.	PUNCT
dpc-2075	295	1	doi	doi	NOUN
dpc-2075	295	2	:	:	PUNCT
dpc-2075	295	3	10.1111	10.1111	NUM
dpc-2075	295	4	/	/	SYM
dpc-2075	295	5	j.1524	j.1524	NOUN
dpc-2075	295	6	-	-	PUNCT
dpc-2075	295	7	4725.2009.01095.x	4725.2009.01095.x	NOUN
dpc-2075	295	8	.	.	PUNCT
dpc-2075	296	1	pmid	pmid	NOUN
dpc-2075	296	2	:	:	PUNCT
dpc-2075	296	3	19415791	19415791	NUM
dpc-2075	296	4	.	.	PUNCT
dpc-2075	297	1	26	26	NUM
dpc-2075	297	2	.	.	PUNCT
dpc-2075	298	1	raza	raza	PROPN
dpc-2075	298	2	sm	sm	PROPN
dpc-2075	298	3	et	et	PROPN
dpc-2075	298	4	al	al	PROPN
dpc-2075	298	5	.	.	PROPN
dpc-2075	299	1	nonmelanoma	nonmelanoma	PROPN
dpc-2075	299	2	cutaneous	cutaneous	ADJ
dpc-2075	299	3	cancers	cancer	NOUN
dpc-2075	299	4	involving	involve	VERB
dpc-2075	299	5	the	the	DET
dpc-2075	299	6	skull	skull	NOUN
dpc-2075	299	7	base	base	NOUN
dpc-2075	299	8	:	:	PUNCT
dpc-2075	299	9	outcomes	outcome	NOUN
dpc-2075	299	10	of	of	ADP
dpc-2075	299	11	aggressive	aggressive	ADJ
dpc-2075	299	12	multimodal	multimodal	NOUN
dpc-2075	299	13	management	management	NOUN
dpc-2075	299	14	.	.	PUNCT
dpc-2075	300	1	j	j	PROPN
dpc-2075	300	2	neurosurg	neurosurg	PROPN
dpc-2075	300	3	.	.	PUNCT
dpc-2075	301	1	2015;123(3):781–788	2015;123(3):781–788	X
dpc-2075	301	2	.	.	X
dpc-2075	301	3	doi	doi	NOUN
dpc-2075	301	4	:	:	PUNCT
dpc-2075	301	5	10.3171/2014.10	10.3171/2014.10	ADJ
dpc-2075	301	6	.	.	PUNCT
dpc-2075	302	1	jns141037.pmid	jns141037.pmid	NOUN
dpc-2075	302	2	:	:	PUNCT
dpc-2075	302	3	25909577	25909577	NUM
dpc-2075	302	4	.	.	PUNCT
dpc-2075	303	1	27	27	NUM
dpc-2075	303	2	.	.	PUNCT
dpc-2075	304	1	cuperus	cuperus	PROPN
dpc-2075	304	2	e	e	NOUN
dpc-2075	304	3	,	,	PUNCT
dpc-2075	304	4	leguit	leguit	NOUN
dpc-2075	304	5	r	r	NOUN
dpc-2075	304	6	,	,	PUNCT
dpc-2075	304	7	albregts	albregts	PROPN
dpc-2075	304	8	m	m	PROPN
dpc-2075	304	9	,	,	PUNCT
dpc-2075	304	10	toonstra	toonstra	PROPN
dpc-2075	304	11	j.	j.	PROPN
dpc-2075	304	12	post	post	PROPN
dpc-2075	304	13	radiation	radiation	NOUN
dpc-2075	304	14	skin	skin	NOUN
dpc-2075	304	15	tumors	tumor	NOUN
dpc-2075	304	16	:	:	PUNCT
dpc-2075	304	17	basal	basal	ADJ
dpc-2075	304	18	cell	cell	NOUN
dpc-2075	304	19	carcinomas	carcinoma	NOUN
dpc-2075	304	20	,	,	PUNCT
dpc-2075	304	21	squamous	squamous	ADJ
dpc-2075	304	22	cell	cell	NOUN
dpc-2075	304	23	carcinomas	carcinoma	NOUN
dpc-2075	304	24	and	and	CCONJ
dpc-2075	304	25	angiosarcomas	angiosarcoma	NOUN
dpc-2075	304	26	.	.	PUNCT
dpc-2075	305	1	a	a	DET
dpc-2075	305	2	review	review	NOUN
dpc-2075	305	3	of	of	ADP
dpc-2075	305	4	this	this	DET
dpc-2075	305	5	late	late	ADJ
dpc-2075	305	6	effect	effect	NOUN
dpc-2075	305	7	of	of	ADP
dpc-2075	305	8	radiotherapy	radiotherapy	NOUN
dpc-2075	305	9	.	.	PUNCT
dpc-2075	306	1	eur	eur	PROPN
dpc-2075	306	2	j	j	PROPN
dpc-2075	306	3	dermatol	dermatol	NOUN
dpc-2075	306	4	.	.	PUNCT
dpc-2075	307	1	2013;23(6):749–757	2013;23(6):749–757	NOUN
dpc-2075	307	2	.	.	PUNCT
dpc-2075	307	3	doi	doi	NOUN
dpc-2075	307	4	:	:	PUNCT
dpc-2075	307	5	10.1684	10.1684	NUM
dpc-2075	307	6	/	/	SYM
dpc-2075	307	7	ejd.2013.2106	ejd.2013.2106	NUM
dpc-2075	307	8	.	.	PUNCT
dpc-2075	308	1	pmid	pmid	NOUN
dpc-2075	308	2	:	:	PUNCT
dpc-2075	308	3	24153098	24153098	NUM
dpc-2075	308	4	.	.	PUNCT
dpc-2075	309	1	28	28	NUM
dpc-2075	309	2	.	.	PUNCT
dpc-2075	310	1	mierzwa	mierzwa	PROPN
dpc-2075	310	2	ml	ml	PROPN
dpc-2075	310	3	.	.	PUNCT
dpc-2075	311	1	radiotherapy	radiotherapy	NOUN
dpc-2075	311	2	for	for	ADP
dpc-2075	311	3	skin	skin	NOUN
dpc-2075	311	4	cancers	cancer	NOUN
dpc-2075	311	5	of	of	ADP
dpc-2075	311	6	the	the	DET
dpc-2075	311	7	face	face	NOUN
dpc-2075	311	8	,	,	PUNCT
dpc-2075	311	9	head	head	NOUN
dpc-2075	311	10	,	,	PUNCT
dpc-2075	311	11	and	and	CCONJ
dpc-2075	311	12	neck	neck	NOUN
dpc-2075	311	13	.	.	PUNCT
dpc-2075	312	1	facial	facial	ADJ
dpc-2075	312	2	plast	plast	PROPN
dpc-2075	312	3	surg	surg	PROPN
dpc-2075	312	4	clin	clin	PROPN
dpc-2075	312	5	north	north	PROPN
dpc-2075	312	6	am	am	PROPN
dpc-2075	312	7	.	.	PUNCT
dpc-2075	313	1	2019	2019	NUM
dpc-2075	313	2	;	;	PUNCT
dpc-2075	313	3	27(1):131–138	27(1):131–138	PROPN
dpc-2075	313	4	.	.	PUNCT
dpc-2075	313	5	doi	doi	PROPN
dpc-2075	313	6	:	:	PUNCT
dpc-2075	313	7	10.1016	10.1016	NUM
dpc-2075	313	8	/	/	SYM
dpc-2075	313	9	j.fsc.2018.08.005	j.fsc.2018.08.005	PROPN
dpc-2075	313	10	.	.	PUNCT
dpc-2075	314	1	pmid	pmid	NOUN
dpc-2075	314	2	:	:	PUNCT
dpc-2075	314	3	30420066	30420066	NUM
dpc-2075	314	4	.	.	PUNCT
dpc-2075	315	1	29	29	NUM
dpc-2075	315	2	.	.	PUNCT
dpc-2075	316	1	garbutcheon	garbutcheon	NOUN
dpc-2075	316	2	-	-	PUNCT
dpc-2075	316	3	singh	singh	PROPN
dpc-2075	316	4	kb	kb	PROPN
dpc-2075	316	5	,	,	PUNCT
dpc-2075	316	6	veness	veness	NOUN
dpc-2075	316	7	,	,	PUNCT
dpc-2075	316	8	mj	mj	PROPN
dpc-2075	316	9	.	.	PUNCT
dpc-2075	317	1	the	the	DET
dpc-2075	317	2	role	role	NOUN
dpc-2075	317	3	of	of	ADP
dpc-2075	317	4	radiotherapy	radiotherapy	NOUN
dpc-2075	317	5	in	in	ADP
dpc-2075	317	6	the	the	DET
dpc-2075	317	7	management	management	NOUN
dpc-2075	317	8	of	of	ADP
dpc-2075	317	9	non	non	ADJ
dpc-2075	317	10	-	-	ADJ
dpc-2075	317	11	melanoma	melanoma	ADJ
dpc-2075	317	12	skin	skin	NOUN
dpc-2075	317	13	cancer	cancer	NOUN
dpc-2075	317	14	.	.	PUNCT
dpc-2075	318	1	australas	australas	PROPN
dpc-2075	318	2	j	j	PROPN
dpc-2075	318	3	dermatol	dermatol	NOUN
dpc-2075	318	4	.	.	PUNCT
dpc-2075	319	1	2019;60(4):265–272	2019;60(4):265–272	NUM
dpc-2075	319	2	.	.	PUNCT
dpc-2075	319	3	doi:10.1111	doi:10.1111	ADJ
dpc-2075	319	4	/	/	SYM
dpc-2075	319	5	ajd.13025	ajd.13025	PROPN
dpc-2075	319	6	.	.	PUNCT
dpc-2075	320	1	pmid	pmid	NOUN
dpc-2075	320	2	:	:	PUNCT
dpc-2075	320	3	30931531	30931531	NUM
dpc-2075	320	4	.	.	PUNCT
dpc-2075	321	1	30	30	NUM
dpc-2075	321	2	.	.	PUNCT
dpc-2075	322	1	buchanan	buchanan	PROPN
dpc-2075	322	2	ma	ma	PROPN
dpc-2075	322	3	,	,	PUNCT
dpc-2075	322	4	levin	levin	PROPN
dpc-2075	322	5	b	b	PROPN
dpc-2075	322	6	,	,	PUNCT
dpc-2075	322	7	veness	veness	ADJ
dpc-2075	322	8	m.	m.	NOUN
dpc-2075	322	9	non	non	ADJ
dpc-2075	322	10	-	-	ADJ
dpc-2075	322	11	melanoma	melanoma	ADJ
dpc-2075	322	12	skin	skin	NOUN
dpc-2075	322	13	cancer	cancer	NOUN
dpc-2075	322	14	:	:	PUNCT
dpc-2075	322	15	primary	primary	ADJ
dpc-2075	322	16	non	non	ADJ
dpc-2075	322	17	-	-	ADJ
dpc-2075	322	18	surgical	surgical	ADJ
dpc-2075	322	19	therapies	therapy	NOUN
dpc-2075	322	20	and	and	CCONJ
dpc-2075	322	21	prevention	prevention	NOUN
dpc-2075	322	22	strategies	strategy	NOUN
dpc-2075	322	23	.	.	PUNCT
dpc-2075	323	1	in	in	ADP
dpc-2075	323	2	:	:	PUNCT
dpc-2075	323	3	non	non	ADJ
dpc-2075	323	4	-	-	ADJ
dpc-2075	323	5	melanoma	melanoma	ADJ
dpc-2075	323	6	skin	skin	NOUN
dpc-2075	323	7	cancer	cancer	NOUN
dpc-2075	323	8	of	of	ADP
dpc-2075	323	9	the	the	DET
dpc-2075	323	10	head	head	NOUN
dpc-2075	323	11	and	and	CCONJ
dpc-2075	323	12	neck	neck	NOUN
dpc-2075	323	13	.	.	PUNCT
dpc-2075	324	1	springer	springer	PROPN
dpc-2075	324	2	india	india	PROPN
dpc-2075	324	3	.	.	PROPN
dpc-2075	325	1	2015	2015	NUM
dpc-2075	325	2	.	.	PUNCT
dpc-2075	326	1	pp	pp	ADP
dpc-2075	326	2	37–51	37–51	NUM
dpc-2075	326	3	.	.	PUNCT
dpc-2075	327	1	doi	doi	NOUN
dpc-2075	327	2	:	:	PUNCT
dpc-2075	327	3	10.1007/978	10.1007/978	NUM
dpc-2075	327	4	-	-	SYM
dpc-2075	327	5	81	81	NUM
dpc-2075	327	6	-	-	PUNCT
dpc-2075	327	7	322	322	NUM
dpc-2075	327	8	-	-	PUNCT
dpc-2075	327	9	2497	2497	NUM
dpc-2075	327	10	-	-	SYM
dpc-2075	327	11	6_4	6_4	NUM
dpc-2075	327	12	.	.	PUNCT
dpc-2075	328	1	pmid	pmid	NOUN
dpc-2075	328	2	:	:	PUNCT
dpc-2075	328	3	26995368	26995368	NUM
dpc-2075	328	4	.	.	PUNCT
dpc-2075	329	1	31	31	NUM
dpc-2075	329	2	.	.	PUNCT
dpc-2075	329	3	veness	veness	PROPN
dpc-2075	329	4	m.	m.	PROPN
dpc-2075	329	5	hypofractionated	hypofractionate	VERB
dpc-2075	329	6	radiotherapy	radiotherapy	NOUN
dpc-2075	329	7	in	in	ADP
dpc-2075	329	8	older	old	ADJ
dpc-2075	329	9	patients	patient	NOUN
dpc-2075	329	10	with	with	ADP
dpc-2075	329	11	non	non	ADJ
dpc-2075	329	12	-	-	ADJ
dpc-2075	329	13	melanoma	melanoma	ADJ
dpc-2075	329	14	skin	skin	NOUN
dpc-2075	329	15	cancer	cancer	NOUN
dpc-2075	329	16	:	:	PUNCT
dpc-2075	329	17	less	less	ADJ
dpc-2075	329	18	is	be	AUX
dpc-2075	329	19	better	well	ADJ
dpc-2075	329	20	.	.	PUNCT
dpc-2075	330	1	australas	australas	PROPN
dpc-2075	330	2	j	j	PROPN
dpc-2075	330	3	dermatol	dermatol	NOUN
dpc-2075	330	4	.	.	PUNCT
dpc-2075	331	1	2018;59(2):124–127	2018;59(2):124–127	X
dpc-2075	331	2	.	.	PUNCT
dpc-2075	332	1	doi	doi	NOUN
dpc-2075	332	2	:	:	PUNCT
dpc-2075	332	3	10.1111	10.1111	NUM
dpc-2075	332	4	/	/	SYM
dpc-2075	332	5	ajd.12609.pmid	ajd.12609.pmid	NOUN
dpc-2075	332	6	:	:	PUNCT
dpc-2075	332	7	28294289	28294289	NUM
dpc-2075	332	8	.	.	PUNCT
dpc-2075	333	1	32	32	NUM
dpc-2075	333	2	.	.	PUNCT
dpc-2075	334	1	gunaratne	gunaratne	PROPN
dpc-2075	334	2	da	da	PROPN
dpc-2075	334	3	,	,	PUNCT
dpc-2075	334	4	veness	veness	PROPN
dpc-2075	334	5	mj	mj	PROPN
dpc-2075	334	6	.	.	PROPN
dpc-2075	334	7	efficacy	efficacy	PROPN
dpc-2075	334	8	of	of	ADP
dpc-2075	334	9	hypofractionated	hypofractionate	VERB
dpc-2075	334	10	radiotherapy	radiotherapy	NOUN
dpc-2075	334	11	in	in	ADP
dpc-2075	334	12	patients	patient	NOUN
dpc-2075	334	13	with	with	ADP
dpc-2075	334	14	non	non	ADJ
dpc-2075	334	15	-	-	ADJ
dpc-2075	334	16	melanoma	melanoma	ADJ
dpc-2075	334	17	skin	skin	NOUN
dpc-2075	334	18	cancer	cancer	NOUN
dpc-2075	334	19	:	:	PUNCT
dpc-2075	334	20	results	result	NOUN
dpc-2075	334	21	of	of	ADP
dpc-2075	334	22	a	a	DET
dpc-2075	334	23	systematic	systematic	ADJ
dpc-2075	334	24	review	review	NOUN
dpc-2075	334	25	.	.	PUNCT
dpc-2075	335	1	j	j	PROPN
dpc-2075	335	2	med	med	PROPN
dpc-2075	335	3	imaging	imaging	PROPN
dpc-2075	335	4	radiat	radiat	PROPN
dpc-2075	335	5	oncol	oncol	ADJ
dpc-2075	335	6	.	.	PUNCT
dpc-2075	336	1	2018;62(3):401	2018;62(3):401	NUM
dpc-2075	336	2	–	–	PUNCT
dpc-2075	336	3	411	411	NUM
dpc-2075	336	4	.	.	PUNCT
dpc-2075	337	1	doi	doi	NOUN
dpc-2075	337	2	:	:	PUNCT
dpc-2075	337	3	10.1111/1754	10.1111/1754	NUM
dpc-2075	337	4	-	-	PUNCT
dpc-2075	337	5	9485.12718.pmid	9485.12718.pmid	NUM
dpc-2075	337	6	:	:	PUNCT
dpc-2075	337	7	29524319	29524319	NUM
dpc-2075	337	8	.	.	PUNCT
dpc-2075	338	1	33	33	NUM
dpc-2075	338	2	.	.	X
dpc-2075	338	3	zaorsky	zaorsky	PROPN
dpc-2075	338	4	ng	ng	PROPN
dpc-2075	338	5	,	,	PUNCT
dpc-2075	338	6	lee	lee	PROPN
dpc-2075	338	7	ct	ct	PROPN
dpc-2075	338	8	,	,	PUNCT
dpc-2075	338	9	zhang	zhang	PROPN
dpc-2075	338	10	e	e	PROPN
dpc-2075	338	11	,	,	PUNCT
dpc-2075	338	12	keith	keith	PROPN
dpc-2075	338	13	sw	sw	PROPN
dpc-2075	338	14	,	,	PUNCT
dpc-2075	338	15	galloway	galloway	PROPN
dpc-2075	338	16	tj	tj	PROPN
dpc-2075	338	17	.	.	PROPN
dpc-2075	338	18	hypofractionated	hypofractionate	VERB
dpc-2075	338	19	radiation	radiation	NOUN
dpc-2075	338	20	therapy	therapy	NOUN
dpc-2075	338	21	for	for	ADP
dpc-2075	338	22	basal	basal	ADJ
dpc-2075	338	23	and	and	CCONJ
dpc-2075	338	24	squamous	squamous	ADJ
dpc-2075	338	25	cell	cell	NOUN
dpc-2075	338	26	skin	skin	NOUN
dpc-2075	338	27	cancer	cancer	NOUN
dpc-2075	338	28	:	:	PUNCT
dpc-2075	338	29	a	a	DET
dpc-2075	338	30	meta	meta	ADJ
dpc-2075	338	31	-	-	PUNCT
dpc-2075	338	32	analysis	analysis	NOUN
dpc-2075	338	33	.	.	PUNCT
dpc-2075	339	1	radiother	radiother	PROPN
dpc-2075	339	2	oncol	oncol	PROPN
dpc-2075	339	3	.	.	PUNCT
dpc-2075	340	1	2017;125(1):13–20	2017;125(1):13–20	X
dpc-2075	340	2	.	.	PUNCT
dpc-2075	340	3	doi	doi	NOUN
dpc-2075	340	4	:	:	PUNCT
dpc-2075	340	5	10.1016	10.1016	NUM
dpc-2075	340	6	/	/	SYM
dpc-2075	340	7	j.radonc.2017.08.011	j.radonc.2017.08.011	PROPN
dpc-2075	340	8	.	.	PUNCT
dpc-2075	341	1	pmid	pmid	NOUN
dpc-2075	341	2	:	:	PUNCT
dpc-2075	341	3	28843727	28843727	NUM
dpc-2075	341	4	.	.	PUNCT
dpc-2075	342	1	34	34	NUM
dpc-2075	342	2	.	.	PUNCT
dpc-2075	343	1	gupta	gupta	PROPN
dpc-2075	343	2	.	.	PUNCT
dpc-2075	344	1	brachytherapy	brachytherapy	NOUN
dpc-2075	344	2	past	past	NOUN
dpc-2075	344	3	,	,	PUNCT
dpc-2075	344	4	present	present	ADJ
dpc-2075	344	5	and	and	CCONJ
dpc-2075	344	6	future	future	NOUN
dpc-2075	344	7	.	.	PUNCT
dpc-2075	345	1	undefined	undefined	ADJ
dpc-2075	345	2	.	.	PUNCT
dpc-2075	346	1	1995	1995	NUM
dpc-2075	346	2	.	.	PUNCT
dpc-2075	347	1	accessed	access	VERB
dpc-2075	347	2	:	:	PUNCT
dpc-2075	347	3	may	may	AUX
dpc-2075	347	4	23	23	NUM
dpc-2075	347	5	,	,	PUNCT
dpc-2075	347	6	2021	2021	NUM
dpc-2075	347	7	.	.	PUNCT
dpc-2075	348	1	/paper	/paper	NOUN
dpc-2075	348	2	/	/	SYM
dpc-2075	348	3	brachytherapy	brachytherapy	NOUN
dpc-2075	348	4	-	-	PUNCT
dpc-2075	348	5	past%2c	past%2c	NOUN
dpc-2075	348	6	-	-	PUNCT
dpc-2075	348	7	present	present	NOUN
dpc-2075	348	8	-	-	PUNCT
dpc-2075	348	9	and	and	CCONJ
dpc-2075	348	10	-	-	PUNCT
dpc-2075	348	11	future	future	NOUN
dpc-2075	348	12	-	-	PUNCT
dpc-2075	348	13	gupta/2d86234c7db52e9ecb3386f5fcffb96205e82703	gupta/2d86234c7db52e9ecb3386f5fcffb96205e82703	NOUN
dpc-2075	348	14	;	;	PUNCT
dpc-2075	348	15	https://inis.iaea.org/search/search.aspx?orig	https://inis.iaea.org/search/search.aspx?orig	NOUN
dpc-2075	348	16	_	_	PRON
dpc-2075	348	17	q	q	X
dpc-2075	349	1	=	=	X
dpc-2075	349	2	rn:28030553	rn:28030553	NUM
dpc-2075	349	3	35	35	NUM
dpc-2075	349	4	.	.	PUNCT
dpc-2075	350	1	sabbas	sabbas	PROPN
dpc-2075	350	2	am	am	PROPN
dpc-2075	350	3	,	,	PUNCT
dpc-2075	350	4	kulidzhanov	kulidzhanov	PROPN
dpc-2075	350	5	fg	fg	PROPN
dpc-2075	350	6	,	,	PUNCT
dpc-2075	350	7	presser	presser	PROPN
dpc-2075	350	8	j	j	PROPN
dpc-2075	350	9	,	,	PUNCT
dpc-2075	350	10	hayes	hayes	PROPN
dpc-2075	350	11	mk	mk	PROPN
dpc-2075	350	12	,	,	PUNCT
dpc-2075	350	13	nori	nori	PROPN
dpc-2075	350	14	d.	d.	PROPN
dpc-2075	350	15	hdr	hdr	PROPN
dpc-2075	350	16	brachytherapy	brachytherapy	NOUN
dpc-2075	350	17	with	with	ADP
dpc-2075	350	18	surface	surface	NOUN
dpc-2075	350	19	applicators	applicator	NOUN
dpc-2075	350	20	:	:	PUNCT
dpc-2075	350	21	technical	technical	ADJ
dpc-2075	350	22	considerations	consideration	NOUN
dpc-2075	350	23	and	and	CCONJ
dpc-2075	350	24	dosimetry	dosimetry	NOUN
dpc-2075	350	25	.	.	PUNCT
dpc-2075	351	1	technol	technol	ADJ
dpc-2075	351	2	cancer	cancer	NOUN
dpc-2075	351	3	res	re	NOUN
dpc-2075	351	4	treat	treat	NOUN
dpc-2075	351	5	.	.	PUNCT
dpc-2075	352	1	2004	2004	NUM
dpc-2075	352	2	;	;	PUNCT
dpc-2075	352	3	3(3):259	3(3):259	NUM
dpc-2075	352	4	–	–	PUNCT
dpc-2075	352	5	267doi	267doi	NUM
dpc-2075	352	6	:	:	PUNCT
dpc-2075	352	7	10.1177/153303460400300304	10.1177/153303460400300304	NUM
dpc-2075	352	8	.	.	PUNCT
dpc-2075	353	1	pmid	pmid	NOUN
dpc-2075	353	2	:	:	PUNCT
dpc-2075	353	3	15161319	15161319	NUM
dpc-2075	353	4	.	.	PUNCT
dpc-2075	354	1	36	36	NUM
dpc-2075	354	2	.	.	PUNCT
dpc-2075	355	1	ouhib	ouhib	NOUN
dpc-2075	355	2	z	z	PROPN
dpc-2075	355	3	et	et	PROPN
dpc-2075	355	4	al	al	PROPN
dpc-2075	355	5	.	.	PUNCT
dpc-2075	356	1	aspects	aspect	NOUN
dpc-2075	356	2	of	of	ADP
dpc-2075	356	3	dosimetry	dosimetry	NOUN
dpc-2075	356	4	and	and	CCONJ
dpc-2075	356	5	clinical	clinical	ADJ
dpc-2075	356	6	practice	practice	NOUN
dpc-2075	356	7	of	of	ADP
dpc-2075	356	8	skin	skin	NOUN
dpc-2075	356	9	brachytherapy	brachytherapy	NOUN
dpc-2075	356	10	:	:	PUNCT
dpc-2075	356	11	the	the	DET
dpc-2075	356	12	american	american	PROPN
dpc-2075	356	13	brachytherapy	brachytherapy	PROPN
dpc-2075	356	14	society	society	PROPN
dpc-2075	356	15	working	working	PROPN
dpc-2075	356	16	group	group	NOUN
dpc-2075	356	17	report	report	NOUN
dpc-2075	356	18	.	.	PUNCT
dpc-2075	357	1	brachytherapy	brachytherapy	NOUN
dpc-2075	357	2	.	.	PUNCT
dpc-2075	358	1	2015;14(6):840–858	2015;14(6):840–858	X
dpc-2075	358	2	.	.	PUNCT
dpc-2075	358	3	doi	doi	NOUN
dpc-2075	358	4	:	:	PUNCT
dpc-2075	358	5	10.1016	10.1016	NUM
dpc-2075	358	6	/	/	SYM
dpc-2075	358	7	j.brachy.2015.06.005	j.brachy.2015.06.005	PROPN
dpc-2075	358	8	.	.	PUNCT
dpc-2075	359	1	pmid	pmid	NOUN
dpc-2075	359	2	:	:	PUNCT
dpc-2075	359	3	26319367	26319367	NUM
dpc-2075	359	4	.	.	PUNCT
dpc-2075	360	1	37	37	NUM
dpc-2075	360	2	.	.	PUNCT
dpc-2075	361	1	bhatnagar	bhatnagar	PROPN
dpc-2075	361	2	a.	a.	PROPN
dpc-2075	361	3	nonmelanoma	nonmelanoma	PROPN
dpc-2075	361	4	skin	skin	NOUN
dpc-2075	361	5	cancer	cancer	NOUN
dpc-2075	361	6	treated	treat	VERB
dpc-2075	361	7	with	with	ADP
dpc-2075	361	8	electronic	electronic	ADJ
dpc-2075	361	9	brachytherapy	brachytherapy	NOUN
dpc-2075	361	10	:	:	PUNCT
dpc-2075	361	11	results	result	NOUN
dpc-2075	361	12	at	at	ADP
dpc-2075	361	13	1	1	NUM
dpc-2075	361	14	year	year	NOUN
dpc-2075	361	15	.	.	PUNCT
dpc-2075	362	1	brachytherapy	brachytherapy	NOUN
dpc-2075	362	2	.	.	PUNCT
dpc-2075	363	1	2013;12(2):134	2013;12(2):134	NUM
dpc-2075	363	2	–	–	PUNCT
dpc-2075	363	3	140	140	NUM
dpc-2075	363	4	.	.	PUNCT
dpc-2075	363	5	doi	doi	NOUN
dpc-2075	363	6	:	:	PUNCT
dpc-2075	363	7	10.1016	10.1016	NUM
dpc-2075	363	8	/	/	SYM
dpc-2075	363	9	j.brachy.2012.08.003	j.brachy.2012.08.003	NOUN
dpc-2075	363	10	.	.	PUNCT
dpc-2075	364	1	pmid	pmid	NOUN
dpc-2075	364	2	:	:	PUNCT
dpc-2075	364	3	23312675	23312675	NUM
dpc-2075	364	4	.	.	PUNCT
dpc-2075	365	1	38	38	NUM
dpc-2075	365	2	.	.	PUNCT
dpc-2075	366	1	ballester	ballester	NOUN
dpc-2075	366	2	-	-	PUNCT
dpc-2075	366	3	sánchez	sánchez	NOUN
dpc-2075	366	4	r	r	NOUN
dpc-2075	366	5	et	et	PROPN
dpc-2075	366	6	al	al	PROPN
dpc-2075	366	7	.	.	PROPN
dpc-2075	366	8	electronic	electronic	ADJ
dpc-2075	366	9	brachytherapy	brachytherapy	NOUN
dpc-2075	366	10	for	for	ADP
dpc-2075	366	11	superficial	superficial	ADJ
dpc-2075	366	12	and	and	CCONJ
dpc-2075	366	13	nodular	nodular	ADJ
dpc-2075	366	14	basal	basal	NOUN
dpc-2075	366	15	cell	cell	NOUN
dpc-2075	366	16	carcinoma	carcinoma	NOUN
dpc-2075	366	17	:	:	PUNCT
dpc-2075	366	18	a	a	DET
dpc-2075	366	19	report	report	NOUN
dpc-2075	366	20	of	of	ADP
dpc-2075	366	21	two	two	NUM
dpc-2075	366	22	prospective	prospective	ADJ
dpc-2075	366	23	pilot	pilot	NOUN
dpc-2075	366	24	trials	trial	NOUN
dpc-2075	366	25	using	use	VERB
dpc-2075	366	26	different	different	ADJ
dpc-2075	366	27	doses	dose	NOUN
dpc-2075	366	28	.	.	PUNCT
dpc-2075	367	1	j	j	PROPN
dpc-2075	367	2	contemp	contemp	PROPN
dpc-2075	367	3	brachytherapy	brachytherapy	NOUN
dpc-2075	367	4	.	.	PUNCT
dpc-2075	368	1	2016;8(1):48–55	2016;8(1):48–55	X
dpc-2075	368	2	.	.	PUNCT
dpc-2075	369	1	doi	doi	NOUN
dpc-2075	369	2	:	:	PUNCT
dpc-2075	369	3	10.5114	10.5114	NUM
dpc-2075	369	4	/	/	SYM
dpc-2075	369	5	jcb.2016.57531	jcb.2016.57531	PROPN
dpc-2075	369	6	.	.	PUNCT
dpc-2075	370	1	pmid	pmid	NOUN
dpc-2075	370	2	:	:	PUNCT
dpc-2075	370	3	26985197	26985197	NUM
dpc-2075	370	4	.	.	PUNCT
dpc-2075	371	1	39	39	NUM
dpc-2075	371	2	.	.	PUNCT
dpc-2075	372	1	ramachandran	ramachandran	PROPN
dpc-2075	372	2	p.	p.	PROPN
dpc-2075	372	3	new	new	ADJ
dpc-2075	372	4	era	era	NOUN
dpc-2075	372	5	of	of	ADP
dpc-2075	372	6	electronic	electronic	ADJ
dpc-2075	372	7	brachytherapy	brachytherapy	NOUN
dpc-2075	372	8	.	.	PUNCT
dpc-2075	373	1	world	world	PROPN
dpc-2075	373	2	j	j	PROPN
dpc-2075	373	3	radiol	radiol	PROPN
dpc-2075	373	4	.	.	PUNCT
dpc-2075	374	1	2017;9(4):148–154	2017;9(4):148–154	X
dpc-2075	374	2	.	.	X
dpc-2075	374	3	doi	doi	NOUN
dpc-2075	374	4	:	:	PUNCT
dpc-2075	374	5	10.4329	10.4329	NUM
dpc-2075	374	6	/	/	SYM
dpc-2075	374	7	wjr.v9.i4.148	wjr.v9.i4.148	PROPN
dpc-2075	374	8	.	.	PUNCT
dpc-2075	375	1	pmid	pmid	NOUN
dpc-2075	375	2	:	:	PUNCT
dpc-2075	375	3	28529679	28529679	NUM
dpc-2075	375	4	.	.	PUNCT
dpc-2075	376	1	40	40	NUM
dpc-2075	376	2	.	.	PUNCT
dpc-2075	377	1	tom	tom	PROPN
dpc-2075	377	2	mc	mc	PROPN
dpc-2075	377	3	et	et	PROPN
dpc-2075	377	4	al	al	PROPN
dpc-2075	377	5	.	.	PUNCT
dpc-2075	378	1	the	the	DET
dpc-2075	378	2	american	american	PROPN
dpc-2075	378	3	brachytherapy	brachytherapy	PROPN
dpc-2075	378	4	society	society	NOUN
dpc-2075	378	5	consensus	consensus	NOUN
dpc-2075	378	6	statement	statement	NOUN
dpc-2075	378	7	for	for	ADP
dpc-2075	378	8	electronic	electronic	ADJ
dpc-2075	378	9	brachytherapy	brachytherapy	NOUN
dpc-2075	378	10	.	.	PUNCT
dpc-2075	379	1	brachytherapy	brachytherapy	NOUN
dpc-2075	379	2	.	.	PUNCT
dpc-2075	380	1	2019;18(3):292–298.doi	2019;18(3):292–298.doi	NUM
dpc-2075	380	2	:	:	PUNCT
dpc-2075	380	3	10.1016	10.1016	NUM
dpc-2075	380	4	/	/	SYM
dpc-2075	380	5	j.brachy.2018.10.006	j.brachy.2018.10.006	X
dpc-2075	380	6	.	.	PUNCT
dpc-2075	381	1	pmid	pmid	NOUN
dpc-2075	381	2	:	:	PUNCT
dpc-2075	381	3	30497939	30497939	NUM
dpc-2075	381	4	.	.	PUNCT
dpc-2075	382	1	41	41	NUM
dpc-2075	382	2	.	.	PUNCT
dpc-2075	383	1	khan	khan	PROPN
dpc-2075	383	2	l	l	PROPN
dpc-2075	383	3	et	et	PROPN
dpc-2075	383	4	al	al	PROPN
dpc-2075	383	5	.	.	PUNCT
dpc-2075	384	1	recommendations	recommendation	NOUN
dpc-2075	384	2	for	for	ADP
dpc-2075	384	3	ctv	ctv	PROPN
dpc-2075	384	4	margins	margin	NOUN
dpc-2075	384	5	in	in	ADP
dpc-2075	384	6	radiotherapy	radiotherapy	NOUN
dpc-2075	384	7	planning	planning	NOUN
dpc-2075	384	8	for	for	ADP
dpc-2075	384	9	non	non	PRON
dpc-2075	384	10	melanoma	melanoma	NOUN
dpc-2075	384	11	skin	skin	NOUN
dpc-2075	384	12	cancer	cancer	NOUN
dpc-2075	384	13	.	.	PUNCT
dpc-2075	385	1	radiother	radiother	PROPN
dpc-2075	385	2	oncol	oncol	PROPN
dpc-2075	385	3	.	.	PUNCT
dpc-2075	386	1	2012;104(2):263–266	2012;104(2):263–266	X
dpc-2075	386	2	.	.	PUNCT
dpc-2075	387	1	doi	doi	NOUN
dpc-2075	387	2	:	:	PUNCT
dpc-2075	387	3	10.1016	10.1016	NUM
dpc-2075	387	4	/	/	SYM
dpc-2075	387	5	j.radonc.2012.06.013	j.radonc.2012.06.013	PROPN
dpc-2075	387	6	.	.	PUNCT
dpc-2075	388	1	pmid	pmid	NOUN
dpc-2075	388	2	:	:	PUNCT
dpc-2075	388	3	22857860	22857860	NUM
dpc-2075	388	4	.	.	PUNCT